Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,A1BG,Alpha-1B-glycoprotein,21296,58,0.42 [0.11-1.67],0.2181473668836697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AAMDC,Mth938 domain-containing protein,20682,56,0.88 [0.54-1.43],0.5955522288435755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AARSD1,Alanyl-tRNA editing protein Aarsd1,24399,63,1.01 [0.68-1.51],0.9528206238087772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABCA2,ATP-binding cassette sub-family A member 2,20607,56,0.85 [0.41-1.78],0.6624989916060566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABHD14B,Protein ABHD14B,24276,64,0.93 [0.63-1.36],0.6937944906901552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABL1,Tyrosine-protein kinase ABL1,24399,63,0.80 [0.57-1.13],0.2143569777177209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABO,Histo-blood group ABO system transferase,21274,56,1.04 [0.88-1.25],0.6269541718311433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABRAXAS2,BRISC complex subunit Abraxas 2,20607,56,0.81 [0.55-1.21],0.3106515355724463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",23935,64,0.85 [0.64-1.12],0.2510619008041901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",20866,52,0.83 [0.53-1.32],0.4376361757959088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",21270,57,0.90 [0.67-1.20],0.4767311041843871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAN,Aggrecan core protein,24303,64,0.77 [0.35-1.69],0.5093819552790996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE,Angiotensin-converting enzyme,21274,56,1.73 [0.65-4.65],0.2730468344178842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE2,Angiotensin-converting enzyme 2,24088,63,0.99 [0.63-1.55],0.9573278929927004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACHE,Acetylcholinesterase,20790,55,0.65 [0.29-1.46],0.2958668639702833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOT13,Acyl-coenzyme A thioesterase 13,21177,56,0.90 [0.72-1.13],0.3706214470764908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,24532,66,0.53 [0.33-0.87],0.0111334446463469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP1,Low molecular weight phosphotyrosine protein phosphatase,20661,55,0.61 [0.32-1.15],0.1265971444767006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP5,Tartrate-resistant acid phosphatase type 5,24603,66,0.88 [0.45-1.70],0.6975411554337072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP6,Lysophosphatidic acid phosphatase type 6,24708,66,0.93 [0.68-1.27],0.6495525731224094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRBP,Acrosin-binding protein,21153,56,1.18 [0.62-2.27],0.6127240109367014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRV1,Acrosomal protein SP-10,20661,55,1.09 [0.79-1.50],0.6065436284599646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACSL1,Long-chain-fatty-acid--CoA ligase 1,20607,56,0.83 [0.38-1.82],0.645483829685016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTA2,"Actin, aortic smooth muscle",24088,63,1.32 [0.87-2.02],0.1961905446118435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN2,Alpha-actinin-2,20607,56,1.32 [0.92-1.90],0.1356252916707061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN4,Alpha-actinin-4,24074,64,0.69 [0.30-1.58],0.3746505869310973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACVRL1,Serine/threonine-protein kinase receptor R3,24322,64,1.46 [0.57-3.75],0.435779138763094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY1,Aminoacylase-1,24532,66,0.72 [0.50-1.04],0.0796812313071898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,20607,56,0.50 [0.32-0.78],0.0023253649262054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACYP1,Acylphosphatase-1,20711,55,0.81 [0.54-1.20],0.2948462852306378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA,Adenosine deaminase,24821,67,0.73 [0.39-1.39],0.3375693930979591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA2,Adenosine deaminase 2,24343,66,0.86 [0.50-1.47],0.5782488296747439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,20661,55,1.79 [1.24-2.60],0.0020539288059146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,24088,63,0.81 [0.39-1.68],0.5701420834288169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,24363,64,1.53 [0.80-2.90],0.1969975793327191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,24821,67,2.35 [1.18-4.66],0.0148289043557538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,24717,65,1.23 [0.56-2.68],0.6042252736877243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,21177,56,1.82 [0.87-3.81],0.1146485036033336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,20661,55,1.26 [0.61-2.62],0.5317456774668781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,24814,66,0.41 [0.17-0.98],0.0444776062112943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,24399,63,0.58 [0.40-0.86],0.0065061240098974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,24088,63,0.90 [0.43-1.88],0.7859883506398541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,20661,55,1.02 [0.50-2.06],0.9565804281358906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,24569,66,1.28 [0.80-2.06],0.3083893167804281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL2,ADAMTS-like protein 2,21263,58,0.35 [0.15-0.81],0.0141976201369298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL4,ADAMTS-like protein 4,20682,56,0.83 [0.29-2.44],0.7406825469417337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL5,ADAMTS-like protein 5,21270,57,1.03 [0.54-1.95],0.9394473791602824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,23935,64,0.93 [0.46-1.86],0.8268968421338632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADD1,Alpha-adducin,20790,55,0.81 [0.56-1.17],0.2554577039016391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRB3,Adhesion G protein-coupled receptor B3,24322,64,1.22 [0.63-2.36],0.5634857330891154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRD1,Adhesion G-protein coupled receptor D1,20790,55,0.83 [0.42-1.63],0.5872293978786911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE1,Adhesion G protein-coupled receptor E1,21177,56,1.05 [0.65-1.70],0.8263515673151882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE2,Adhesion G protein-coupled receptor E2,24614,65,0.92 [0.41-2.02],0.8270646785117645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE5,Adhesion G protein-coupled receptor E5,24677,66,0.94 [0.44-1.98],0.8648852691558763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRF5,Adhesion G protein-coupled receptor F5,21270,57,1.73 [0.73-4.14],0.2148460673602213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG1,Adhesion G-protein coupled receptor G1,24399,63,0.75 [0.46-1.20],0.231539803521705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG2,Adhesion G-protein coupled receptor G2,24532,66,0.94 [0.41-2.14],0.8792730251173377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRV1,Adhesion G-protein coupled receptor V1,20613,54,1.17 [0.85-1.59],0.3313928393891567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH1B,All-trans-retinol dehydrogenase,20790,55,0.58 [0.39-0.85],0.0059810272710998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,24088,63,0.75 [0.57-0.98],0.0382686198256929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADIPOQ,Adiponectin,21296,58,1.25 [0.85-1.83],0.2543200032224687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADM,Pro-adrenomedullin,24740,66,2.44 [1.03-5.78],0.0415735382785763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADRA2A,Alpha-2A adrenergic receptor,20607,56,0.98 [0.68-1.39],0.8976013769176027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFAP1,Actin filament-associated protein 1,20790,55,1.05 [0.78-1.41],0.7487974212662352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFM,Afamin,21296,58,0.30 [0.08-1.10],0.0690921273294426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFP,Alpha-fetoprotein,24286,64,1.19 [0.86-1.65],0.2837173626756095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGBL2,Cytosolic carboxypeptidase 2,20613,54,1.13 [0.84-1.51],0.416042804888632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGER,Advanced glycosylation end product-specific receptor,24448,65,0.82 [0.47-1.44],0.4932216003196499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR2,Anterior gradient protein 2 homolog,23741,60,1.19 [0.95-1.49],0.1411231801372485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR3,Anterior gradient protein 3,23904,64,0.97 [0.66-1.42],0.8800184339108633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRN,Agrin,24614,65,0.89 [0.45-1.79],0.7499266289532542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRP,Agouti-related protein,24821,67,1.02 [0.68-1.53],0.9295981764728992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGT,Angiotensinogen,21274,56,1.27 [0.41-3.91],0.6825206181215369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGXT,Serine--pyruvate aminotransferase,24532,66,0.84 [0.63-1.13],0.2452705864938432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHCY,Adenosylhomocysteinase,24532,66,0.92 [0.67-1.27],0.6083673823078952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK,Neuroblast differentiation-associated protein AHNAK,20682,56,0.60 [0.26-1.40],0.2351457954461258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK2,Protein AHNAK2,20682,56,0.81 [0.32-2.03],0.6493381163183595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,21153,56,0.87 [0.57-1.32],0.5083646231025638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSG,Alpha-2-HS-glycoprotein,21274,56,1.46 [0.57-3.75],0.4265802731270739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSP,Alpha-hemoglobin-stabilizing protein,24473,65,0.95 [0.73-1.24],0.7100383075563675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIDA,"Axin interactor, dorsalization-associated protein",20684,55,0.95 [0.70-1.30],0.7606229447185842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1,Allograft inflammatory factor 1,23935,64,1.07 [0.71-1.62],0.7505731531867997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1L,Allograft inflammatory factor 1-like,20682,56,0.97 [0.61-1.53],0.8858910434065533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",24355,63,0.91 [0.73-1.13],0.3811919711765957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK1,Adenylate kinase isoenzyme 1,24532,66,0.91 [0.65-1.29],0.5980080274994514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK2,"Adenylate kinase 2, mitochondrial",21213,57,1.00 [0.79-1.27],0.9855304183836482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKAP12,A-kinase anchor protein 12,20790,55,1.16 [0.36-3.71],0.803167523190538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B1,Aldo-keto reductase family 1 member B1,23935,64,0.87 [0.65-1.18],0.3732312168945084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B10,Aldo-keto reductase family 1 member B10,20684,55,0.81 [0.51-1.28],0.365409139560538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1C4,Aldo-keto reductase family 1 member C4,24088,63,0.85 [0.53-1.37],0.5130524937344547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR7L,Aflatoxin B1 aldehyde reductase member 4,20661,55,0.69 [0.45-1.06],0.0920095386584582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT1S1,Proline-rich AKT1 substrate 1,23939,60,0.81 [0.57-1.14],0.2233601495943006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT2,RAC-beta serine/threonine-protein kinase,21237,57,0.89 [0.73-1.09],0.2544779732450673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT3,RAC-gamma serine/threonine-protein kinase,23807,63,0.97 [0.66-1.43],0.890786441774793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALCAM,CD166 antigen,24814,66,1.62 [0.53-4.95],0.3967308148368147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH1A1,Retinal dehydrogenase 1,24511,65,0.80 [0.52-1.22],0.3028851151104695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH2,"Aldehyde dehydrogenase, mitochondrial",21153,56,0.81 [0.44-1.47],0.4805789425389921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",24482,66,0.73 [0.49-1.08],0.1117098690592889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",21237,57,0.80 [0.45-1.41],0.4339602803767551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALMS1,Alstrom syndrome protein 1,20866,52,0.67 [0.33-1.35],0.2665120920408327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPI,Intestinal-type alkaline phosphatase,20661,55,0.99 [0.80-1.23],0.9598497851261708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPP,"Alkaline phosphatase, placental type",24399,63,1.15 [0.93-1.42],0.1851204744349673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBN,Ameloblastin,24074,64,1.12 [0.53-2.35],0.7658108121767545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBP,Protein AMBP,24709,66,1.27 [0.40-4.00],0.6879298675542931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,21263,58,0.99 [0.37-2.63],0.9840120656854076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMFR,E3 ubiquitin-protein ligase AMFR,23939,60,1.11 [0.80-1.53],0.5362411536654825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO1,Amphoterin-induced protein 1,20684,55,1.38 [0.95-1.98],0.0881008196351738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO2,Amphoterin-induced protein 2,24399,63,0.55 [0.20-1.46],0.2301535201807632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMN,Protein amnionless,24074,64,0.89 [0.56-1.43],0.6287409735235802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOT,Angiomotin,20790,55,1.71 [0.97-3.02],0.0657482556417458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOTL2,Angiomotin-like protein 2,21086,56,1.16 [0.73-1.85],0.5267639639706024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMPD3,AMP deaminase 3,21213,57,0.87 [0.62-1.24],0.4554253720912938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,19939,53,0.65 [0.36-1.17],0.154282181676667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2A,Pancreatic alpha-amylase,23604,61,0.74 [0.45-1.20],0.2209337262798573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2B,Alpha-amylase 2B,22866,61,0.69 [0.43-1.13],0.1423320651542198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANG,Angiogenin,24418,66,0.57 [0.29-1.11],0.0991006789569904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT1,Angiopoietin-1,24437,65,0.99 [0.77-1.28],0.951784101810018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT2,Angiopoietin-2,24740,66,1.04 [0.59-1.85],0.8860848499625501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL1,Angiopoietin-related protein 1,24171,65,1.03 [0.49-2.18],0.9409198043549104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL2,Angiopoietin-related protein 2,24533,65,0.87 [0.50-1.52],0.6340162401741546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL3,Angiopoietin-related protein 3,24507,66,0.98 [0.53-1.83],0.9525651388639926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL4,Angiopoietin-related protein 4,24579,65,2.01 [1.25-3.24],0.004171955308602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL7,Angiopoietin-related protein 7,24740,66,1.35 [0.77-2.37],0.2909976954990918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANK2,Ankyrin-2,20607,56,0.81 [0.53-1.25],0.34972132148362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,20661,55,0.82 [0.59-1.15],0.2489778149374121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRA2,Ankyrin repeat family A protein 2,20513,53,0.62 [0.37-1.06],0.0797299118562839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRD54,Ankyrin repeat domain-containing protein 54,23935,64,0.87 [0.58-1.32],0.5189754868057836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,20682,56,1.06 [0.59-1.90],0.8551339232642863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANPEP,Aminopeptidase N,24533,66,0.63 [0.28-1.41],0.2569455402252096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA1,Annexin A1,20661,55,0.99 [0.56-1.74],0.969686317657068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA10,Annexin A10,23939,60,0.96 [0.71-1.30],0.7909131715587375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA11,Annexin A11,24468,66,0.81 [0.60-1.09],0.158255254925919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA2,Annexin A2,20385,55,0.68 [0.45-1.02],0.0649126426406835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA3,Annexin A3,24717,65,0.91 [0.67-1.24],0.5675064024741772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA4,Annexin A4,24408,66,0.92 [0.68-1.24],0.5872768208505852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA5,Annexin A5,23866,60,1.00 [0.47-2.14],0.9921694209035568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC1,Amiloride-sensitive amine oxidase [copper-containing],24074,64,1.10 [0.77-1.58],0.5971003664539727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC3,Membrane primary amine oxidase,24578,66,0.77 [0.37-1.59],0.4837419526793638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP1G2,AP-1 complex subunit gamma-like 2,21153,56,0.94 [0.68-1.29],0.6830103089550748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP2B1,AP-2 complex subunit beta,20684,55,0.71 [0.39-1.28],0.2540279312665807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3B1,AP-3 complex subunit beta-1,21177,56,0.82 [0.58-1.15],0.2472479740571391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3S2,AP-3 complex subunit sigma-2,21213,57,0.91 [0.53-1.58],0.745314279845368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,24399,63,0.72 [0.42-1.23],0.2311399433900287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APCS,Serum amyloid P-component,21119,58,0.70 [0.34-1.41],0.3174675951714865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24675,66,0.91 [0.63-1.32],0.631288555428558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APLP1,Amyloid-like protein 1,24532,66,1.10 [0.72-1.69],0.6481494676024653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA1,Apolipoprotein A-I,21296,58,0.90 [0.35-2.31],0.8227523846358789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA2,Apolipoprotein A-II,21274,56,1.44 [0.85-2.43],0.1768673522319692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA4,Apolipoprotein A-IV,21296,58,0.73 [0.34-1.57],0.41904400950162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOB,Apolipoprotein B-100,21274,56,1.63 [0.52-5.12],0.4039512829112666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOBR,Apolipoprotein B receptor,20682,56,1.17 [0.64-2.14],0.608605517968561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOC1,Apolipoprotein C-I,21254,58,0.86 [0.43-1.74],0.6744817070370037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOD,Apolipoprotein D,20297,56,1.03 [0.57-1.87],0.9301107132948568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOE,Apolipoprotein E,21296,58,0.88 [0.58-1.33],0.5427141716604408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOF,Apolipoprotein F,21274,56,1.71 [0.50-5.91],0.3958104465210396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOH,Beta-2-glycoprotein 1,24511,65,1.12 [0.62-2.05],0.7038544064890648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOL1,Apolipoprotein L1,21274,56,0.90 [0.58-1.41],0.6519104061853334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOM,Apolipoprotein M,24549,66,1.02 [0.46-2.28],0.9615521016535488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APP,Amyloid-beta precursor protein,24468,64,1.04 [0.75-1.44],0.8329193535488221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APPL2,DCC-interacting protein 13-beta,20790,55,0.91 [0.73-1.14],0.4252989541142394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APRT,Adenine phosphoribosyltransferase,24336,64,0.82 [0.53-1.29],0.4005651122075258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARAF,Serine/threonine-protein kinase A-Raf,20866,52,1.05 [0.71-1.55],0.8069180187022739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AREG,Amphiregulin,24399,63,1.43 [0.90-2.26],0.1279811511590759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARF6,ADP-ribosylation factor 6,21177,56,0.92 [0.73-1.16],0.4758601930816288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARFIP1,Arfaptin-1,21237,57,0.97 [0.67-1.40],0.8578403940451778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG1,Arginase-1,24403,64,0.90 [0.59-1.37],0.6293160422711461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG2,"Arginase-2, mitochondrial",21153,56,0.91 [0.49-1.68],0.7592143792910945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP1,Rho GTPase-activating protein 1,23935,64,0.82 [0.51-1.31],0.406914417215418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP25,Rho GTPase-activating protein 25,23935,64,1.08 [0.76-1.54],0.6767572906322521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP30,Rho GTPase-activating protein 30,20866,52,0.87 [0.42-1.80],0.7041614274725614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP45,Rho GTPase-activating protein 45,20790,55,0.77 [0.56-1.06],0.1131523050801957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP5,Rho GTPase-activating protein 5,20513,53,0.75 [0.49-1.14],0.1819835497769211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF1,Rho guanine nucleotide exchange factor 1,21213,57,0.87 [0.66-1.15],0.3206320298114139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF10,Rho guanine nucleotide exchange factor 10,21237,57,0.96 [0.73-1.26],0.7554487870017337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF12,Rho guanine nucleotide exchange factor 12,24511,66,0.84 [0.68-1.03],0.0940049730561416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF5,Rho guanine nucleotide exchange factor 5,20613,54,1.04 [0.74-1.46],0.8102318682652412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID3A,AT-rich interactive domain-containing protein 3A,20613,54,1.38 [0.77-2.47],0.2759594998239923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID4B,AT-rich interactive domain-containing protein 4B,23939,60,0.83 [0.45-1.52],0.5406637535454238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL13B,ADP-ribosylation factor-like protein 13B,20607,56,0.91 [0.62-1.34],0.6416314378649933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,20607,56,0.94 [0.50-1.77],0.8518674693673518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARMCX2,Armadillo repeat-containing X-linked protein 2,20613,54,1.15 [0.80-1.64],0.4594907387862409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNT,Aryl hydrocarbon receptor nuclear translocator,24074,64,1.28 [0.78-2.08],0.330254571775085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,20607,56,1.24 [0.82-1.86],0.30986163141627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSA,Arylsulfatase A,24511,65,1.08 [0.66-1.77],0.757474147097073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSB,Arylsulfatase B,24399,63,0.86 [0.57-1.30],0.4763537121536699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART3,Ecto-ADP-ribosyltransferase 3,24578,66,1.32 [0.68-2.54],0.4096737071223573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART5,Ecto-ADP-ribosyltransferase 5,20613,54,0.90 [0.57-1.44],0.6728057200503998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARTN,Artemin,24074,64,1.14 [0.75-1.71],0.5454581824084863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH1,Acid ceramidase,21085,57,1.09 [0.64-1.83],0.7582375457977517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH2,Neutral ceramidase,24363,64,0.88 [0.59-1.30],0.5117872131741652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR1,Asialoglycoprotein receptor 1,24363,64,2.17 [1.09-4.29],0.0268227130017842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR2,Asialoglycoprotein receptor 2,21274,56,2.14 [0.81-5.69],0.1264338979456954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPN,Asporin,21270,57,0.63 [0.24-1.69],0.3605495276532501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPSCR1,Tether containing UBX domain for GLUT4,21237,57,0.91 [0.63-1.32],0.6150409266396983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASRGL1,Isoaspartyl peptidase/L-asparaginase,20682,56,0.87 [0.68-1.12],0.2896122247910626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASS1,Argininosuccinate synthase,20607,56,0.66 [0.48-0.93],0.0160866272193279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF2,Cyclic AMP-dependent transcription factor ATF-2,23939,60,0.82 [0.54-1.24],0.3456764538949094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF4,Cyclic AMP-dependent transcription factor ATF-4,20513,53,0.88 [0.39-2.00],0.7633650047433135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG16L1,Autophagy-related protein 16-1,21177,56,0.90 [0.67-1.21],0.4663377953558814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG4A,Cysteine protease ATG4A,23935,64,0.94 [0.64-1.36],0.7305793191121912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATOX1,Copper transport protein ATOX1,24569,66,0.92 [0.69-1.24],0.6030825357817975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,20607,56,1.34 [0.95-1.87],0.0925572189490324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,20607,56,0.74 [0.31-1.78],0.5073311012241233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,20607,56,0.40 [0.17-0.94],0.0363315659541513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B4,Protein ATP1B4,20513,53,1.04 [0.56-1.94],0.9029577400926146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP2B4,Plasma membrane calcium-transporting ATPase 4,20607,56,0.93 [0.61-1.42],0.739016391890487
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5F1D,"ATP synthase subunit delta, mitochondrial",20607,56,0.85 [0.48-1.50],0.5709100191632632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5IF1,"ATPase inhibitor, mitochondrial",24614,65,0.88 [0.73-1.07],0.2100759562655522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5PO,"ATP synthase subunit O, mitochondrial",23939,60,1.29 [0.85-1.95],0.2378501625774872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6AP2,Renin receptor,23935,64,1.47 [1.01-2.13],0.0439454064520834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1D,V-type proton ATPase subunit D,24399,63,1.34 [0.66-2.73],0.4163085296956144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1F,V-type proton ATPase subunit F,23892,60,0.87 [0.61-1.24],0.447927523733392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G1,V-type proton ATPase subunit G 1,20682,56,0.95 [0.67-1.36],0.7971389454562201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G2,V-type proton ATPase subunit G 2,20607,56,0.90 [0.68-1.19],0.4484682834993162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRAID,All-trans retinoic acid-induced differentiation factor,21177,56,0.92 [0.36-2.32],0.8596220795216517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRN,"Attractin, Isoform 2",21296,58,0.33 [0.07-1.45],0.1409343987722437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN10,Ataxin-10,23939,60,0.95 [0.70-1.30],0.7556109994457879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2,Ataxin-2,20613,54,0.71 [0.51-0.98],0.0377646835937674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2L,Ataxin-2-like protein,21237,57,1.02 [0.60-1.72],0.9555404076204914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN3,Ataxin-3,21213,57,0.94 [0.63-1.41],0.7637651801079519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXIN1,Axin-1,24511,66,0.84 [0.67-1.05],0.1185229256694123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXL,Tyrosine-protein kinase receptor UFO,24578,66,0.99 [0.44-2.20],0.9731191992571288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZI2,5-azacytidine-induced protein 2,21237,57,0.96 [0.61-1.52],0.8639536378208253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZU1,Azurocidin,23769,63,1.07 [0.82-1.41],0.6021515373524627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B2M,Beta-2-microglobulin,21296,58,1.27 [0.77-2.07],0.3467508169743402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,20607,56,0.39 [0.10-1.47],0.164096525011026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",20682,56,0.98 [0.48-1.97],0.9496929243406188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GALT1,"Beta-1,4-galactosyltransferase 1",24614,65,2.52 [1.15-5.51],0.0204353331280776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GAT1,"Beta-1,4-glucuronyltransferase 1",24511,65,1.20 [0.49-2.92],0.6919148433529407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BABAM1,BRISC and BRCA1-A complex member 1,20661,55,0.98 [0.40-2.38],0.9593018447811772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BACH1,Transcription regulator protein BACH1,24511,66,0.89 [0.66-1.19],0.4282480348279116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG3,BAG family molecular chaperone regulator 3,24322,64,1.33 [0.75-2.37],0.3274353076805096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG4,BAG family molecular chaperone regulator 4,20661,55,0.88 [0.52-1.51],0.6538215370666975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG6,Large proline-rich protein BAG6,24088,63,1.10 [0.60-2.01],0.7650153324935984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,23935,64,0.78 [0.54-1.13],0.1857391171073087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAMBI,BMP and activin membrane-bound inhibitor homolog,23935,64,1.43 [0.70-2.91],0.3215588601121172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BANK1,B-cell scaffold protein with ankyrin repeats,24511,66,0.85 [0.70-1.03],0.1047267064759368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAP18,Chromatin complexes subunit BAP18,21213,57,1.01 [0.72-1.43],0.9501309671065938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BATF,Basic leucine zipper transcriptional factor ATF-like,20684,55,0.94 [0.68-1.30],0.720794058831949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAX,Apoptosis regulator BAX,23902,60,1.00 [0.77-1.28],0.982851998991893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAM,Basal cell adhesion molecule,24511,65,1.06 [0.41-2.70],0.906880609947996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAN,Brevican core protein,24363,64,1.14 [0.59-2.19],0.7019203991336087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",21270,57,1.24 [0.57-2.71],0.5818881062877123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",20613,54,0.77 [0.43-1.39],0.3863940089036642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCHE,Cholinesterase,20876,56,0.52 [0.21-1.29],0.1613148502218107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2,Apoptosis regulator Bcl-2,21177,56,0.83 [0.47-1.45],0.50625009279179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L1,Bcl-2-like protein 1,21213,57,0.93 [0.73-1.20],0.5968617567089836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",24511,66,0.68 [0.44-1.04],0.075740325591328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L15,Bcl-2-like protein 15,20661,55,0.99 [0.64-1.53],0.9754852373346512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7A,B-cell CLL/lymphoma 7 protein family member A,20513,53,1.25 [0.92-1.70],0.1500707606698303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7B,B-cell CLL/lymphoma 7 protein family member B,21153,56,0.54 [0.26-1.11],0.0915060960563952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCR,Breakpoint cluster region protein,24511,66,0.83 [0.65-1.05],0.1184778325868604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BDNF,Brain-derived neurotrophic factor,21263,58,0.96 [0.71-1.30],0.794031123922117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BECN1,Beclin-1,20682,56,0.94 [0.61-1.45],0.7857238366433195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BEX3,Protein BEX3,20513,53,0.86 [0.46-1.60],0.6396165027298378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGLAP,Osteocalcin,21263,58,0.96 [0.71-1.30],0.7971629638171143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGN,Biglycan,23902,64,0.96 [0.79-1.16],0.6444128980488404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHLHE40,Class E basic helix-loop-helix protein 40,20613,54,0.84 [0.56-1.27],0.4042479509884783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,20607,56,0.75 [0.28-2.02],0.5699202371498941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BID,BH3-interacting domain death agonist,24511,66,1.12 [0.82-1.53],0.4703361411207114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIN2,Bridging integrator 2,24511,65,0.92 [0.72-1.17],0.4789871837119134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIRC2,Baculoviral IAP repeat-containing protein 2,23935,64,0.86 [0.60-1.23],0.4126709911323689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLMH,Bleomycin hydrolase,24814,66,1.18 [0.60-2.29],0.6330727310659694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLNK,B-cell linker protein,20661,55,1.07 [0.55-2.08],0.8483032217917221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,20613,54,0.96 [0.67-1.38],0.8376869182714785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,21213,57,0.74 [0.38-1.44],0.3769415743585687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLVRB,Flavin reductase,24511,65,0.96 [0.69-1.34],0.8136113782069093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP10,Bone morphogenetic protein 10,20790,55,0.74 [0.30-1.81],0.5140430778201859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP4,Bone morphogenetic protein 4,24322,64,0.70 [0.42-1.19],0.1918655344768989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP6,Bone morphogenetic protein 6,24041,63,0.60 [0.38-0.97],0.0383380056782692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMPER,BMP-binding endothelial regulator protein,20790,55,0.68 [0.35-1.32],0.2579202970207842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,21270,57,1.16 [0.57-2.36],0.6738089738966611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20661,55,0.82 [0.44-1.52],0.5264398210531915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOC,Brother of CDO,24088,63,0.72 [0.28-1.87],0.4976118958058251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA1,BolA-like protein 1,20613,54,0.76 [0.45-1.28],0.3058043924510675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA2_BOLA2B,BolA-like protein 2,20682,56,0.90 [0.57-1.43],0.6525357874769906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFA2,BPI fold-containing family A member 2,19946,53,1.12 [0.88-1.44],0.3508330283494763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB1,BPI fold-containing family B member 1,24471,65,0.82 [0.58-1.16],0.259742285166613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB2,BPI fold-containing family B member 2,21237,57,0.85 [0.55-1.31],0.4575422220747418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRAP,BRCA1-associated protein,20979,56,0.90 [0.72-1.12],0.3473618236575324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD1,Bromodomain-containing protein 1,20866,52,1.60 [0.82-3.13],0.1682777918772223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD2,Bromodomain-containing protein 2,20613,54,1.12 [0.55-2.30],0.7562002029779207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD3,Bromodomain-containing protein 3,20607,56,0.92 [0.53-1.62],0.775127381513784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRDT,Bromodomain testis-specific protein,20607,56,1.15 [0.58-2.30],0.6834898784207808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRK1,Protein BRICK1,23939,60,0.73 [0.43-1.23],0.2334722768881997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRME1,Break repair meiotic recombinase recruitment factor 1,20613,54,0.57 [0.26-1.22],0.1446095210638828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRSK2,Serine/threonine-protein kinase BRSK2,21237,57,0.69 [0.34-1.42],0.3182682834941672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSG,Basigin,24773,67,1.48 [0.46-4.71],0.5078706978155746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSND,Barttin,20513,53,0.72 [0.30-1.75],0.4718170234794198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,24755,65,1.56 [0.84-2.88],0.1578801170480615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST2,Bone marrow stromal antigen 2,24755,65,0.87 [0.56-1.36],0.5408509284624041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTC,Probetacellulin,23935,64,0.96 [0.71-1.31],0.8120624040036869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTD,Biotinidase,21296,58,0.32 [0.11-0.97],0.0432103649178687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTLA,B- and T-lymphocyte attenuator,20513,53,0.83 [0.57-1.22],0.3464686316380746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN1A1,Butyrophilin subfamily 1 member A1,21115,56,1.36 [0.85-2.19],0.202568569167832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN2A1,Butyrophilin subfamily 2 member A1,24614,65,1.25 [0.51-3.04],0.6221138153181572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN3A2,Butyrophilin subfamily 3 member A2,24511,66,0.97 [0.53-1.75],0.9093624190397178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTNL10,Butyrophilin-like protein 10,20513,53,1.58 [1.04-2.42],0.0328564732910248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C19orf12,Protein C19orf12,23939,60,0.79 [0.53-1.18],0.2513472535072217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1GALT1C1,C1GALT1-specific chaperone 1,20607,56,0.83 [0.36-1.92],0.6658903259658966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QA,Complement C1q subcomponent subunit A,24690,66,1.54 [0.60-3.97],0.3663217898573305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",21237,57,1.13 [0.84-1.54],0.4163451279271675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QL2,Complement C1q-like protein 2,20661,55,0.73 [0.38-1.38],0.3308163099745598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,24578,66,1.12 [0.68-1.85],0.6627922368823072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,20790,55,0.48 [0.28-0.85],0.0110342861611151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,21237,57,1.09 [0.51-2.33],0.8191827112276058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,20751,55,1.48 [0.83-2.66],0.184170524071823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1R,Complement C1r subcomponent,21296,58,0.52 [0.11-2.47],0.4103844377235282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1RL,Complement C1r subcomponent-like protein,21260,58,0.33 [0.10-1.08],0.067350855691628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1S,Complement C1s subcomponent,21296,58,0.67 [0.20-2.24],0.519012886604733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2,Complement C2,24549,66,2.03 [0.70-5.88],0.1906881810809529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2CD2L,Phospholipid transfer protein C2CD2L,23892,60,1.13 [0.69-1.86],0.6317988620319994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2orf69,UPF0565 protein C2orf69,20684,55,0.88 [0.54-1.44],0.6133399936723134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C3,Complement C3,20237,57,0.51 [0.25-1.03],0.0604961472790597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C4BPB,C4b-binding protein beta chain,24569,66,0.99 [0.57-1.72],0.9773354808123436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C5,Complement C5,21296,58,0.69 [0.13-3.72],0.6647107885228398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7,Complement component C7,20810,58,0.92 [0.42-2.06],0.846177428898541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7orf50,Uncharacterized protein C7orf50,21213,57,0.70 [0.20-2.49],0.586211598210965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C8B,Complement component C8 beta chain,21296,58,1.73 [0.76-3.97],0.1937087118413705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9,Complement component C9,21274,56,1.12 [0.69-1.81],0.6479099096209845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9orf40,Uncharacterized protein C9orf40,21177,56,0.91 [0.66-1.25],0.5590183786816755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA1,Carbonic anhydrase 1,23948,66,1.03 [0.72-1.48],0.855655894084739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA11,Carbonic anhydrase-related protein 11,23935,64,1.25 [0.69-2.25],0.4561557365899943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA12,Carbonic anhydrase 12,24399,63,1.04 [0.51-2.11],0.9165169790394316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA13,Carbonic anhydrase 13,24239,66,0.89 [0.73-1.09],0.2544188397047138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA14,Carbonic anhydrase 14,24740,66,1.00 [0.54-1.87],0.9924574530818896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA2,Carbonic anhydrase 2,24440,65,1.01 [0.74-1.38],0.960164674720225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA3,Carbonic anhydrase 3,24772,66,1.55 [1.13-2.11],0.0063939988533719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA4,Carbonic anhydrase 4,24814,66,0.89 [0.35-2.25],0.8053441002758341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA5A,"Carbonic anhydrase 5A, mitochondrial",24088,63,0.97 [0.76-1.24],0.8111479418897085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA6,Carbonic anhydrase 6,24434,65,1.13 [0.80-1.61],0.4838710455308485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA7,Carbonic anhydrase 7,20866,52,1.05 [0.50-2.22],0.8924451541594779
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA8,Carbonic anhydrase-related protein,20661,55,0.84 [0.29-2.43],0.7474488527736558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA9,Carbonic anhydrase 9,24740,66,1.37 [0.84-2.22],0.2065098337659031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CABP2,Calcium-binding protein 2,20684,55,1.12 [0.78-1.60],0.5332828299567456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,20613,54,0.97 [0.43-2.19],0.937199420151273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,20607,56,0.76 [0.43-1.35],0.3496744428995522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,20613,54,0.79 [0.49-1.29],0.3514819696123163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,21237,57,0.91 [0.68-1.23],0.5463327545027264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACYBP,Calcyclin-binding protein,20744,55,0.90 [0.70-1.16],0.4204438826714962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CADPS,Calcium-dependent secretion activator 1,20684,55,0.75 [0.37-1.53],0.4349481043972482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB1,Calbindin,24399,63,1.37 [0.79-2.38],0.2641621282117699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB2,Calretinin,23939,60,0.59 [0.26-1.36],0.2173330981356099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCA,Calcitonin,24316,64,1.14 [0.81-1.61],0.4590635043165962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCB,Calcitonin gene-related peptide 2,21213,57,1.18 [0.65-2.14],0.5906964696249581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,24670,66,0.91 [0.74-1.12],0.3833158845788722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,20682,56,0.99 [0.71-1.38],0.9449616905358816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALY,Neuron-specific vesicular protein calcyon,20607,56,0.43 [0.18-1.02],0.0556479794959794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,23935,64,0.66 [0.38-1.12],0.1216862017461211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,20684,55,0.78 [0.46-1.33],0.3646164686595317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,21237,57,0.96 [0.75-1.21],0.7125522534952702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CANT1,Soluble calcium-activated nucleotidase 1,24462,65,2.88 [0.96-8.64],0.0596263784822148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPG,Macrophage-capping protein,24368,65,0.89 [0.61-1.29],0.542495789411672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPN3,Calpain-3,21153,56,0.72 [0.33-1.56],0.4007536647124585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPS,Calcyphosin,21213,57,0.88 [0.63-1.24],0.4660386499502413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CARHSP1,Calcium-regulated heat-stable protein 1,23939,60,1.07 [0.69-1.65],0.7772191666742138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASC3,Protein CASC3,20684,55,0.95 [0.51-1.77],0.8819838349445174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP1,Caspase-1,23939,60,1.04 [0.76-1.44],0.7900607719336278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP10,Caspase-10,23939,60,0.82 [0.60-1.12],0.212105946502995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP2,Caspase-2,24511,66,0.79 [0.57-1.10],0.1663940765592755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP3,Caspase-3,24814,66,0.90 [0.71-1.15],0.406820947814837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP4,Caspase-4,20866,52,1.12 [0.98-1.28],0.0964339294038676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP7,Caspase-7,21213,57,0.86 [0.64-1.16],0.3342178023029679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP8,Caspase-8,24677,66,1.00 [0.71-1.40],0.9973366181665146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP9,Caspase-9,20661,55,0.89 [0.58-1.36],0.5855435508533717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASQ2,Calsequestrin-2,20607,56,0.66 [0.33-1.31],0.2308761715681243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAT,Catalase,20949,56,0.91 [0.56-1.48],0.7187456200967419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLIF,Cobalamin binding intrinsic factor,24504,66,0.95 [0.69-1.31],0.7647963700878397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN1,Cerebellin-1,20613,54,0.91 [0.67-1.24],0.5503211646441917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN4,Cerebellin-4,24740,66,0.56 [0.28-1.13],0.1038521121901825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBS,Cystathionine beta-synthase,20682,56,0.44 [0.23-0.82],0.0104548257637024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBX2,Chromobox protein homolog 2,20607,56,1.04 [0.56-1.92],0.8972220949620149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,24363,64,0.89 [0.66-1.21],0.4697983906309514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCAR2,Cell cycle and apoptosis regulator protein 2,21213,57,0.80 [0.45-1.41],0.4395964154400329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC134,Coiled-coil domain-containing protein 134,21153,56,0.85 [0.50-1.46],0.559800872131099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC28A,Coiled-coil domain-containing protein 28A,20684,55,0.90 [0.37-2.17],0.8083302877208604
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC50,Coiled-coil domain-containing protein 50,21237,57,0.93 [0.65-1.31],0.6642703580321492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC80,Coiled-coil domain-containing protein 80,24532,66,1.19 [0.61-2.32],0.6135184505627812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,20682,56,1.02 [0.67-1.56],0.9226998358752356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL11,Eotaxin,24821,67,1.02 [0.58-1.78],0.9512093137085608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL13,C-C motif chemokine 13,24781,67,0.77 [0.56-1.05],0.1024180568691644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL14,C-C motif chemokine 14,24418,66,1.14 [0.67-1.94],0.6238360311409259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL15,C-C motif chemokine 15,24814,66,1.27 [0.78-2.06],0.3417552367089623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL16,C-C motif chemokine 16,24814,66,1.46 [0.91-2.33],0.1158145871906683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL17,C-C motif chemokine 17,24450,65,0.89 [0.70-1.13],0.3454087440529209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL18,C-C motif chemokine 18,24155,66,0.72 [0.51-1.03],0.0745317853934072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL19,C-C motif chemokine 19,24755,65,0.89 [0.71-1.11],0.2972078293773486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL2,C-C motif chemokine 2,24322,64,0.93 [0.61-1.42],0.75032582021004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL20,C-C motif chemokine 20,24821,67,0.81 [0.61-1.09],0.1665556720356958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL21,C-C motif chemokine 21,24614,65,0.70 [0.38-1.27],0.2403022632367154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL22,C-C motif chemokine 22,24224,64,0.97 [0.62-1.50],0.8808701940055619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL23,C-C motif chemokine 23,24614,65,1.54 [0.91-2.60],0.104590493982872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL24,C-C motif chemokine 24,24579,65,0.96 [0.74-1.25],0.7803029190875069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL25,C-C motif chemokine 25,24821,67,1.13 [0.74-1.74],0.5634041439274144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL26,C-C motif chemokine 26,24511,66,0.78 [0.60-1.03],0.084204549219556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL27,C-C motif chemokine 27,24532,66,1.06 [0.75-1.51],0.7338936692363474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL28,C-C motif chemokine 28,24437,65,0.88 [0.59-1.30],0.5169531290440932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL3,C-C motif chemokine 3,24511,66,1.30 [0.97-1.74],0.0773801523158732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL4,C-C motif chemokine 4,24526,65,0.90 [0.62-1.31],0.5801431970570359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL5,C-C motif chemokine 5,24578,66,0.94 [0.76-1.16],0.5586169094679136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL7,C-C motif chemokine 7,24511,66,0.78 [0.51-1.19],0.2478224174527623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL8,C-C motif chemokine 8,24709,66,1.37 [0.96-1.97],0.0831829451966187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN1,CCN family member 1,24365,63,1.10 [0.81-1.48],0.5381282556061893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN2,CCN family member 2,24512,65,1.01 [0.70-1.47],0.9426853940912052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN3,CCN family member 3,24773,66,1.24 [0.64-2.43],0.5211427606835964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN4,CCN family member 4,24740,66,1.41 [0.85-2.36],0.1848704445172362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN5,CCN family member 5,24511,65,1.83 [1.07-3.13],0.0261179354823333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCND2,G1/S-specific cyclin-D2,20866,52,1.05 [0.52-2.14],0.8929041505782751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCNE1,G1/S-specific cyclin-E1,20661,55,0.99 [0.76-1.30],0.969532513658643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCS,Copper chaperone for superoxide dismutase,24363,64,0.73 [0.45-1.18],0.1974746730407148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCT5,T-complex protein 1 subunit epsilon,23935,64,0.78 [0.45-1.33],0.3570502001268726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD101,Immunoglobulin superfamily member 2,21177,56,1.05 [0.58-1.90],0.8772781809962765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD109,CD109 antigen,24511,65,1.51 [0.77-2.93],0.2286741690938867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD14,Monocyte differentiation antigen CD14,23969,65,0.97 [0.56-1.67],0.9038402290420636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD160,CD160 antigen,24821,67,0.91 [0.56-1.48],0.6931253512048068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD163,Scavenger receptor cysteine-rich type 1 protein M130,24578,66,0.97 [0.58-1.63],0.912542345512373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164,Sialomucin core protein 24,24511,65,1.68 [1.11-2.54],0.0134634632773567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164L2,CD164 sialomucin-like 2 protein,20684,55,0.54 [0.25-1.15],0.1099105143783916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD177,CD177 antigen,24476,65,1.07 [0.90-1.29],0.4398178910925425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD1C,T-cell surface glycoprotein CD1c,24569,66,2.06 [0.79-5.38],0.1396309262658588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2,T-cell surface antigen CD2,20607,56,0.42 [0.17-1.01],0.0535817776864275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200,OX-2 membrane glycoprotein,24511,66,2.50 [1.34-4.66],0.0039886457466276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200R1,Cell surface glycoprotein CD200 receptor 1,24430,66,0.50 [0.25-0.97],0.0392212988876983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD207,C-type lectin domain family 4 member K,23983,62,2.00 [1.10-3.61],0.0220055183357198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD209,CD209 antigen,24557,66,1.47 [0.84-2.55],0.1768222914818353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD22,B-cell receptor CD22,24821,67,0.82 [0.47-1.43],0.4948555289372139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD226,CD226 antigen,20661,55,1.11 [0.60-2.05],0.7481752056687353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD244,Natural killer cell receptor 2B4,24821,67,0.74 [0.33-1.66],0.4707054607360018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD248,Endosialin,21263,58,1.41 [0.75-2.65],0.2818825814334174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD27,CD27 antigen,24569,66,1.46 [0.84-2.54],0.177374831660057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD274,Programmed cell death 1 ligand 1,24363,64,1.48 [0.80-2.72],0.210840855433087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD276,CD276 antigen,24494,65,1.19 [0.62-2.25],0.60319538401138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD28,T-cell-specific surface glycoprotein CD28,23935,64,1.18 [0.63-2.19],0.609575900963101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2AP,CD2-associated protein,24532,66,0.98 [0.69-1.37],0.8874650061690891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300A,CMRF35-like molecule 8,20790,55,0.99 [0.40-2.41],0.9763770285639822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300C,CMRF35-like molecule 6,24755,65,1.45 [0.75-2.80],0.271894505388542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300E,CMRF35-like molecule 2,24664,65,1.68 [0.98-2.88],0.0597286879124778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LF,CMRF35-like molecule 1,24740,66,1.15 [0.77-1.72],0.4912672491868026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LG,CMRF35-like molecule 9,24511,65,1.86 [1.03-3.37],0.0396060416014865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD302,CD302 antigen,24399,63,1.46 [0.68-3.13],0.3257427127571989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD33,Myeloid cell surface antigen CD33,24569,66,0.93 [0.71-1.21],0.5804561083800719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD34,Hematopoietic progenitor cell antigen CD34,24660,65,1.21 [0.49-2.99],0.6734444197237444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD36,Platelet glycoprotein 4,20661,55,0.79 [0.44-1.45],0.4540541287096061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,24399,63,1.07 [0.50-2.25],0.866397003230886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3D,T-cell surface glycoprotein CD3 delta chain,20613,54,0.96 [0.44-2.06],0.9080677262005088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3E,T-cell surface glycoprotein CD3 epsilon chain,20866,52,1.11 [0.56-2.19],0.7607130727904758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3G,T-cell surface glycoprotein CD3 gamma chain,20661,55,0.98 [0.74-1.31],0.9038458718577436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD4,T-cell surface glycoprotein CD4,24466,65,0.69 [0.30-1.59],0.3855743294065739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40,Tumor necrosis factor receptor superfamily member 5,24491,65,0.92 [0.59-1.43],0.7140786142958302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40LG,CD40 ligand,24821,67,1.04 [0.79-1.36],0.7893008307097304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD46,Membrane cofactor protein,24332,65,1.00 [0.46-2.19],0.9983694255423308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD48,CD48 antigen,24579,65,1.66 [0.79-3.51],0.1801203407966942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5,T-cell surface glycoprotein CD5,24709,66,1.25 [0.65-2.40],0.5093811417441416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD55,Complement decay-accelerating factor,23642,63,1.64 [0.80-3.35],0.1782091150761289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD58,Lymphocyte function-associated antigen 3,24443,65,0.81 [0.23-2.85],0.7490115997419715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD59,CD59 glycoprotein,23599,64,2.79 [1.25-6.23],0.012277815840382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5L,CD5 antigen-like,21186,58,0.82 [0.47-1.41],0.4700164904188287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD6,T-cell differentiation antigen CD6,24773,67,0.91 [0.61-1.37],0.6578310310600662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD63,CD63 antigen,24322,64,0.99 [0.64-1.51],0.9460688486053468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD69,Early activation antigen CD69,24399,66,0.90 [0.70-1.14],0.385681681586386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD7,T-cell antigen CD7,20627,55,0.70 [0.37-1.34],0.285007180928527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD70,CD70 antigen,24511,66,0.99 [0.59-1.66],0.9781342983128892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD72,B-cell differentiation antigen CD72,20790,55,1.26 [0.67-2.39],0.4748149978537073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD74,HLA class II histocompatibility antigen gamma chain,24755,65,1.62 [0.87-3.03],0.1293049819603437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD79B,B-cell antigen receptor complex-associated protein beta chain,24821,67,1.26 [0.75-2.11],0.3823747034081958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD80,T-lymphocyte activation antigen CD80,21270,57,0.60 [0.26-1.37],0.2261845682023757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD82,CD82 antigen,20866,52,1.23 [0.72-2.10],0.4429694800392206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD83,CD83 antigen,24511,66,1.18 [0.61-2.31],0.6197191682501422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD84,SLAM family member 5,24511,66,0.85 [0.43-1.70],0.651402297170846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD86,T-lymphocyte activation antigen CD86,21177,56,0.88 [0.37-2.09],0.7730218760769797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD8A,T-cell surface glycoprotein CD8 alpha chain,24755,65,0.81 [0.51-1.28],0.3629602459309857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD93,Complement component C1q receptor,23547,65,1.50 [0.74-3.05],0.2641664014892985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99,CD99 antigen,24511,65,3.20 [1.09-9.35],0.033596063960661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99L2,CD99 antigen-like protein 2,24511,65,3.23 [1.37-7.61],0.0073507908959703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDA,Cytidine deaminase,21236,57,0.88 [0.52-1.49],0.6285064095388101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDAN1,Codanin-1,21213,57,1.83 [0.90-3.72],0.0958819579780936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC123,Cell division cycle protein 123 homolog,20513,53,1.14 [0.80-1.62],0.4598989260079777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC25A,M-phase inducer phosphatase 1,20513,53,1.13 [0.62-2.04],0.694837396394389
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC26,Anaphase-promoting complex subunit CDC26,21141,56,0.83 [0.57-1.20],0.3194501884486805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC27,Cell division cycle protein 27 homolog,23935,64,0.95 [0.65-1.38],0.7737025003642131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC37,Hsp90 co-chaperone Cdc37,24569,66,0.91 [0.70-1.18],0.4669883450591447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC42BPB,Serine/threonine-protein kinase MRCK beta,21177,56,0.89 [0.69-1.15],0.3818457180888723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDCP1,CUB domain-containing protein 1,24363,64,0.94 [0.60-1.48],0.7823741387214369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH1,Cadherin-1,23660,64,1.00 [0.58-1.72],0.9866278920306586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH15,Cadherin-15,24708,65,1.02 [0.69-1.50],0.9126187344450316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH17,Cadherin-17,24532,66,1.19 [0.87-1.63],0.279180530595876
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH2,Cadherin-2,24532,66,0.55 [0.30-1.02],0.0585252189413217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH22,Cadherin-22,20866,52,1.25 [0.54-2.87],0.6012279677296308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH23,Cadherin-23,21213,57,1.02 [0.40-2.58],0.9670136503259606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH3,Cadherin-3,24755,65,1.96 [1.10-3.50],0.0232274560947569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH4,Cadherin-4,20613,54,0.54 [0.28-1.05],0.0704122211484612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH5,Cadherin-5,24814,66,1.99 [1.01-3.90],0.0454615368052939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH6,Cadherin-6,24532,66,1.07 [0.60-1.91],0.8076284644380871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR1,Cadherin-related family member 1,23939,60,0.84 [0.47-1.50],0.5511013263964162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR2,Cadherin-related family member 2,24399,63,0.83 [0.61-1.12],0.2221926037782883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR5,Cadherin-related family member 5,24532,66,0.48 [0.29-0.78],0.0030246688645392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK1,Cyclin-dependent kinase 1,20513,53,1.29 [0.64-2.63],0.4783595889148826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,21237,57,0.99 [0.65-1.51],0.9575777267343496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKL5,Cyclin-dependent kinase-like 5,20613,54,0.82 [0.47-1.42],0.4766451124449525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN1A,Cyclin-dependent kinase inhibitor 1,24399,63,0.77 [0.63-0.95],0.01484037403226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,24399,63,0.85 [0.68-1.06],0.1444404090167808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDNF,Cerebral dopamine neurotrophic factor,24399,63,1.29 [0.68-2.45],0.4312717643354563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,24538,65,0.42 [0.19-0.93],0.0318060408900373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDSN,Corneodesmosin,24740,67,1.39 [0.84-2.31],0.2035385893981433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,24530,65,1.27 [0.43-3.76],0.6699138051315378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,21177,56,0.80 [0.59-1.09],0.1558877592929243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,20866,52,0.87 [0.56-1.36],0.5385691643649979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,21177,56,1.34 [0.71-2.53],0.3708178119379119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,20866,52,0.78 [0.40-1.54],0.4805689513897693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,24511,66,1.07 [0.83-1.38],0.5949455756000844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,23935,64,1.19 [0.78-1.81],0.4160579504802795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,23584,62,1.14 [0.79-1.64],0.487300408964338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,21263,58,0.78 [0.40-1.51],0.455466472914925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,24088,63,1.14 [0.73-1.78],0.5655276922813692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPA,CCAAT/enhancer-binding protein alpha,20661,55,0.72 [0.31-1.65],0.4359450955957666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPB,CCAAT/enhancer-binding protein beta,24088,63,0.64 [0.34-1.21],0.1676944630096521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA2A,Chymotrypsin-like elastase family member 2A,21263,58,0.84 [0.55-1.28],0.4134585602198403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA3A,Chymotrypsin-like elastase family member 3A,24769,66,1.11 [0.76-1.62],0.6006274239967868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,20790,55,0.47 [0.18-1.20],0.1122511301669013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEMIP2,Cell surface hyaluronidase,20661,55,1.70 [1.14-2.54],0.0090578511138324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEND1,Cell cycle exit and neuronal differentiation protein 1,20613,54,1.03 [0.67-1.58],0.8945791052595023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPF,Centromere protein F,20866,52,0.91 [0.55-1.49],0.7053068727145536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPJ,Centromere protein J,20866,52,0.89 [0.60-1.34],0.5798499585715545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP112,Centrosomal protein of 112 kDa,20607,56,0.82 [0.42-1.59],0.554260009431005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP152,Centrosomal protein of 152 kDa,20513,53,1.29 [0.79-2.09],0.3118548723537438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP164,Centrosomal protein of 164 kDa,24074,64,0.95 [0.66-1.39],0.8054363330701494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP170,Centrosomal protein of 170 kDa,20682,56,1.08 [0.77-1.49],0.664788576353283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP20,Centrosomal protein 20,23935,64,0.90 [0.66-1.21],0.480254439460508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP290,Centrosomal protein of 290 kDa,20866,52,0.95 [0.56-1.60],0.837644002272915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP350,Centrosome-associated protein 350,20513,53,0.84 [0.40-1.77],0.6543386514145535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP43,Centrosomal protein 43,23893,61,0.84 [0.60-1.17],0.2979528374262626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP85,Centrosomal protein of 85 kDa,23935,64,1.15 [0.82-1.61],0.4123266112407597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CERT,Ceramide transfer protein,23939,60,1.07 [0.74-1.55],0.7162706342989204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES1,Liver carboxylesterase 1,24554,66,0.84 [0.63-1.11],0.2184051930888834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES2,Cocaine esterase,24399,63,1.19 [0.80-1.75],0.3915901999148399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES3,Carboxylesterase 3,24399,63,0.87 [0.62-1.23],0.4402564562858079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN2,Centrin-2,23939,60,0.70 [0.49-1.01],0.0538798414756071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN3,Centrin-3,21177,56,0.94 [0.68-1.30],0.7068432491537545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFB,Complement factor B,20906,58,0.49 [0.23-1.03],0.0600057832485406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFC1,Cryptic protein,23935,64,1.23 [0.82-1.85],0.3165864417839065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFD,Complement factor D,21296,58,1.50 [0.45-5.07],0.512497677939042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFH,Complement factor H,20074,54,0.73 [0.42-1.29],0.2855439221657244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR2,Complement factor H-related protein 2,21144,58,0.81 [0.54-1.22],0.3209223888988778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR4,Complement factor H-related protein 4,21257,58,1.08 [0.76-1.54],0.6665749590382959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR5,Complement factor H-related protein 5,21006,56,1.11 [0.59-2.08],0.7569524631036623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFI,Complement factor I,21296,58,0.73 [0.38-1.40],0.3394755594037749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFP,Properdin,21296,58,0.64 [0.20-2.10],0.4626024303997622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGA,Glycoprotein hormones alpha chain,24511,65,1.27 [0.97-1.66],0.0795049260941097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,21274,56,1.39 [1.08-1.81],0.0120381546349792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGN,Cingulin,20684,55,1.06 [0.57-1.97],0.8570935676821936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGREF1,Cell growth regulator with EF hand domain protein 1,24532,66,1.29 [0.77-2.15],0.3414691114699688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,23935,64,0.89 [0.61-1.31],0.5614256474330253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAD,Chondroadherin,20790,55,0.93 [0.55-1.58],0.7980351046187684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",21213,57,1.19 [0.64-2.21],0.5879413162630767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD6,MICOS complex subunit MIC25,21153,56,0.76 [0.45-1.28],0.3017205891945488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHEK2,Serine/threonine-protein kinase Chk2,24088,63,1.16 [0.61-2.20],0.6460327974914437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGA,Chromogranin-A,21263,58,1.21 [0.92-1.60],0.1728281905782474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGB,Secretogranin-1,24667,65,1.27 [0.72-2.24],0.3998694531873671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHI3L1,Chitinase-3-like protein 1,23924,64,1.11 [0.83-1.47],0.4889111817037571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHIT1,Chitotriosidase-1,24607,66,0.96 [0.84-1.10],0.5424529926280032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHL1,Neural cell adhesion molecule L1-like protein,24535,66,1.20 [0.61-2.38],0.6016266156905734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHM,Rab proteins geranylgeranyltransferase component A 1,20684,55,0.95 [0.62-1.46],0.8197474929010609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP1A,Charged multivesicular body protein 1a,24363,64,0.93 [0.71-1.23],0.6085222730870778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP6,Charged multivesicular body protein 6,21270,57,0.89 [0.57-1.40],0.6224978231381171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHP1,Calcineurin B homologous protein 1,20613,54,0.67 [0.44-1.04],0.0721994343509315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL1,Chordin-like protein 1,24579,65,0.95 [0.47-1.95],0.8973483124463646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL2,Chordin-like protein 2,24532,66,0.91 [0.61-1.35],0.6238254603861899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRM1,Muscarinic acetylcholine receptor M1,20684,55,1.54 [0.95-2.49],0.0820705214116974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIAPIN1,Anamorsin,24569,66,0.92 [0.65-1.29],0.6266606222800162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CILP,Cartilage intermediate layer protein 1,21263,58,0.72 [0.47-1.11],0.1341109526893907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CINP,Cyclin-dependent kinase 2-interacting protein,20866,52,1.25 [0.77-2.03],0.3693747203529157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIRBP,Cold-inducible RNA-binding protein,21177,56,0.97 [0.74-1.26],0.8050076893882909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIT,Citron Rho-interacting kinase,20684,55,0.81 [0.44-1.48],0.4903441121587042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKAP4,Cytoskeleton-associated protein 4,24685,67,1.80 [0.85-3.81],0.124141570662478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKB,Creatine kinase B-type,21263,58,1.22 [0.79-1.86],0.3671760069068138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",24396,65,0.95 [0.69-1.31],0.759636573241464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLASP1,CLIP-associating protein 1,20513,53,1.01 [0.71-1.44],0.9431515167200316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLC,Galectin-10,24496,65,0.93 [0.67-1.30],0.6730096378570818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC10A,C-type lectin domain family 10 member A,24363,64,2.11 [1.15-3.87],0.0161181948933047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC11A,C-type lectin domain family 11 member A,24464,65,1.10 [0.69-1.76],0.6849533968028597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC12A,C-type lectin domain family 12 member A,20661,55,0.46 [0.12-1.77],0.2574938256093646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC14A,C-type lectin domain family 14 member A,24511,65,1.37 [0.67-2.80],0.3917797062216833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1A,C-type lectin domain family 1 member A,24088,63,2.69 [1.44-5.04],0.0019220932639095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1B,C-type lectin domain family 1 member B,24755,65,0.90 [0.71-1.13],0.3461094909705468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC2L,C-type lectin domain family 2 member L,20684,55,1.04 [0.65-1.68],0.8564955696890802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC3B,Tetranectin,20812,58,0.33 [0.10-1.08],0.0673008923244365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4A,C-type lectin domain family 4 member A,24511,66,1.14 [0.61-2.15],0.6818505748453814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4C,C-type lectin domain family 4 member C,24511,66,0.90 [0.57-1.44],0.6693412695851684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4D,C-type lectin domain family 4 member D,24511,66,0.97 [0.67-1.40],0.8705746100994795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4G,C-type lectin domain family 4 member G,24511,66,1.05 [0.54-2.02],0.8877115774054154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4M,C-type lectin domain family 4 member M,21228,58,1.34 [0.81-2.24],0.2561512969471731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC5A,C-type lectin domain family 5 member A,24442,66,1.54 [0.74-3.20],0.2524953352025721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC6A,C-type lectin domain family 6 member A,23935,64,1.56 [0.99-2.45],0.0536063930031548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC7A,C-type lectin domain family 7 member A,24821,67,0.80 [0.61-1.06],0.123078454938787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLGN,Calmegin,20684,55,1.02 [0.57-1.83],0.9509707352889438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIC5,Chloride intracellular channel protein 5,20684,55,0.89 [0.38-2.10],0.7911010267946448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLINT1,Clathrin interactor 1,20513,53,1.01 [0.58-1.76],0.9637946835181672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIP2,CAP-Gly domain-containing linker protein 2,24511,66,0.86 [0.71-1.04],0.1107523151802289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLMP,CXADR-like membrane protein,24740,66,1.73 [0.60-5.00],0.3133527111827271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLNS1A,Methylosome subunit pICln,20684,55,1.23 [0.61-2.51],0.562576538401456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",24316,64,0.85 [0.67-1.07],0.1715759161064209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPS,Colipase,24473,65,1.29 [0.95-1.76],0.103084576437669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSPN,Claspin,23892,60,1.34 [0.84-2.13],0.2144353716544425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN1,Calsyntenin-1,23939,60,0.70 [0.42-1.15],0.1598995411591117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN2,Calsyntenin-2,24821,67,0.43 [0.23-0.80],0.0070624353610739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN3,Calsyntenin-3,21213,57,0.92 [0.40-2.12],0.8446815165155971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLTA,Clathrin light chain A,24088,63,0.72 [0.43-1.22],0.2239283089142097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLU,Clusterin,21296,58,0.38 [0.09-1.65],0.1957913391047181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLUL1,Clusterin-like protein 1,24492,65,0.86 [0.53-1.40],0.540859112260205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMC1,COX assembly mitochondrial protein homolog,21270,57,0.86 [0.65-1.14],0.2974472460412531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMIP,C-Maf-inducing protein,21153,56,0.93 [0.69-1.27],0.6671221080522229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNDP1,Beta-Ala-His dipeptidase,24578,66,0.92 [0.57-1.49],0.7456526046380371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNGB3,Cyclic nucleotide-gated cation channel beta-3,20613,54,1.19 [0.82-1.73],0.3675631226300927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",20643,55,0.91 [0.65-1.26],0.560106062771736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY2,Protein canopy homolog 2,24088,63,0.60 [0.36-1.00],0.0504889910920772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY4,Protein canopy homolog 4,24399,63,0.86 [0.64-1.15],0.3137144552804157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNST,Consortin,24532,66,0.90 [0.74-1.09],0.2789200975108048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTF,Ciliary neurotrophic factor,20613,54,1.94 [1.05-3.59],0.0342262550258467
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN1,Contactin-1,24814,66,0.48 [0.21-1.08],0.0767956586486099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN2,Contactin-2,24740,66,0.69 [0.42-1.14],0.1436796283201024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN3,Contactin-3,24511,65,0.89 [0.45-1.78],0.7446835134962596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN4,Contactin-4,24511,65,0.92 [0.36-2.34],0.8579576967650648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN5,Contactin-5,24589,65,0.89 [0.48-1.65],0.7165433709656284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP2,Contactin-associated protein-like 2,24511,66,0.96 [0.56-1.63],0.8768518134772085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP4,Contactin-associated protein-like 4,20684,55,1.05 [0.84-1.32],0.6573941646331385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COCH,Cochlin,21270,57,1.04 [0.60-1.81],0.8773441191607413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL15A1,Collagen alpha-1(XV) chain,21263,58,0.70 [0.26-1.83],0.4613494503908579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL18A1,Collagen alpha-1(XVIII) chain,24593,66,1.62 [0.61-4.26],0.3324362883787713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL1A1,Collagen alpha-1(I) chain,24814,66,1.15 [0.48-2.77],0.7533133035947768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL24A1,Collagen alpha-1(XXIV) chain,21177,56,0.73 [0.50-1.07],0.1101938896320485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL28A1,Collagen alpha-1(XXVIII) chain,20684,55,1.01 [0.72-1.41],0.9687080647161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL2A1,Collagen alpha-1(II) chain,20682,56,1.03 [0.75-1.42],0.8433223810351491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL3A1,Collagen alpha-1(III) chain,21263,58,2.12 [0.80-5.59],0.1305294976659675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A1,Collagen alpha-1(IV) chain,24532,66,1.22 [0.70-2.12],0.487335910935574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A4,Collagen alpha-4(IV) chain,20831,52,1.04 [0.63-1.72],0.874461107158836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL5A1,Collagen alpha-1(V) chain,20790,55,0.88 [0.44-1.76],0.7262506091025664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL6A3,Collagen alpha-3(VI) chain,24814,66,1.45 [0.74-2.82],0.2782849336804844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A1,Collagen alpha-1(IX) chain,24511,66,0.87 [0.53-1.45],0.6052831339813454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A2,Collagen alpha-2(IX) chain,20866,52,1.32 [0.85-2.04],0.2224506773865688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COLEC12,Collectin-12,24494,65,1.08 [0.44-2.67],0.8596806850511001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD1,COMM domain-containing protein 1,20682,56,0.91 [0.60-1.38],0.6521787632994012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD9,COMM domain-containing protein 9,21153,56,1.02 [0.54-1.92],0.9504122246431336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMP,Cartilage oligomeric matrix protein,24239,66,0.73 [0.38-1.41],0.3497710643439808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMT,Catechol O-methyltransferase,23814,63,0.96 [0.73-1.24],0.7344370635923528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPB2,Coatomer subunit beta',20607,56,1.15 [0.64-2.07],0.6312830925429833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPE,Coatomer subunit epsilon,23939,60,1.56 [1.19-2.06],0.00151644733175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",20682,56,1.19 [0.71-2.00],0.5131635662024947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO1A,Coronin-1A,24010,64,1.15 [0.92-1.44],0.2135420855418739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO6,Coronin-6,20613,54,1.68 [1.00-2.83],0.0484158512322665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",24399,63,0.87 [0.62-1.21],0.3978014361087945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX6B1,Cytochrome c oxidase subunit 6B1,21270,57,0.81 [0.36-1.81],0.6016350467773661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA1,Carboxypeptidase A1,24814,66,1.11 [0.77-1.58],0.5801523664261143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA2,Carboxypeptidase A2,24666,65,0.79 [0.56-1.11],0.176967517475409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA4,Carboxypeptidase A4,20375,53,1.46 [0.78-2.74],0.238978830666113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB1,Carboxypeptidase B,24814,66,1.07 [0.74-1.55],0.7059664731414261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB2,Carboxypeptidase B2,21254,58,0.38 [0.13-1.12],0.0803789116595897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPE,Carboxypeptidase E,24562,66,0.82 [0.49-1.38],0.4585539302891348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPLX2,Complexin-2,20513,53,0.37 [0.14-0.98],0.0445062342965819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPM,Carboxypeptidase M,24651,65,0.77 [0.41-1.47],0.4339215208768954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",20661,55,0.37 [0.13-1.02],0.0537927369646328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPPED1,Serine/threonine-protein phosphatase CPPED1,24755,65,0.93 [0.67-1.29],0.673955571386373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPQ,Carboxypeptidase Q,21227,58,0.47 [0.28-0.80],0.0054040323335812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPTP,Ceramide-1-phosphate transfer protein,20607,56,1.10 [0.61-1.99],0.7442902369503731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPVL,Probable serine carboxypeptidase CPVL,24697,65,1.32 [0.76-2.28],0.3193496180951998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM1,Probable carboxypeptidase X1,24569,66,1.01 [0.74-1.39],0.9271582489175882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM2,Inactive carboxypeptidase-like protein X2,21270,57,0.79 [0.27-2.26],0.6552431045034532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR1,Complement receptor type 1,21189,56,1.08 [0.52-2.25],0.8294818780080533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR2,Complement receptor type 2,24578,66,0.88 [0.55-1.42],0.6107515113391235
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,23935,64,1.10 [0.86-1.40],0.4614039429648102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRADD,Death domain-containing protein CRADD,24316,64,0.98 [0.74-1.31],0.9077767763926804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREB3,Cyclic AMP-responsive element-binding protein 3,20513,53,1.16 [0.76-1.76],0.4856763531351222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREBZF,CREB/ATF bZIP transcription factor,20513,53,1.53 [0.67-3.53],0.3153184545215726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREG1,Protein CREG1,24165,64,1.11 [0.62-1.96],0.7314860899825115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD1,Protein disulfide isomerase CRELD1,20790,55,1.23 [0.61-2.44],0.5637635333237818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD2,Protein disulfide isomerase CRELD2,24579,65,0.85 [0.55-1.30],0.4420162407679188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRH,Corticoliberin,23894,64,0.91 [0.71-1.18],0.4957250265331072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHBP,Corticotropin-releasing factor-binding protein,24494,65,0.49 [0.22-1.07],0.0726632808865872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHR1,Corticotropin-releasing factor receptor 1,24088,63,0.91 [0.62-1.33],0.6118397399082259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIM1,Cysteine-rich motor neuron 1 protein,24614,65,3.14 [1.21-8.13],0.0186329271584578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIP2,Cysteine-rich protein 2,24363,64,0.54 [0.28-1.04],0.0667648176699642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP2,Cysteine-rich secretory protein 2,24740,66,0.92 [0.63-1.35],0.6848646082604656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP3,Cysteine-rich secretory protein 3,21068,56,1.10 [0.42-2.87],0.8528630922446896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRKL,Crk-like protein,24528,65,0.88 [0.72-1.08],0.2269011409075975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRLF1,Cytokine receptor-like factor 1,24614,65,1.23 [0.52-2.90],0.630747278302535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRNN,Cornulin,23781,65,1.05 [0.75-1.48],0.7616066957444156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAC1,Cartilage acidic protein 1,24814,66,0.72 [0.36-1.45],0.3631594597663214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAM,Cytotoxic and regulatory T-cell molecule,24363,64,0.81 [0.51-1.27],0.3529940153249911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAP,Cartilage-associated protein,20684,55,1.15 [0.72-1.81],0.562320024380008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRX,Cone-rod homeobox protein,24088,63,1.02 [0.83-1.25],0.8856461466384258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB1,Beta-crystallin B1,21270,57,0.86 [0.58-1.27],0.4466513042207255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB2,Beta-crystallin B2,21213,57,1.15 [0.79-1.67],0.455125000467568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYGD,Gamma-crystallin D,21213,57,1.15 [0.89-1.50],0.282755946580689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYM,Ketimine reductase mu-crystallin,20613,54,1.30 [1.00-1.69],0.0497027313490177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYZL1,Quinone oxidoreductase-like protein 1,20682,56,0.85 [0.64-1.12],0.2471346830514279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSDE1,Cold shock domain-containing protein E1,20607,56,1.04 [0.85-1.27],0.7185934464592418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1,Macrophage colony-stimulating factor 1,24614,65,1.92 [0.86-4.28],0.1110565096105985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1R,Macrophage colony-stimulating factor 1 receptor,21274,56,1.41 [0.77-2.58],0.2600433429021808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2,Granulocyte-macrophage colony-stimulating factor,20607,56,0.59 [0.27-1.29],0.1827987569158014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,24363,64,0.81 [0.56-1.18],0.274824730653414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RB,Cytokine receptor common subunit beta,20661,55,1.43 [0.78-2.62],0.2503158288140817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3,Granulocyte colony-stimulating factor,24074,64,1.46 [0.95-2.23],0.0824514265176949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3R,Granulocyte colony-stimulating factor receptor,20661,55,0.92 [0.37-2.27],0.8496864221080818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSH1,Chorionic somatomammotropin hormone 1,21274,56,1.59 [1.28-1.99],3.425041669067441e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK1D,Casein kinase I isoform delta,20661,55,0.80 [0.52-1.24],0.3217646250242329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK2A1,Casein kinase II subunit alpha,21237,57,1.02 [0.58-1.78],0.955402165754789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG4,Chondroitin sulfate proteoglycan 4,21263,58,1.27 [0.59-2.73],0.5375715622791497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG5,Chondroitin sulfate proteoglycan 5,20613,54,0.87 [0.49-1.54],0.6367685208577873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSRP3,Cysteine and glycine-rich protein 3,20607,56,1.12 [0.88-1.43],0.3555880170380943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST1,Cystatin-SN,18424,51,1.49 [1.16-1.90],0.001538241197706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST3,Cystatin-C,24537,66,1.26 [0.56-2.86],0.5802292925078412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST5,Cystatin-D,24075,62,1.42 [0.95-2.13],0.0858025045742954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST6,Cystatin-M,23901,65,0.87 [0.54-1.40],0.5598823548919567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST7,Cystatin-F,24526,65,1.08 [0.87-1.34],0.4752116201667974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSTB,Cystatin-B,24174,65,1.05 [0.63-1.75],0.8447978257002897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTAG1A_CTAG1B,Cancer/testis antigen 1,20820,52,1.17 [0.72-1.89],0.533473466565686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTBS,Di-N-acetylchitobiase,20980,56,0.97 [0.38-2.50],0.9563337685095724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTF1,Cardiotrophin-1,24088,63,0.98 [0.75-1.28],0.8922758579131719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTHRC1,Collagen triple helix repeat-containing protein 1,21263,58,1.11 [0.44-2.83],0.8200749965292354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTLA4,Cytotoxic T-lymphocyte protein 4,21263,58,0.80 [0.34-1.89],0.6180587161461839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTNNA1,Catenin alpha-1,20613,54,0.93 [0.43-2.03],0.8529115201944257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRB1,Chymotrypsinogen B,24511,65,0.96 [0.64-1.44],0.8423860771984174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRC,Chymotrypsin-C,24495,65,1.08 [0.76-1.54],0.6734631597618347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRL,Chymotrypsin-like protease CTRL-1,21213,57,1.11 [0.76-1.63],0.5881113503519952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSB,Cathepsin B,24504,66,1.79 [1.21-2.64],0.0033299499655524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSC,Dipeptidyl peptidase 1,24443,65,1.20 [0.74-1.95],0.4601825648477742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSD,Cathepsin D,22853,62,1.19 [0.69-2.06],0.5374622674710662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSE,Cathepsin E,20790,55,0.83 [0.51-1.35],0.4507234052714017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSF,Cathepsin F,24569,66,0.91 [0.53-1.56],0.7363761209891143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSH,Pro-cathepsin H,24021,63,0.78 [0.57-1.05],0.1017138404606141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSL,Cathepsin L1,24532,66,0.60 [0.23-1.53],0.2832811673544361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSO,Cathepsin O,24821,67,1.48 [0.75-2.94],0.2579563910878409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSS,Cathepsin S,19370,50,0.80 [0.25-2.50],0.6962725948003021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSV,Cathepsin L2,24665,65,0.88 [0.51-1.51],0.6354123007313427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSZ,Cathepsin Z,24486,66,1.34 [0.66-2.68],0.4162080519946993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CUZD1,CUB and zona pellucida-like domain-containing protein 1,20684,55,1.30 [0.72-2.34],0.3890665628528295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CWC15,Spliceosome-associated protein CWC15 homolog,21060,56,1.10 [0.77-1.57],0.588882857304269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CX3CL1,Fractalkine,24363,64,1.74 [0.95-3.21],0.0743024209731287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXADR,Coxsackievirus and adenovirus receptor,24511,66,0.95 [0.61-1.47],0.8103500302351674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL1,Growth-regulated alpha protein,24444,65,0.86 [0.67-1.10],0.2370047972943814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL10,C-X-C motif chemokine 10,24614,65,1.05 [0.76-1.45],0.7800936452482532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL11,C-X-C motif chemokine 11,24755,65,1.04 [0.79-1.38],0.7745786626386562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL12,Stromal cell-derived factor 1,24074,64,1.08 [0.63-1.88],0.7730138630045407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL13,C-X-C motif chemokine 13,24755,65,1.05 [0.73-1.51],0.7950072995035955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL14,C-X-C motif chemokine 14,24074,64,0.93 [0.63-1.38],0.7336024794542553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL16,C-X-C motif chemokine 16,24764,66,2.36 [0.95-5.84],0.0635244721339399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL17,C-X-C motif chemokine 17,24821,67,0.70 [0.42-1.18],0.1838735324689851
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL3,C-X-C motif chemokine 3,24491,65,0.90 [0.72-1.13],0.3771149064787312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL5,C-X-C motif chemokine 5,24447,66,0.86 [0.71-1.04],0.1225049423636355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL6,C-X-C motif chemokine 6,24821,67,0.85 [0.64-1.13],0.2556827300711981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL8,Interleukin-8,24329,66,0.86 [0.60-1.21],0.3829036559965175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL9,C-X-C motif chemokine 9,24614,65,1.18 [0.87-1.61],0.2885587411426463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5A,Cytochrome b5,20513,53,0.66 [0.41-1.05],0.0795766781277112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5R2,NADH-cytochrome b5 reductase 2,20922,55,0.72 [0.45-1.16],0.18295952727425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",20607,56,0.96 [0.71-1.32],0.8176380695540363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTH3,Cytohesin-3,20513,53,0.96 [0.67-1.39],0.839117157949108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTL1,Cytokine-like protein 1,21263,58,1.03 [0.35-3.02],0.9579805612171196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAAM1,Disheveled-associated activator of morphogenesis 1,20790,55,0.95 [0.69-1.31],0.7561613896677949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAB2,Disabled homolog 2,24740,66,0.92 [0.76-1.11],0.4021461993616885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAG1,Dystroglycan,24614,65,0.85 [0.54-1.33],0.4720672877260331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAND5,DAN domain family member 5,20661,55,1.03 [0.65-1.63],0.901323636240541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPK2,Death-associated protein kinase 2,20661,55,1.03 [0.67-1.60],0.8853380803999882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,24511,66,0.87 [0.74-1.03],0.1021801141077002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DARS1,"Aspartate--tRNA ligase, cytoplasmic",24316,64,0.84 [0.62-1.13],0.2419504950358449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBH,Dopamine beta-hydroxylase,21240,56,0.89 [0.73-1.09],0.2714350437783701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBI,Acyl-CoA-binding protein,24395,65,0.96 [0.72-1.26],0.7458585512599698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBN1,Drebrin,20661,55,0.70 [0.40-1.21],0.1971530753967341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBNL,Drebrin-like protein,24614,65,0.87 [0.69-1.10],0.2535474314695493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",24569,66,2.19 [1.27-3.76],0.0046692997315922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCC,Netrin receptor DCC,20684,55,0.92 [0.28-3.01],0.8944232026092225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCDC2C,Doublecortin domain-containing protein 2C,20513,53,0.93 [0.59-1.44],0.7321401105189547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCLRE1C,Protein artemis,20513,53,0.69 [0.28-1.68],0.4123632040666829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCN,Decorin,24088,63,0.73 [0.25-2.12],0.5634350332470546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTD,Deoxycytidylate deaminase,20790,55,0.88 [0.67-1.15],0.3346310385657803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN1,Dynactin subunit 1,24740,66,0.84 [0.60-1.17],0.3074437150324388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN2,Dynactin subunit 2,24399,63,0.99 [0.78-1.25],0.9310685305049916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN6,Dynactin subunit 6,23939,60,0.91 [0.65-1.29],0.6034565689571263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTPP1,dCTP pyrophosphatase 1,24532,66,0.80 [0.40-1.61],0.5345611687212726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D1,DCN1-like protein 1,20613,54,0.92 [0.64-1.33],0.6644308086174414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D2,DCN1-like protein 2,20513,53,1.28 [1.00-1.64],0.0471163768204901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCXR,L-xylulose reductase,24569,66,0.53 [0.34-0.81],0.0035848742843422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDA1,DET1- and DDB1-associated protein 1,20607,56,0.72 [0.35-1.49],0.3729074703571168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",24399,63,0.84 [0.50-1.40],0.5043941654579998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDC,Aromatic-L-amino-acid decarboxylase,24504,66,0.92 [0.58-1.46],0.7249533332687086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDHD2,Phospholipase DDHD2,21237,57,0.88 [0.60-1.28],0.4973930866940761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDI2,Protein DDI1 homolog 2,20790,55,0.90 [0.64-1.27],0.5560452788071151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDR1,Epithelial discoidin domain-containing receptor 1,24755,65,1.70 [0.69-4.18],0.2459470540860908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDT,D-dopachrome decarboxylase,21263,58,0.65 [0.34-1.25],0.1999779415017923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX1,ATP-dependent RNA helicase DDX1,21177,56,1.09 [0.69-1.73],0.7168186414383031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX25,ATP-dependent RNA helicase DDX25,20684,55,0.81 [0.38-1.73],0.5780051595608059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX39A,ATP-dependent RNA helicase DDX39A,20661,55,0.84 [0.25-2.76],0.7710090884027954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX4,Probable ATP-dependent RNA helicase DDX4,20661,55,0.89 [0.54-1.47],0.6501909041686373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX53,Probable ATP-dependent RNA helicase DDX53,20684,55,1.66 [1.05-2.62],0.0316359859241669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX58,Antiviral innate immune response receptor RIG-I,23935,64,0.97 [0.66-1.43],0.8893285590042408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",24511,66,0.88 [0.70-1.10],0.2631322284297316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFA1_DEFA1B,Neutrophil defensin 1,23995,63,1.25 [0.85-1.84],0.2652405038453148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB103A_DEFB103B,Beta-defensin 103,20516,55,0.69 [0.32-1.46],0.3320151834106866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB104A_DEFB104B,Beta-defensin 104,20613,54,1.21 [0.81-1.80],0.3557420276918753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB116,Beta-defensin 116,20613,54,1.20 [0.91-1.57],0.1931302510886269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB118,Beta-defensin 118,20613,54,0.99 [0.63-1.56],0.9549112039038568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB4A_DEFB4B,Beta-defensin 4A,24141,63,0.98 [0.84-1.14],0.804631467719325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENND2B,DENN domain-containing protein 2B,20607,56,1.13 [0.72-1.77],0.6047400946634907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENR,Density-regulated protein,20661,55,0.75 [0.46-1.23],0.2578137782090116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DFFA,DNA fragmentation factor subunit alpha,24821,67,0.82 [0.59-1.13],0.2255972327339696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGCR6,Protein DGCR6,20613,54,1.23 [0.76-1.99],0.3986646247961589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKA,Diacylglycerol kinase alpha,20661,55,0.94 [0.58-1.53],0.8132022316692594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKZ,Diacylglycerol kinase zeta,24074,64,1.22 [0.68-2.20],0.5087154508558378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHODH,Dihydroorotate dehydrogenase,20607,56,1.12 [0.67-1.88],0.6563577256410352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHPS,Deoxyhypusine synthase,21153,56,0.48 [0.23-1.02],0.0579016213374095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,21213,57,0.97 [0.57-1.67],0.9153225094469724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIABLO,"Diablo homolog, mitochondrial",24442,66,0.92 [0.75-1.11],0.3796261216274685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK1C,Divergent protein kinase domain 1C,20684,55,1.09 [0.61-1.96],0.7720492001113803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK2B,Divergent protein kinase domain 2B,20790,55,0.75 [0.29-1.92],0.5440695229598778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK1,Dickkopf-related protein 1,24755,65,0.93 [0.65-1.33],0.6845737925240731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK3,Dickkopf-related protein 3,24814,66,1.19 [0.56-2.54],0.6496083993519373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK4,Dickkopf-related protein 4,24320,64,0.76 [0.46-1.26],0.2897764520175822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKKL1,Dickkopf-like protein 1,24399,63,0.98 [0.76-1.28],0.899119433363691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLG4,Disks large homolog 4,21213,57,1.00 [0.70-1.42],0.993572548817421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLGAP5,Disks large-associated protein 5,21237,57,0.87 [0.50-1.52],0.62995013123129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLK1,Protein delta homolog 1,24814,66,0.91 [0.62-1.33],0.6199912340956821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL1,Delta-like protein 1,24569,66,2.49 [1.20-5.15],0.0138731005122414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL4,Delta-like protein 4,20682,56,1.02 [0.77-1.35],0.899447439378225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMD,Dystrophin,20682,56,1.10 [0.67-1.80],0.6979528270272339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMP1,Dentin matrix acidic phosphoprotein 1,20682,56,1.13 [0.72-1.78],0.5852014689092935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA1,DnaJ homolog subfamily A member 1,20513,53,1.11 [0.67-1.85],0.6760534148763002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA2,DnaJ homolog subfamily A member 2,24733,67,0.88 [0.68-1.14],0.3296264316700082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA4,DnaJ homolog subfamily A member 4,21213,57,0.83 [0.58-1.19],0.2995593217746688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB1,DnaJ homolog subfamily B member 1,24399,63,0.88 [0.68-1.14],0.3353283459888881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB14,DnaJ homolog subfamily B member 14,21177,56,1.03 [0.70-1.50],0.8898662977409376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB2,DnaJ homolog subfamily B member 2,20790,55,0.85 [0.52-1.39],0.516698806989714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB6,DnaJ homolog subfamily B member 6,20591,54,0.90 [0.66-1.22],0.495310501619566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB8,DnaJ homolog subfamily B member 8,24088,63,1.02 [0.70-1.50],0.9056724399693722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC21,DnaJ homolog subfamily C member 21,21213,57,0.70 [0.34-1.41],0.3150900182869225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC6,Putative tyrosine-protein phosphatase auxilin,20682,56,0.92 [0.67-1.25],0.5838868439914706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC9,DnaJ homolog subfamily C member 9,21177,56,0.89 [0.64-1.24],0.4898422882462757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNER,Delta and Notch-like epidermal growth factor-related receptor,24458,65,0.55 [0.23-1.30],0.1719912235368159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNLZ,DNL-type zinc finger protein,20613,54,0.91 [0.65-1.26],0.5612378586932556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM1,Dynamin-1,21177,56,0.86 [0.69-1.06],0.163294212669445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM3,Dynamin-3,21237,57,1.07 [0.68-1.68],0.7834216876422361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNMBP,Dynamin-binding protein,24363,64,0.93 [0.65-1.34],0.6943418359109141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPEP,Aspartyl aminopeptidase,21213,57,0.84 [0.57-1.26],0.4045457555593186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,24563,65,0.97 [0.64-1.48],0.8981229755555272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOC2B,Double C2-like domain-containing protein beta,20684,55,1.09 [0.58-2.08],0.7812530202696237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOCK9,Dedicator of cytokinesis protein 9,20613,54,0.95 [0.75-1.20],0.6595214360048405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK1,Docking protein 1,21213,57,0.91 [0.77-1.09],0.3164623127461196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK2,Docking protein 2,24532,66,0.92 [0.77-1.10],0.3742462766252797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP1,Dipeptidase 1,24316,64,0.72 [0.46-1.11],0.1391244928881722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP2,Dipeptidase 2,24399,63,1.22 [0.57-2.62],0.605203587922407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP10,Inactive dipeptidyl peptidase 10,24511,66,0.79 [0.41-1.53],0.485368883479441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP4,Dipeptidyl peptidase 4,24009,65,0.33 [0.17-0.67],0.0021193831055238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP6,Dipeptidyl aminopeptidase-like protein 6,24399,63,0.94 [0.48-1.85],0.8534060671834389
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP7,Dipeptidyl peptidase 2,24327,65,1.42 [1.00-2.03],0.0509145709114148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPT,Dermatopontin,24814,66,0.79 [0.36-1.76],0.5706740807321993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPY30,Protein dpy-30 homolog,24675,66,0.81 [0.55-1.19],0.2803340558076677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRAXIN,Draxin,24363,64,0.93 [0.55-1.57],0.7868674485889882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRG2,Developmentally-regulated GTP-binding protein 2,24399,63,0.78 [0.52-1.17],0.2324138983960359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSC2,Desmocollin-2,24213,64,1.55 [0.80-3.00],0.1978690377966488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSCAM,Down syndrome cell adhesion molecule,21237,57,1.72 [0.87-3.42],0.1199960021766538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG2,Desmoglein-2,24511,65,1.62 [0.71-3.67],0.2514934369640894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG3,Desmoglein-3,24669,66,1.10 [0.57-2.09],0.7826807562629284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG4,Desmoglein-4,24309,63,0.73 [0.47-1.15],0.1773889495180078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTD1,D-aminoacyl-tRNA deacylase 1,20790,55,0.94 [0.70-1.27],0.7025244853809941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTNB,Dystrobrevin beta,21117,56,1.19 [0.69-2.05],0.5266026903736805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX2,Probable E3 ubiquitin-protein ligase DTX2,20684,55,0.84 [0.53-1.32],0.4405686063483822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX3,Probable E3 ubiquitin-protein ligase DTX3,24399,63,1.03 [0.40-2.66],0.9548650142997296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTYMK,Thymidylate kinase,21270,57,0.95 [0.66-1.36],0.7636175114517154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUOX2,Dual oxidase 2,24088,63,0.99 [0.72-1.35],0.9480619112831292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP13,Dual specificity protein phosphatase 13 isoform A,21153,56,0.74 [0.39-1.40],0.3508035454788906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP29,Dual specificity phosphatase 29,20684,55,1.14 [0.81-1.60],0.4474726140273064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP3,Dual specificity protein phosphatase 3,23939,60,0.78 [0.57-1.07],0.128477129901261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",21177,56,0.91 [0.71-1.16],0.4461372276778474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DXO,Decapping and exoribonuclease protein,21213,57,1.04 [0.61-1.80],0.8755291225721669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,21153,56,0.70 [0.36-1.35],0.2837126640795535
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT1,Dynein light chain Tctex-type 1,20684,55,0.84 [0.59-1.19],0.3246246235067627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT3,Dynein light chain Tctex-type 3,21153,56,0.77 [0.42-1.41],0.3921315681594988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,24363,64,0.86 [0.68-1.09],0.2252754735799465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBI3_IL27,Interleukin-27,24708,66,2.42 [1.34-4.37],0.0032574810767435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECE1,Endothelin-converting enzyme 1,23939,60,1.24 [0.65-2.35],0.5158527734052638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",21270,57,0.98 [0.70-1.37],0.9136564620731668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHS1,"Enoyl-CoA hydratase, mitochondrial",20682,56,0.84 [0.64-1.10],0.2138507510412039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECI2,Enoyl-CoA delta isomerase 2,20607,56,1.01 [0.67-1.53],0.9539148496391904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECM1,Extracellular matrix protein 1,20696,57,0.42 [0.24-0.72],0.0016837848511869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECSCR,Endothelial cell-specific chemotaxis regulator,20613,54,0.99 [0.59-1.65],0.9549401752127026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDA2R,Tumor necrosis factor receptor superfamily member 27,24740,66,1.31 [0.69-2.48],0.4128808424403895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDAR,Tumor necrosis factor receptor superfamily member EDAR,24511,66,0.84 [0.66-1.06],0.1415358341117474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDDM3B,Epididymal secretory protein E3-beta,21153,56,1.26 [0.81-1.96],0.302399939809763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,20607,56,0.89 [0.43-1.87],0.7625159258161512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDF1,Endothelial differentiation-related factor 1,21237,57,0.99 [0.69-1.42],0.9618011719486862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,24088,63,1.05 [0.57-1.93],0.8832401434903047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDN1,Endothelin-1,20682,56,0.94 [0.38-2.37],0.90120847044448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDNRB,Endothelin receptor type B,20661,55,0.84 [0.44-1.60],0.5956831387171854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EEF1D,Elongation factor 1-delta,21270,57,0.94 [0.71-1.24],0.6443488805944715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB14,EF-hand calcium-binding domain-containing protein 14,21177,56,1.68 [0.77-3.68],0.1949218199933514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB2,Dynein regulatory complex protein 8,20866,52,1.09 [0.52-2.26],0.8215911161120736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,24529,66,1.44 [0.71-2.94],0.310490194183113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFHD1,EF-hand domain-containing protein D1,21237,57,0.76 [0.35-1.66],0.493336635033421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA1,Ephrin-A1,24467,65,3.09 [1.51-6.33],0.0020372306072315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA4,Ephrin-A4,24322,64,2.39 [1.19-4.79],0.0138573601894977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNB2,Ephrin-B2,20684,55,1.23 [0.89-1.70],0.2122186067963833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGF,Pro-epidermal growth factor,24453,65,0.90 [0.73-1.11],0.3289549227745744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFL7,Epidermal growth factor-like protein 7,23935,64,1.37 [0.81-2.32],0.236164388129627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFLAM,Pikachurin,21177,56,0.76 [0.32-1.80],0.5310005234453874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFR,Epidermal growth factor receptor,24814,66,0.78 [0.20-3.01],0.7130127090130469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGLN1,Egl nine homolog 1,24511,66,0.84 [0.54-1.31],0.4370159037352181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHBP1,EH domain-binding protein 1,21270,57,0.81 [0.57-1.16],0.2511385953155545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHD3,EH domain-containing protein 3,20682,56,0.87 [0.70-1.07],0.1868210463821693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",21213,57,0.82 [0.49-1.37],0.4529422384598248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",21115,56,0.95 [0.75-1.20],0.6647168167490255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,20607,56,1.02 [0.68-1.53],0.9357057209497668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,20682,56,1.16 [0.66-2.03],0.6104284310662871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4B,Eukaryotic translation initiation factor 4B,24363,64,0.76 [0.53-1.11],0.1524516570251882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4E,Eukaryotic translation initiation factor 4E,20661,55,0.93 [0.69-1.23],0.5982015659651437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,24532,66,0.86 [0.61-1.21],0.383217448910224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,24821,67,0.90 [0.73-1.12],0.3419843243731454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,21237,57,0.88 [0.59-1.32],0.5366695976982202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5,Eukaryotic translation initiation factor 5,20607,56,1.11 [0.64-1.91],0.7114509257122755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5A,Eukaryotic translation initiation factor 5A-1,24074,64,1.19 [0.59-2.40],0.6308620062496818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAC1,Zinc phosphodiesterase ELAC protein 1,21237,57,0.85 [0.64-1.14],0.2745026571868364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAVL4,ELAV-like protein 4,20613,54,0.87 [0.62-1.22],0.424573339790661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELN,Elastin,21270,57,1.81 [0.86-3.80],0.1171323519734187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOA,Elongin-A,24399,63,1.04 [0.71-1.53],0.840198416991947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOB,Elongin-B,20607,56,0.74 [0.35-1.56],0.4291434586030803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENAH,Protein enabled homolog,24074,64,0.60 [0.37-0.98],0.042203335853597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENDOU,Poly(U)-specific endoribonuclease,19656,52,1.60 [1.02-2.52],0.0410465807972978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENG,Endoglin,24814,66,1.16 [0.32-4.17],0.8235456570932171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO1,Alpha-enolase,24500,65,0.82 [0.62-1.08],0.1531661870631253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO2,Gamma-enolase,24755,65,0.88 [0.63-1.23],0.4546887805004547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO3,Beta-enolase,20682,56,0.88 [0.56-1.37],0.5650498857276566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOPH1,Enolase-phosphatase E1,21153,56,0.98 [0.61-1.55],0.9222966238097466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,20607,56,0.91 [0.35-2.38],0.8479777328349373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPEP,Glutamyl aminopeptidase,20607,56,1.10 [0.65-1.88],0.7140055848412543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,24814,66,1.54 [0.71-3.37],0.277897055288387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,24614,65,0.79 [0.52-1.21],0.2781554774386501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,20682,56,0.63 [0.32-1.26],0.1890177619137938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,23798,63,1.11 [0.86-1.44],0.4129140442014646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENSA,Alpha-endosulfine,21153,56,0.76 [0.45-1.28],0.3058598562538868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,23935,64,1.13 [0.68-1.89],0.6313306881037627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,24088,63,0.84 [0.30-2.40],0.7507903302374432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,24088,63,1.48 [0.61-3.59],0.3860839236243167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTR1,Endosome-associated-trafficking regulator 1,20682,56,1.04 [0.69-1.58],0.8538832644410002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EP300,Histone acetyltransferase p300,20661,55,1.10 [0.49-2.48],0.8112642597596065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPB41L5,Band 4.1-like protein 5,20684,55,1.06 [0.73-1.54],0.7717647620360565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPCAM,Epithelial cell adhesion molecule,24498,65,1.02 [0.82-1.29],0.8358120948364253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPGN,Epigen,21153,56,0.56 [0.24-1.30],0.1776789822403073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA1,Ephrin type-A receptor 1,24563,65,1.67 [0.85-3.29],0.1374736151153176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA10,Ephrin type-A receptor 10,23939,60,0.82 [0.54-1.25],0.3609829618916669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA2,Ephrin type-A receptor 2,23642,61,1.50 [0.70-3.22],0.2972826896512845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA4,Ephrin type-A receptor 4,20790,55,1.17 [0.47-2.92],0.7396334636681076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB4,Ephrin type-B receptor 4,24814,66,3.06 [1.45-6.48],0.0034504456119775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB6,Ephrin type-B receptor 6,24316,64,2.23 [1.09-4.56],0.0273118536638382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHX2,Bifunctional epoxide hydrolase 2,24088,63,0.67 [0.43-1.05],0.0816347142392044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPN1,Epsin-1,20866,52,0.77 [0.37-1.58],0.476811114228619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPO,Erythropoietin,24511,66,1.06 [0.80-1.39],0.7039891903259801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPPK1,Epiplakin,20682,56,1.19 [0.85-1.66],0.3216137052891881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,24707,66,0.71 [0.34-1.51],0.3783185090282248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB2,Receptor tyrosine-protein kinase erbB-2,24569,66,0.85 [0.36-2.00],0.70133654779412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB3,Receptor tyrosine-protein kinase erbB-3,24399,65,1.12 [0.36-3.45],0.8427854255270737
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB4,Receptor tyrosine-protein kinase erbB-4,24569,66,0.57 [0.24-1.35],0.2005419061764241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBIN,Erbin,24399,63,0.85 [0.68-1.05],0.1269835266491875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERC2,ERC protein 2,20684,55,0.94 [0.66-1.35],0.7498979959250557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERCC1,DNA excision repair protein ERCC-1,20513,53,1.23 [0.64-2.33],0.5354048744811348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EREG,Proepiregulin,24316,64,0.97 [0.73-1.27],0.8062237669843789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERI1,3'-5' exoribonuclease 1,20866,52,1.14 [0.55-2.37],0.7238929646085273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERMAP,Erythroid membrane-associated protein,20661,55,1.16 [0.65-2.06],0.6115480294707281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,21153,56,0.90 [0.46-1.78],0.7632483271137214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP29,Endoplasmic reticulum resident protein 29,20790,55,0.92 [0.74-1.14],0.4233636178804849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP44,Endoplasmic reticulum resident protein 44,24365,63,0.69 [0.29-1.64],0.4064500587018098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,20607,56,1.22 [0.77-1.93],0.397211775587641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESAM,Endothelial cell-selective adhesion molecule,24814,66,1.39 [0.71-2.74],0.3384303076278974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESM1,Endothelial cell-specific molecule 1,24494,65,0.97 [0.50-1.85],0.9187715970474776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESPL1,Separin,20513,53,1.13 [0.74-1.72],0.5818872702625003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESR1,Estrogen receptor,20661,55,0.58 [0.31-1.10],0.0940464760624496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESYT2,Extended synaptotagmin-2,21213,57,1.00 [0.73-1.36],0.9751106432603216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI2B,Protein EVI2B,20513,53,0.81 [0.38-1.72],0.5802440582705184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI5,Ecotropic viral integration site 5 protein homolog,20661,55,0.99 [0.74-1.31],0.9255236591721964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVPL,Envoplakin,20866,52,0.77 [0.31-1.88],0.5640034594524101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXOSC10,Exosome component 10,20607,56,0.91 [0.58-1.44],0.6911083033434169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXTL1,Exostosin-like 1,20607,56,0.82 [0.45-1.49],0.510292415130291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EZR,Ezrin,24755,65,0.57 [0.23-1.43],0.2303611716508821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F10,Coagulation factor X,21274,56,0.66 [0.24-1.82],0.4271519948429048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11,Coagulation factor XI,20988,58,0.38 [0.15-0.96],0.0395591122212289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11R,Junctional adhesion molecule A,24511,65,0.96 [0.65-1.42],0.8435218406801581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F12,Coagulation factor XII,21296,58,0.95 [0.52-1.74],0.8633311433608744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F13B,Coagulation factor XIII B chain,21186,58,0.55 [0.22-1.38],0.2005737616737905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2,Prothrombin,21296,58,0.42 [0.08-2.22],0.3103447514494356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2R,Proteinase-activated receptor 1,24579,65,0.82 [0.56-1.19],0.2994388065779363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F3,Tissue factor,24583,65,1.38 [0.61-3.10],0.4420925212337431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F7,Coagulation factor VII,24538,66,0.96 [0.46-1.99],0.9133744824554544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F9,Coagulation factor IX,24549,66,0.53 [0.16-1.70],0.285704035355072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP1,"Fatty acid-binding protein, liver",24494,65,0.91 [0.71-1.16],0.4495619346905017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP2,"Fatty acid-binding protein, intestinal",24532,66,0.90 [0.67-1.20],0.4682225800012269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP3,"Fatty acid-binding protein, heart",21270,57,1.29 [0.81-2.07],0.2832052575137712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP4,"Fatty acid-binding protein, adipocyte",24814,66,0.75 [0.47-1.18],0.2154583952654983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP5,Fatty acid-binding protein 5,24688,65,0.88 [0.63-1.21],0.4220978358026572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP6,Gastrotropin,24055,63,1.08 [0.72-1.63],0.6945591734676074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP9,Fatty acid-binding protein 9,24511,66,1.01 [0.68-1.50],0.9443885540031272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FADD,FAS-associated death domain protein,24532,66,0.89 [0.67-1.18],0.4254359669113272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM13A,Protein FAM13A,21177,56,0.90 [0.62-1.33],0.6077566607049625
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171A2,Protein FAM171A2,21237,57,0.79 [0.64-0.97],0.0230101655069374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171B,Protein FAM171B,21153,56,1.03 [0.42-2.55],0.9410501146110324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM172A,Cotranscriptional regulator FAM172A,20682,56,0.98 [0.65-1.48],0.918160224138175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM20A,Pseudokinase FAM20A,21270,57,0.66 [0.41-1.07],0.0908450121626204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3B,Protein FAM3B,24399,63,1.16 [0.60-2.24],0.6502234963802325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3C,Protein FAM3C,24504,66,1.53 [0.72-3.25],0.2684897620931308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3D,Protein FAM3D,21177,56,0.99 [0.73-1.33],0.9258707674320774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAP,Prolyl endopeptidase FAP,24814,66,0.50 [0.22-1.10],0.0844838573597172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FARSA,Phenylalanine--tRNA ligase alpha subunit,20684,55,1.09 [0.76-1.56],0.6270475470697359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAS,Tumor necrosis factor receptor superfamily member 6,24724,66,1.03 [0.54-1.98],0.930349101191732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FASLG,Tumor necrosis factor ligand superfamily member 6,24821,67,1.38 [0.77-2.47],0.2843694635731649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBLN2,Fibulin-2,21263,58,1.00 [0.42-2.35],0.9965249735684334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBN2,Fibrillin-2,20684,55,1.18 [0.77-1.79],0.4488319730844038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBP1,"Fructose-1,6-bisphosphatase 1",24532,66,0.70 [0.52-0.94],0.0191461142023099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21270,57,0.68 [0.47-0.99],0.0434141654467611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAR,Immunoglobulin alpha Fc receptor,24511,66,1.20 [0.76-1.90],0.4257736344316948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,21237,57,1.01 [0.36-2.87],0.9815715387883486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER2,Low affinity immunoglobulin epsilon Fc receptor,24511,65,1.63 [1.08-2.44],0.0190296116184773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,24384,66,0.93 [0.67-1.30],0.684706264670521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,23935,64,0.95 [0.64-1.40],0.7792911222309234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,24498,66,1.50 [0.94-2.39],0.086524795202011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN1,Ficolin-1,21240,56,1.18 [0.72-1.93],0.5084495264696418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN2,Ficolin-2,24379,65,0.66 [0.43-1.02],0.0628520256573226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL1,Fc receptor-like protein 1,24532,66,0.86 [0.52-1.44],0.5759922733430587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL2,Fc receptor-like protein 2,24714,67,0.84 [0.51-1.37],0.4742919306343441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL3,Fc receptor-like protein 3,24074,64,0.94 [0.61-1.44],0.7647047049106399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL5,Fc receptor-like protein 5,24511,65,1.04 [0.70-1.54],0.8551887827627744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL6,Fc receptor-like protein 6,24511,66,0.94 [0.68-1.30],0.6904244483943346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRLB,Fc receptor-like B,23935,64,1.21 [0.86-1.71],0.2724967749772822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX1,"Adrenodoxin, mitochondrial",20607,56,1.02 [0.69-1.51],0.914229975360181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX2,"Ferredoxin-2, mitochondrial",20607,56,1.16 [0.76-1.77],0.4822103607132599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FEN1,Flap endonuclease 1,23935,64,1.01 [0.73-1.40],0.96831123928772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FES,Tyrosine-protein kinase Fes/Fps,23935,64,0.96 [0.60-1.55],0.8796557353551755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FETUB,Fetuin-B,24549,66,0.91 [0.49-1.70],0.772426237547434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGA,Fibrinogen alpha chain,20801,58,0.63 [0.27-1.46],0.2853959268514475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",21237,57,0.98 [0.72-1.33],0.8912026816836751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF12,Fibroblast growth factor 12,20661,55,1.21 [0.80-1.82],0.3682019554270782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF16,Fibroblast growth factor 16,20661,55,0.54 [0.28-1.06],0.0723287446632639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF19,Fibroblast growth factor 19,24614,65,0.93 [0.70-1.23],0.6205392860534166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF2,Fibroblast growth factor 2,24511,66,0.84 [0.60-1.18],0.3246310758701308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF20,Fibroblast growth factor 20,20661,55,0.89 [0.47-1.68],0.7197342327850329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF21,Fibroblast growth factor 21,24708,66,1.03 [0.86-1.24],0.7142080448621901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF23,Fibroblast growth factor 23,24701,65,1.16 [0.82-1.64],0.3984889081877998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF3,Fibroblast growth factor 3,20661,55,0.80 [0.31-2.10],0.6501326824947666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF5,Fibroblast growth factor 5,24074,64,1.52 [0.81-2.84],0.189614074132169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF6,Fibroblast growth factor 6,20661,55,0.62 [0.27-1.41],0.2556785462376841
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF7,Fibroblast growth factor 7,20513,53,1.10 [0.82-1.47],0.5327354211484463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF9,Fibroblast growth factor 9,20470,53,1.06 [0.55-2.07],0.8611767493868965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP1,Fibroblast growth factor-binding protein 1,24569,66,0.93 [0.48-1.83],0.8432257175723391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP2,Fibroblast growth factor-binding protein 2,21263,58,1.02 [0.62-1.69],0.9228748603225296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP3,Fibroblast growth factor-binding protein 3,21213,57,0.80 [0.40-1.59],0.5284688248580578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR2,Fibroblast growth factor receptor 2,24569,66,1.15 [0.42-3.12],0.7847476313350921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR4,Fibroblast growth factor receptor 4,20790,55,0.99 [0.60-1.61],0.9532771932109654
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGL1,Fibrinogen-like protein 1,21274,56,1.51 [1.01-2.25],0.0441489027972811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGR,Tyrosine-protein kinase Fgr,23939,60,1.00 [0.69-1.45],0.999773815491564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FH,"Fumarate hydratase, mitochondrial",20613,54,0.85 [0.59-1.23],0.3907691619569714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIP2A,FHF complex subunit HOOK interacting protein 2A,20607,56,0.91 [0.53-1.58],0.7433225024450056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIT,Bis(5'-adenosyl)-triphosphatase,23939,60,1.04 [0.76-1.42],0.7948874744497306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FIS1,Mitochondrial fission 1 protein,24475,65,0.93 [0.70-1.24],0.6223276113388823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,21237,57,0.89 [0.69-1.14],0.345933236337645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,24623,66,0.92 [0.76-1.12],0.4051077319144619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,24363,64,0.99 [0.60-1.63],0.9573414318621776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,24363,64,0.93 [0.74-1.17],0.5136206264607719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,23892,60,0.96 [0.58-1.59],0.8806343656541646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBPL,FK506-binding protein-like,21177,56,0.82 [0.53-1.27],0.3822011762018575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLI1,Friend leukemia integration 1 transcription factor,23935,64,0.99 [0.81-1.21],0.9042524535592504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,24363,64,0.76 [0.35-1.69],0.5061763053720097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT1,Vascular endothelial growth factor receptor 1,24358,63,1.94 [1.00-3.74],0.0485141891884384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3,Receptor-type tyrosine-protein kinase FLT3,23935,64,0.79 [0.37-1.70],0.546564158043858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3LG,Fms-related tyrosine kinase 3 ligand,24821,67,0.64 [0.34-1.22],0.1747426234154537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT4,Vascular endothelial growth factor receptor 3,24569,66,0.83 [0.45-1.54],0.5549877245717284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMNL1,Formin-like protein 1,23939,60,1.04 [0.75-1.44],0.8100704580407669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMR1,Synaptic functional regulator FMR1,23935,64,0.87 [0.46-1.63],0.6600471826844452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FN1,Fibronectin,21296,58,0.69 [0.41-1.18],0.1772920255355645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNDC1,Fibronectin type III domain-containing protein 1,21213,57,0.77 [0.45-1.33],0.350332714443678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,21153,56,0.64 [0.29-1.42],0.2743412533745216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLH1,Glutamate carboxypeptidase 2,20661,55,0.94 [0.73-1.22],0.6323920134087946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR1,Folate receptor alpha,24450,66,1.21 [0.54-2.68],0.6455864866638712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR2,Folate receptor beta,24755,65,0.81 [0.37-1.74],0.5850751900053586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR3,Folate receptor gamma,24491,65,0.98 [0.87-1.10],0.7028056243834978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOS,Proto-oncogene c-Fos,20470,53,1.00 [0.48-2.06],0.9912645669578672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOSB,Protein fosB,23939,60,1.18 [0.72-1.93],0.5080734077139666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXJ3,Forkhead box protein J3,20661,55,1.06 [0.61-1.82],0.8420581580499299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO1,Forkhead box protein O1,24511,66,0.87 [0.68-1.13],0.2990554790359184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO3,Forkhead box protein O3,23935,64,0.98 [0.78-1.23],0.8740926067017485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD4B,FERM domain-containing protein 4B,20607,56,0.92 [0.62-1.36],0.6713201227337041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD7,FERM domain-containing protein 7,20684,55,1.18 [0.57-2.43],0.6629421671715567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRZB,Secreted frizzled-related protein 3,24286,63,0.41 [0.20-0.82],0.0118660684014155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSHB,Follitropin subunit beta,20682,56,0.74 [0.49-1.11],0.1434111551025335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FST,Follistatin,24579,65,1.48 [0.99-2.21],0.0590024050032313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL1,Follistatin-related protein 1,20682,56,0.68 [0.22-2.07],0.4941650704025846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL3,Follistatin-related protein 3,24459,65,1.92 [0.95-3.84],0.0676071814803136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FTCD,Formimidoyltransferase-cyclodeaminase,21177,57,0.72 [0.52-0.99],0.0424660050702957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUCA1,Tissue alpha-L-fucosidase,24645,66,1.05 [0.80-1.37],0.7418841473239572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUOM,Fucose mutarotase,20790,55,0.56 [0.39-0.81],0.0018818156136563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FURIN,Furin,24569,66,0.99 [0.52-1.86],0.9652749903831472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUS,RNA-binding protein FUS,23896,63,1.36 [0.82-2.25],0.2392650472453765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",20831,52,0.88 [0.55-1.40],0.5863543137264464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,24755,65,1.32 [0.81-2.18],0.2673934536367897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT8,"Alpha-(1,6)-fucosyltransferase",24363,64,0.76 [0.51-1.13],0.1696651931387667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXN,"Frataxin, mitochondrial",24740,66,0.96 [0.71-1.28],0.7589224681608071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXYD5,FXYD domain-containing ion transport regulator 5,24074,64,0.85 [0.60-1.21],0.3622395140326476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FYB1,FYN-binding protein 1,24473,65,0.87 [0.69-1.11],0.2575353180421482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD10,Frizzled-10,20684,55,0.93 [0.59-1.48],0.7698327928656099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD8,Frizzled-8,20613,54,1.19 [0.68-2.06],0.5471229924790044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAP,Gamma-aminobutyric acid receptor-associated protein,21153,56,1.41 [0.92-2.17],0.1192270000384922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,20866,52,1.17 [0.84-1.64],0.3434320187164276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,20613,54,0.80 [0.50-1.29],0.3604982650868434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD1,Glutamate decarboxylase 1,20513,53,1.31 [0.48-3.59],0.5988922300527016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD2,Glutamate decarboxylase 2,20661,55,0.77 [0.40-1.48],0.4316572609187116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,20866,52,0.75 [0.37-1.50],0.4173059377433578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,20682,56,0.84 [0.50-1.38],0.4846237948239941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAGE2A,G antigen 2A,20513,53,0.90 [0.57-1.43],0.663275889666384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAL,Galanin peptides,24614,65,0.85 [0.60-1.19],0.3361782724470407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,24399,63,1.40 [0.64-3.08],0.3959769253843364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,24740,66,0.94 [0.40-2.18],0.8770263927670218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24074,64,1.40 [0.83-2.34],0.2061355877904365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,21270,57,1.38 [0.55-3.47],0.4893943228110766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT7,N-acetylgalactosaminyltransferase 7,24399,63,0.76 [0.27-2.20],0.615980852711433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAMT,Guanidinoacetate N-methyltransferase,20607,56,0.62 [0.26-1.51],0.2918756917303886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,20344,52,0.72 [0.35-1.48],0.3705483868035452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GART,Trifunctional purine biosynthetic protein adenosine-3,21237,57,0.74 [0.26-2.15],0.5836038063604421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS2,Growth arrest-specific protein 2,20866,52,0.96 [0.57-1.62],0.879463242887091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS6,Growth arrest-specific protein 6,24636,65,0.76 [0.32-1.82],0.5427450988091227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GASK1A,Golgi-associated kinase 1A,20607,56,0.62 [0.34-1.13],0.1171050733429531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAST,Gastrin,21213,57,1.01 [0.81-1.25],0.9368101364007864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,20513,53,0.93 [0.34-2.52],0.8824650861101512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",20682,56,0.90 [0.64-1.26],0.5325628905328943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBA,Lysosomal acid glucosylceramidase,20684,55,1.12 [0.71-1.76],0.637256574987964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP1,Guanylate-binding protein 1,21174,57,0.82 [0.56-1.21],0.3179170300265236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP2,Guanylate-binding protein 2,24074,64,0.85 [0.58-1.24],0.4098581072199251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP4,Guanylate-binding protein 4,23939,60,0.92 [0.57-1.50],0.7427255874137992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP6,Guanylate-binding protein 6,20607,56,0.85 [0.45-1.60],0.6120451720885657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GC,Vitamin D-binding protein,21296,58,0.77 [0.30-2.02],0.5985902668092655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCC1,GRIP and coiled-coil domain-containing protein 1,21213,57,0.93 [0.74-1.18],0.5579464693509075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCG,Pro-glucagon,23935,64,1.08 [0.91-1.30],0.3774148078687428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20279,54,0.54 [0.29-1.00],0.0508845250949406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCLM,Glutamate--cysteine ligase regulatory subunit,20607,56,0.63 [0.32-1.25],0.1882210523104214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",24399,63,1.13 [0.59-2.17],0.7077413671706261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF15,Growth/differentiation factor 15,24814,66,1.53 [1.06-2.20],0.0217800279922122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF2,Growth/differentiation factor 2,24532,66,0.69 [0.37-1.29],0.2441258372829846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDNF,Glial cell line-derived neurotrophic factor,23939,60,0.94 [0.51-1.74],0.8483715361805232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GET3,ATPase GET3,21270,57,0.80 [0.48-1.33],0.3945959285892053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFAP,Glial fibrillary acidic protein,23901,64,0.96 [0.58-1.60],0.887773041322165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFER,FAD-linked sulfhydryl oxidase ALR,23935,64,0.86 [0.60-1.23],0.4127480570347701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,23935,64,0.86 [0.69-1.07],0.1821629762799547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA1,GDNF family receptor alpha-1,24708,66,0.89 [0.39-2.03],0.7813180952857552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA2,GDNF family receptor alpha-2,24399,63,0.85 [0.29-2.48],0.7596937962025148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA3,GDNF family receptor alpha-3,24282,64,0.51 [0.23-1.16],0.1078688169550352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRAL,GDNF family receptor alpha-like,20607,57,1.09 [0.73-1.64],0.6689879099704144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGA1,ADP-ribosylation factor-binding protein GGA1,23939,60,0.93 [0.67-1.31],0.6903097702479959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGACT,Gamma-glutamylaminecyclotransferase,21270,57,0.90 [0.63-1.29],0.5612820508469906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGCT,Gamma-glutamylcyclotransferase,21233,57,0.94 [0.56-1.58],0.8097851447075124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGH,Gamma-glutamyl hydrolase,24061,66,0.61 [0.32-1.18],0.1407971049401587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT1,Glutathione hydrolase 1 proenzyme,24467,65,0.62 [0.38-1.02],0.0573037982159325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT5,Glutathione hydrolase 5 proenzyme,24363,64,0.52 [0.21-1.30],0.1610377060221505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH1,Somatotropin,24504,66,1.08 [0.96-1.21],0.187096822037464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH2,Growth hormone variant,23935,64,0.91 [0.78-1.06],0.2278665683285915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHR,Growth hormone receptor,20790,55,0.61 [0.25-1.50],0.2815603444989578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRHR,Growth hormone-releasing hormone receptor,23939,60,0.84 [0.53-1.35],0.4809538098445991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRL,Appetite-regulating hormone,24532,66,1.36 [1.03-1.81],0.0315494238907131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GID8,Glucose-induced degradation protein 8 homolog,21237,57,0.64 [0.25-1.64],0.3496354899200586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIGYF2,GRB10-interacting GYF protein 2,21237,57,0.94 [0.67-1.31],0.6944827499375235
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP7,GTPase IMAP family member 7,20790,55,0.64 [0.26-1.54],0.315110775896584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP8,GTPase IMAP family member 8,20513,53,1.16 [0.72-1.87],0.5337820612493853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIP,Gastric inhibitory polypeptide,20682,56,1.24 [0.71-2.16],0.4516849236570169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC2,PDZ domain-containing protein GIPC2,21213,57,1.19 [0.50-2.82],0.700778939800019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC3,PDZ domain-containing protein GIPC3,21177,56,0.91 [0.71-1.16],0.4411834960092125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPR,Gastric inhibitory polypeptide receptor,20661,55,0.79 [0.42-1.51],0.4783728203290889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIT1,ARF GTPase-activating protein GIT1,20661,55,0.93 [0.71-1.22],0.6123331849575646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GJA8,Gap junction alpha-8 protein,20513,53,0.79 [0.48-1.30],0.3575450744715814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GKN1,Gastrokine-1,23475,60,1.74 [0.79-3.81],0.1681614264116975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLA,Alpha-galactosidase A,20744,55,0.87 [0.44-1.74],0.698882345840775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLB1,Beta-galactosidase,24363,64,0.82 [0.48-1.39],0.4598328457660827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLI2,Zinc finger protein GLI2,20661,55,0.87 [0.39-1.92],0.7231206205724766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLO1,Lactoylglutathione lyase,24088,63,1.16 [0.80-1.70],0.427973989243402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLOD4,Glyoxalase domain-containing protein 4,24440,65,0.89 [0.49-1.64],0.7187921532564965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLP1R,Glucagon-like peptide 1 receptor,20613,54,0.73 [0.33-1.61],0.4426779014945251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX,Glutaredoxin-1,24379,65,0.96 [0.66-1.41],0.8436134938763311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",20790,55,0.90 [0.67-1.21],0.4870645690697311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,23939,60,0.83 [0.48-1.45],0.5195167312373189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLYR1,Putative oxidoreductase GLYR1,21153,56,1.19 [0.84-1.70],0.3290330944056903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GM2A,Ganglioside GM2 activator,20759,56,1.58 [1.04-2.39],0.0303624334329655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMFG,Glia maturation factor gamma,21270,57,0.92 [0.65-1.31],0.656813034441311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR,GMP reductase 1,24821,67,0.80 [0.52-1.21],0.2823731078568787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR2,GMP reductase 2,20790,55,0.85 [0.57-1.26],0.4148468457971529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNAS,Neuroendocrine secretory protein 55,21237,57,0.83 [0.60-1.16],0.2748380458309817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,23935,64,0.91 [0.64-1.28],0.5796632506017705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,20684,55,1.03 [0.64-1.65],0.9135769228422584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNLY,Granulysin,24511,65,1.05 [0.68-1.60],0.8398239980195696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA1,Glucosamine-6-phosphate isomerase 1,20682,56,0.74 [0.31-1.80],0.5098254987139679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA2,Glucosamine-6-phosphate isomerase 2,20790,55,0.58 [0.28-1.20],0.142716167414744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLGA3,Golgin subfamily A member 3,21237,57,0.83 [0.59-1.17],0.2934269168079878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLM2,Protein GOLM2,24755,65,0.61 [0.22-1.67],0.3363605264001858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,24511,66,0.84 [0.68-1.04],0.1025254642893296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GORASP2,Golgi reassembly-stacking protein 2,21177,56,0.85 [0.49-1.48],0.5664246104900674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOT1,"Aspartate aminotransferase, cytoplasmic",21263,58,0.56 [0.31-1.02],0.0570964795434716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BA,Platelet glycoprotein Ib alpha chain,24388,66,0.99 [0.50-1.94],0.96678939226366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BB,Platelet glycoprotein Ib beta chain,20607,56,0.80 [0.55-1.18],0.2624740909575931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,23774,63,1.30 [1.03-1.63],0.0259483138763158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP5,Platelet glycoprotein V,20790,55,0.81 [0.40-1.64],0.5581340179233605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP6,Platelet glycoprotein VI,24473,65,0.91 [0.71-1.17],0.4637577523716608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPA33,Cell surface A33 antigen,24399,63,1.01 [0.85-1.19],0.9203586001039656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC1,Glypican-1,24740,66,2.25 [1.07-4.74],0.0332037540280958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC5,Glypican-5,24363,64,1.13 [0.76-1.67],0.5519316844975971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPD1,Glycerol-3-phosphate dehydrogenase,21153,56,0.47 [0.28-0.82],0.0071972347855811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPHA2,Glycoprotein hormone alpha-2,21177,56,1.01 [0.60-1.71],0.9675725502675084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPI,Glucose-6-phosphate isomerase,21274,56,0.78 [0.45-1.36],0.3808022656836543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,21177,56,1.04 [0.73-1.50],0.8148368614175989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPKOW,G-patch domain and KOW motifs-containing protein,23939,60,1.46 [0.83-2.58],0.1862989635378307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPNMB,Transmembrane glycoprotein NMB,23875,65,0.50 [0.24-1.05],0.0673255326981091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR101,Probable G-protein coupled receptor 101,20613,54,0.83 [0.50-1.37],0.468800634069029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR158,Probable G-protein coupled receptor 158,21237,57,0.61 [0.26-1.45],0.264542730766643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR15L,Protein GPR15L,21177,56,0.82 [0.55-1.22],0.3213848314435562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR37,Prosaposin receptor GPR37,24088,63,1.39 [0.98-1.97],0.0674685271048496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPRC5C,G-protein coupled receptor family C group 5 member C,21153,56,0.60 [0.34-1.06],0.0771922363898114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRAP2,GRB2-related adapter protein 2,24532,66,0.91 [0.77-1.07],0.2459884790158162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,21270,57,0.80 [0.54-1.18],0.2633929609969095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIK2,"Glutamate receptor ionotropic, kainate 2",21237,57,1.49 [0.92-2.40],0.1014636475294671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",20613,54,1.44 [1.09-1.92],0.0111967959858774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRK5,G protein-coupled receptor kinase 5,24088,63,0.80 [0.49-1.30],0.3645802147365984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRN,Progranulin,24392,65,2.87 [1.34-6.15],0.006560981264902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRP,Gastrin-releasing peptide,20682,56,0.83 [0.51-1.33],0.4373658172723269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRPEL1,"GrpE protein homolog 1, mitochondrial",24399,63,0.91 [0.62-1.32],0.6157797123645744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRSF1,G-rich sequence factor 1,20396,53,0.98 [0.71-1.36],0.9166344222976665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSAP,Gamma-secretase-activating protein,23935,64,0.88 [0.65-1.19],0.4090340033257553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSN,Gelsolin,21188,56,1.59 [0.39-6.41],0.5171740158240881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSR,"Glutathione reductase, mitochondrial",21153,56,0.62 [0.33-1.20],0.1560991163351354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA1,Glutathione S-transferase A1,24496,65,0.76 [0.58-1.00],0.0530820478388941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA3,Glutathione S-transferase A3,23935,64,0.76 [0.56-1.04],0.0842141479044862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTM4,Glutathione S-transferase Mu 4,20607,56,0.80 [0.52-1.23],0.3024694806174164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTP1,Glutathione S-transferase P,23786,60,1.24 [0.92-1.66],0.1574003793601208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTT2B,Glutathione S-transferase theta-2B,21213,57,1.01 [0.91-1.12],0.8420592480044748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,20866,52,1.03 [0.72-1.46],0.8705588736697334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTPBP2,GTP-binding protein 2,20684,55,0.86 [0.62-1.19],0.3528558414022205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCA2A,Guanylin,24392,65,1.40 [0.70-2.78],0.3371047163952204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCY2C,Heat-stable enterotoxin receptor,20866,52,0.95 [0.68-1.32],0.7514215164887605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUK1,Guanylate kinase,20607,56,1.01 [0.55-1.85],0.9788216484028364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUSB,Beta-glucuronidase,24603,66,1.01 [0.70-1.46],0.9440140982810628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GYS1,"Glycogen [starch] synthase, muscle",24088,63,0.99 [0.78-1.26],0.9549917856128732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMA,Granzyme A,24821,67,0.80 [0.42-1.54],0.5104580987872552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMB,Granzyme B,24511,66,0.80 [0.55-1.15],0.2198775765111872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMH,Granzyme H,24088,63,0.97 [0.71-1.31],0.8303363360253031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,H2AP,Huntingtin-interacting protein M,20513,53,1.27 [0.88-1.85],0.2036689376911264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",20607,56,0.66 [0.37-1.18],0.1594840562695901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",24677,66,1.01 [0.75-1.36],0.9386701640760636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAO1,Hydroxyacid oxidase 1,24740,66,0.91 [0.77-1.08],0.2806787603901626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HARS1,"Histidine--tRNA ligase, cytoplasmic",24511,65,0.90 [0.68-1.20],0.4748708173154928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR1,Hepatitis A virus cellular receptor 1,24709,66,1.26 [0.88-1.80],0.1983665354272131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR2,Hepatitis A virus cellular receptor 2,24511,65,1.46 [0.77-2.77],0.24124980915442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBEGF,Proheparin-binding EGF-like growth factor,24677,66,0.93 [0.69-1.24],0.6075776462813858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBQ1,Hemoglobin subunit theta-1,24740,66,1.06 [0.75-1.50],0.7565270637176076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBZ,Hemoglobin subunit zeta,21270,57,1.05 [0.83-1.33],0.6998826554156103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCG22,Protein PBMUCL2,20607,56,1.00 [0.62-1.62],0.9971328235429278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCLS1,Hematopoietic lineage cell-specific protein,24821,67,0.77 [0.53-1.12],0.1750516476087086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC8,Histone deacetylase 8,20661,55,0.79 [0.47-1.32],0.3610268450858755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC9,Histone deacetylase 9,20613,54,1.23 [0.90-1.68],0.2013350929312911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDDC2,5'-deoxynucleotidase HDDC2,21177,56,0.76 [0.42-1.39],0.3754668976317478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGF,Hepatoma-derived growth factor,24710,66,0.91 [0.72-1.14],0.4012912970488762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGFL2,Hepatoma-derived growth factor-related protein 2,21213,57,0.99 [0.67-1.46],0.9506406665220896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEBP1,Heme-binding protein 1,24088,63,1.06 [0.73-1.55],0.7460193900005392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEG1,Protein HEG homolog 1,20790,55,0.55 [0.21-1.46],0.230299205531933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPACAM2,HEPACAM family member 2,21213,57,0.59 [0.32-1.08],0.086116645305469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPH,Hephaestin,21270,57,0.87 [0.36-2.11],0.7606885470237802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEXIM1,Protein HEXIM1,24511,66,0.81 [0.62-1.06],0.1310207722277525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGF,Hepatocyte growth factor,24821,67,0.77 [0.40-1.47],0.4241167501802311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGFAC,Hepatocyte growth factor activator,21077,56,0.49 [0.21-1.13],0.095455198824947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,23935,64,0.96 [0.72-1.28],0.7879144520883347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HHEX,Hematopoietically-expressed homeobox protein HHEX,21213,57,0.90 [0.65-1.25],0.5266245619037466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIF1A,Hypoxia-inducible factor 1-alpha,20661,55,0.90 [0.59-1.39],0.648274610570957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1,Huntingtin-interacting protein 1,20607,56,0.88 [0.41-1.90],0.7415212160748248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1R,Huntingtin-interacting protein 1-related protein,21178,56,1.05 [0.62-1.78],0.8484222681252092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HJV,Hemojuvelin,21237,57,0.96 [0.54-1.71],0.8920401638077882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HK2,Hexokinase-2,24088,63,1.14 [0.51-2.51],0.753804499014424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",21237,57,1.03 [0.47-2.23],0.9469720310335696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",24428,66,0.53 [0.28-1.00],0.0511013928080351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24511,66,2.61 [1.37-4.98],0.0035189031029837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMBS,Porphobilinogen deaminase,24740,66,0.85 [0.52-1.38],0.5046497740255113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMCN2,Hemicentin-2,20748,55,0.90 [0.57-1.41],0.6494792043962572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",20682,56,0.81 [0.47-1.39],0.4469190336609547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",20607,56,0.88 [0.48-1.63],0.6854320835206236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMMR,Hyaluronan mediated motility receptor,20477,53,0.75 [0.40-1.43],0.388139692346504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX1,Heme oxygenase 1,24257,66,0.94 [0.59-1.50],0.8004319102580637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX2,Heme oxygenase 2,23939,60,0.99 [0.62-1.60],0.9817741399640942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNF1A,Hepatocyte nuclear factor 1-alpha,20684,55,1.16 [0.87-1.54],0.3093478757494384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNMT,Histamine N-methyltransferase,24241,64,0.83 [0.52-1.33],0.4349253794101166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,24002,63,0.95 [0.72-1.27],0.7427920534156955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,21237,57,1.14 [0.72-1.81],0.582648754646397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPCAL1,Hippocalcin-like protein 1,24821,67,0.84 [0.64-1.11],0.2111045138158289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPGDS,Hematopoietic prostaglandin D synthase,23935,64,1.07 [0.59-1.94],0.8260696483672894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPSE,Heparanase,20982,56,0.84 [0.64-1.09],0.1842586037371836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRAS,GTPase Hras,20837,52,0.80 [0.56-1.16],0.2430070160432362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,20682,56,1.28 [0.66-2.48],0.4691168453311688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRG,Histidine-rich glycoprotein,21186,58,0.62 [0.40-0.98],0.0426103878574644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS1BP3,HCLS1-binding protein 3,20682,56,0.92 [0.69-1.22],0.5702426423496597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,24399,63,0.65 [0.36-1.17],0.1477913490404366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,24740,66,1.36 [0.76-2.42],0.3043221933182746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,20661,55,0.97 [0.44-2.17],0.9444507596089832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSBP1,Heat shock factor-binding protein 1,20682,56,0.93 [0.71-1.21],0.5852197842390761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,24511,66,1.92 [1.11-3.34],0.0204950553237027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,21213,57,1.16 [0.78-1.72],0.4750851466060339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B3,Testosterone 17-beta-dehydrogenase 3,20607,56,1.10 [0.65-1.86],0.7125816961705422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,20682,56,0.66 [0.37-1.16],0.1490027121897124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSP90B1,Endoplasmin,23835,60,0.88 [0.60-1.30],0.526447615704729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA1A,Heat shock 70 kDa protein 1A,24563,65,0.86 [0.63-1.18],0.345941991672315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA2,Heat shock-related 70 kDa protein 2,21153,56,0.83 [0.37-1.86],0.6464003068125326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB1,Heat shock protein beta-1,24113,64,0.93 [0.68-1.26],0.6400184536294743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB6,Heat shock protein beta-6,24740,66,1.95 [1.19-3.21],0.0083141420419317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,24303,66,1.76 [0.75-4.13],0.1917509903285587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1A,5-hydroxytryptamine receptor 1A,20613,54,1.02 [0.73-1.43],0.8914429803699242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1B,5-hydroxytryptamine receptor 1B,20613,54,1.01 [0.55-1.85],0.9805428877659728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTRA2,"Serine protease HTRA2, mitochondrial",24569,66,0.82 [0.58-1.18],0.2905580222304658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYAL1,Hyaluronidase-1,24341,66,1.02 [0.40-2.64],0.9616675458318618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYOU1,Hypoxia up-regulated protein 1,24814,66,2.83 [1.05-7.61],0.0391834771994635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICA1,Islet cell autoantigen 1,24074,64,0.86 [0.65-1.15],0.3159006537209425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM1,Intercellular adhesion molecule 1,24388,66,0.92 [0.43-1.99],0.8333853350847764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM2,Intercellular adhesion molecule 2,24814,66,1.16 [0.58-2.31],0.6804292901248623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM3,Intercellular adhesion molecule 3,24814,66,0.95 [0.40-2.29],0.9128416531512474
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM4,Intercellular adhesion molecule 4,24511,66,1.03 [0.68-1.54],0.8994136910712331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM5,Intercellular adhesion molecule 5,24532,66,0.82 [0.51-1.34],0.4365337367892802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICOSLG,ICOS ligand,24399,63,0.64 [0.20-2.07],0.4525087887822767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ID4,DNA-binding protein inhibitor ID-4,20866,52,0.67 [0.31-1.44],0.3033311047731745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDI2,Isopentenyl-diphosphate delta-isomerase 2,23939,60,1.01 [0.62-1.64],0.9771232757631308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDO1,"Indoleamine 2,3-dioxygenase 1",20682,56,0.73 [0.48-1.13],0.1566193907902946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDS,Iduronate 2-sulfatase,24821,67,0.49 [0.05-4.97],0.5496109923211248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDUA,Alpha-L-iduronidase,24740,66,0.91 [0.57-1.44],0.6794579399724665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20697,54,0.57 [0.28-1.18],0.1322753319669629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,20866,52,0.84 [0.49-1.46],0.5461062064659721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,20866,52,1.11 [0.56-2.20],0.7606340542364141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNAR1,Interferon alpha/beta receptor 1,21177,56,0.55 [0.20-1.52],0.250366412499897
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNG,Interferon gamma,24074,64,1.05 [0.86-1.27],0.6332066713338638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR1,Interferon gamma receptor 1,24614,65,1.38 [0.48-3.99],0.5519747851474801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR2,Interferon gamma receptor 2,24363,64,1.34 [0.89-2.00],0.1589969526529762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL1,Interferon lambda-1,23939,60,1.18 [0.72-1.95],0.5060387306119669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL2,Interferon lambda-2,20613,54,0.75 [0.44-1.28],0.2851220104940986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNLR1,Interferon lambda receptor 1,24511,66,0.93 [0.51-1.72],0.822261029999815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNW1,Interferon omega-1,20607,56,0.73 [0.32-1.69],0.4620442896077029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFT20,Intraflagellar transport protein 20 homolog,20684,55,0.98 [0.55-1.76],0.9582324770292664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGBP1,Immunoglobulin-binding protein 1,21237,57,0.85 [0.56-1.29],0.4447699690635455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,20613,54,1.32 [0.92-1.89],0.1376943933122191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,21263,58,0.85 [0.32-2.24],0.7382401875108795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF1R,Insulin-like growth factor 1 receptor,24399,63,0.81 [0.28-2.33],0.689866742689506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,20607,56,1.04 [0.62-1.77],0.8761402896937112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2R,Cation-independent mannose-6-phosphate receptor,24511,65,2.96 [1.22-7.16],0.0161729196890156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP1,Insulin-like growth factor-binding protein 1,24772,66,1.20 [1.01-1.43],0.0431058664567616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP2,Insulin-like growth factor-binding protein 2,24767,66,1.30 [0.91-1.85],0.1482262706810823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP3,Insulin-like growth factor-binding protein 3,24578,66,0.59 [0.29-1.23],0.1609720524056921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP4,Insulin-like growth factor-binding protein 4,24191,65,2.40 [1.59-3.61],2.899256220159732e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP6,Insulin-like growth factor-binding protein 6,24389,66,1.75 [0.86-3.58],0.1254342560723932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP7,Insulin-like growth factor-binding protein 7,24814,66,0.57 [0.26-1.26],0.163351890573979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBPL1,Insulin-like growth factor-binding protein-like 1,24532,66,1.66 [0.89-3.08],0.1108218276395151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFL4,Insulin growth factor-like family member 4,20661,55,1.10 [0.82-1.48],0.51234043394783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGHMBP2,DNA-binding protein SMUBP-2,20607,56,0.87 [0.54-1.40],0.5755758246891209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLC2,Immunoglobulin lambda constant 2,21265,58,1.06 [0.41-2.76],0.9050286805399088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLON5,IgLON family member 5,20513,53,1.31 [1.10-1.55],0.0027511713220832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF21,Immunoglobulin superfamily member 21,20682,56,0.75 [0.37-1.52],0.4296754923386487
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF3,Immunoglobulin superfamily member 3,24399,63,1.59 [0.96-2.62],0.0703379237488295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF8,Immunoglobulin superfamily member 8,24532,66,1.31 [0.65-2.65],0.4563221587809826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF9,Protein turtle homolog A,21270,57,0.86 [0.63-1.17],0.3413903288105939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKBKG,NF-kappa-B essential modulator,24511,66,0.83 [0.66-1.05],0.1224225777307015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKZF2,Zinc finger protein Helios,23935,64,1.11 [0.91-1.35],0.3126659279273891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10,Interleukin-10,24074,64,1.21 [0.96-1.52],0.1089663289674223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RA,Interleukin-10 receptor subunit alpha,24074,64,0.89 [0.58-1.36],0.5953915848954339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RB,Interleukin-10 receptor subunit beta,24614,65,1.62 [0.78-3.34],0.1929059721370713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL11,Interleukin-11,24074,64,1.04 [0.74-1.46],0.810287638674137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12A_IL12B,Interleukin-12,24399,63,1.09 [0.81-1.46],0.5888589294726777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12B,Interleukin-12 subunit beta,24821,67,1.12 [0.75-1.69],0.5708047773198122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB1,Interleukin-12 receptor subunit beta-1,24074,64,0.84 [0.46-1.54],0.5761440160040753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB2,Interleukin-12 receptor subunit beta-2,20661,55,1.17 [0.66-2.08],0.5857661862451917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13,Interleukin-13,24074,64,1.02 [0.66-1.56],0.9381349137460704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA1,Interleukin-13 receptor subunit alpha-1,24176,62,1.30 [0.47-3.56],0.6098114636799219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA2,Interleukin-13 receptor subunit alpha-2,20613,54,1.71 [0.69-4.19],0.245166944637109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15,Interleukin-15,24511,66,1.54 [0.82-2.87],0.1760300931745392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15RA,Interleukin-15 receptor subunit alpha,24074,64,1.51 [0.79-2.89],0.2163333661568113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL16,Pro-interleukin-16,24821,67,1.25 [0.80-1.95],0.3300059930846248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17A,Interleukin-17A,24031,64,1.09 [0.67-1.79],0.7176081985924896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17C,Interleukin-17C,24074,64,1.28 [0.96-1.71],0.0912280829289842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17D,Interleukin-17D,24074,64,1.06 [0.55-2.05],0.8678579874583033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17F,Interleukin-17F,24074,64,1.17 [0.92-1.48],0.1913373639688718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RA,Interleukin-17 receptor A,24511,65,0.93 [0.56-1.54],0.775918681851157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RB,Interleukin-17 receptor B,24193,64,1.07 [0.71-1.62],0.7386354951354515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18,Interleukin-18,24403,65,1.00 [0.61-1.62],0.9848219770419148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18BP,Interleukin-18-binding protein,24578,66,1.55 [0.76-3.15],0.2304002800879903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18R1,Interleukin-18 receptor 1,24821,67,1.23 [0.64-2.37],0.5262844949808895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18RAP,Interleukin-18 receptor accessory protein,24208,64,0.91 [0.79-1.04],0.1713456775344307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL19,Interleukin-19,23924,64,1.02 [0.74-1.41],0.8868853776661968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1A,Interleukin-1 alpha,24074,64,1.02 [0.69-1.51],0.9188263857236464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1B,Interleukin-1 beta,23955,62,0.92 [0.60-1.39],0.6900120792515918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R1,Interleukin-1 receptor type 1,24467,65,1.50 [0.57-3.90],0.4081006484960698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R2,Interleukin-1 receptor type 2,24454,65,0.58 [0.19-1.78],0.3454905650586211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RAP,Interleukin-1 receptor accessory protein,24511,65,1.07 [0.65-1.74],0.7932455775768943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL1,Interleukin-1 receptor-like 1,24724,66,0.88 [0.56-1.39],0.583929217937621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL2,Interleukin-1 receptor-like 2,24074,64,1.00 [0.57-1.76],0.9977577094899358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RN,Interleukin-1 receptor antagonist protein,24438,65,0.95 [0.63-1.42],0.7901062146119853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2,Interleukin-2,24074,64,0.76 [0.38-1.54],0.4515910568584906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20,Interleukin-20,24074,64,1.13 [0.76-1.67],0.5447852024045934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RA,Interleukin-20 receptor subunit alpha,24074,64,0.90 [0.53-1.53],0.7016552949297875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RB,Interleukin-20 receptor subunit beta,20661,55,0.91 [0.49-1.67],0.7502649644006845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL21R,Interleukin-21 receptor,20661,55,1.02 [0.64-1.63],0.9242795035468786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22,Interleukin-22,21153,56,1.01 [0.68-1.49],0.966449730732965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22RA1,Interleukin-22 receptor subunit alpha-1,24074,64,0.85 [0.48-1.49],0.5624683650119608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL24,Interleukin-24,24074,64,1.15 [0.75-1.76],0.513535145885226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL25,Interleukin-25,20437,53,0.99 [0.46-2.14],0.986272995234923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RA,Interleukin-2 receptor subunit alpha,24352,65,1.04 [0.59-1.84],0.8859205131447896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RB,Interleukin-2 receptor subunit beta,24074,64,0.98 [0.54-1.79],0.9494581078318308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RG,Cytokine receptor common subunit gamma,21153,56,1.01 [0.51-1.98],0.9794273720174452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3,Interleukin-3,20513,53,1.13 [0.72-1.78],0.597820621082241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31,Interleukin-31,20661,55,0.67 [0.37-1.20],0.1774212436039928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31RA,Interleukin-31 receptor subunit alpha,20589,53,0.93 [0.48-1.78],0.8184074153511766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL32,Interleukin-32,24511,66,0.83 [0.48-1.41],0.4848768180656567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL33,Interleukin-33,24074,64,1.07 [0.61-1.87],0.8141330399090996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL34,Interleukin-34,23902,60,0.67 [0.36-1.23],0.1942364341570913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36A,Interleukin-36 alpha,20661,55,0.70 [0.39-1.23],0.2135873299698912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36G,Interleukin-36 gamma,20596,55,0.92 [0.61-1.39],0.7032907973304955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3RA,Interleukin-3 receptor subunit alpha,24074,64,1.19 [0.59-2.38],0.6302744636258714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4,Interleukin-4,24074,64,1.28 [0.95-1.74],0.103678747521291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4R,Interleukin-4 receptor subunit alpha,24511,66,1.75 [1.00-3.07],0.0491897612508231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5,Interleukin-5,24074,64,0.92 [0.78-1.09],0.3571613900586662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5RA,Interleukin-5 receptor subunit alpha,24511,66,1.03 [0.69-1.55],0.8682783180860179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6,Interleukin-6,24399,63,1.16 [0.89-1.52],0.2805393373060674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6R,Interleukin-6 receptor subunit alpha,24341,66,1.38 [0.73-2.60],0.3190494901446815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6ST,Interleukin-6 receptor subunit beta,24532,66,0.79 [0.23-2.78],0.7172996816352692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7,Interleukin-7,24511,66,0.79 [0.56-1.12],0.1842065779599574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7R,Interleukin-7 receptor subunit alpha,24511,65,0.78 [0.52-1.17],0.2280025123607829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL9,Interleukin-9,20866,52,1.19 [0.80-1.78],0.383849892484552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23904,60,0.83 [0.55-1.25],0.371830963307831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMMT,MICOS complex subunit MIC60,21153,56,1.60 [1.09-2.36],0.0168976888172297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPA1,Inositol monophosphatase 1,24363,64,0.88 [0.61-1.27],0.5059552155129047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPACT,Protein IMPACT,21213,57,0.83 [0.53-1.30],0.4146128948254111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPG1,Interphotoreceptor matrix proteoglycan 1,20613,54,0.89 [0.36-2.20],0.7981890130675731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ING1,Inhibitor of growth protein 1,23892,60,1.31 [0.89-1.93],0.1717311495561302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBB,Inhibin beta B chain,20790,55,0.90 [0.53-1.53],0.694527811496499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBC,Inhibin beta C chain,24511,65,0.94 [0.56-1.58],0.8232839426696816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP1,Inositol polyphosphate 1-phosphatase,24399,63,0.86 [0.57-1.30],0.47015632008907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20682,56,0.86 [0.55-1.35],0.518454985284759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",21237,57,0.42 [0.20-0.88],0.0213236828864854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",24399,63,0.78 [0.62-0.98],0.031655857755527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL3,Insulin-like 3,21213,57,1.14 [0.80-1.62],0.4676010592714557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL4,Early placenta insulin-like peptide,21153,56,1.34 [0.98-1.84],0.0643026437614626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL5,Insulin-like peptide INSL5,21177,56,0.84 [0.64-1.11],0.2287201452989565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSR,Insulin receptor,20661,55,0.63 [0.13-3.12],0.5750132366951057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IPCEF1,Interactor protein for cytohesin exchange factors 1,24322,64,0.87 [0.68-1.10],0.2465174623795513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IQGAP2,Ras GTPase-activating-like protein IQGAP2,24399,63,0.72 [0.47-1.10],0.1313679356468257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24088,63,1.16 [0.92-1.45],0.2001770783347589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK1,Interleukin-1 receptor-associated kinase 1,24074,64,0.83 [0.60-1.15],0.2672752911888921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK4,Interleukin-1 receptor-associated kinase 4,24511,66,0.86 [0.71-1.05],0.1454961992015366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,23573,60,0.84 [0.46-1.56],0.5840674495813423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM1,Isthmin-1,24511,66,1.09 [0.63-1.88],0.7570049996145528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM2,Isthmin-2,21263,58,1.31 [0.83-2.06],0.2489555269110315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IST1,IST1 homolog,21026,56,0.97 [0.76-1.26],0.844629959046587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA11,Integrin alpha-11,24511,66,0.89 [0.47-1.69],0.7257023414259454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA2,Integrin alpha-2,20790,55,1.39 [0.64-3.03],0.4093426025736996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA5,Integrin alpha-5,24511,65,0.59 [0.24-1.44],0.2465294653286884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA6,Integrin alpha-6,24511,66,1.16 [0.79-1.70],0.4566605965756741
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAL,Integrin alpha-L,20661,55,1.47 [0.79-2.74],0.2267516076076976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAM,Integrin alpha-M,24511,65,1.40 [0.71-2.76],0.3347965389420519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAV,Integrin alpha-V,24740,66,2.02 [0.53-7.69],0.3023567015847352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAX,Integrin alpha-X,20866,52,1.02 [0.61-1.68],0.9524510077621816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1,Integrin beta-1,24456,66,0.77 [0.28-2.13],0.607802326248297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP1,Integrin beta-1-binding protein 1,23935,64,1.03 [0.60-1.78],0.9176130450630208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP2,Integrin beta-1-binding protein 2,24088,63,0.90 [0.74-1.10],0.3140303344623811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB2,Integrin beta-2,24364,66,1.05 [0.49-2.26],0.8922820483477505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB5,Integrin beta-5,24569,66,0.98 [0.56-1.74],0.9572964884555296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB6,Integrin beta-6,24074,64,0.82 [0.39-1.74],0.6059076765358129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB7,Integrin beta-7,24740,66,0.92 [0.57-1.50],0.7485440748863629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGBL1,Integrin beta-like protein 1,21263,58,0.68 [0.33-1.42],0.3065465124513858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,21296,58,1.21 [0.34-4.27],0.771251730710607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,24578,66,1.42 [0.80-2.53],0.233324888746767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,21296,58,0.70 [0.25-1.93],0.4863176975011576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,21153,56,0.90 [0.49-1.63],0.718482404963019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITM2A,Integral membrane protein 2A,24511,66,1.10 [0.77-1.58],0.6091758494483348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPA,Inosine triphosphate pyrophosphatase,20607,56,0.80 [0.54-1.18],0.2625240780572678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",20682,56,1.09 [0.78-1.53],0.6058215605349129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",20613,54,0.96 [0.55-1.68],0.8939805441028272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",23939,60,1.06 [0.67-1.66],0.8066067242052661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IZUMO1,Izumo sperm-egg fusion protein 1,20513,53,0.83 [0.45-1.54],0.5518685697940573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM2,Junctional adhesion molecule B,24755,65,1.26 [0.53-3.02],0.6004898412610242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM3,Junctional adhesion molecule C,20790,55,0.89 [0.52-1.52],0.6710358850909175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JCHAIN,Immunoglobulin J chain,24074,64,0.89 [0.62-1.28],0.5160813730808378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,20513,53,0.86 [0.52-1.43],0.5539496800435846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JPT2,Jupiter microtubule associated homolog 2,21177,56,0.93 [0.70-1.24],0.6268210087838244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JUN,Transcription factor AP-1,24074,64,1.02 [0.67-1.55],0.923957091693528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,24399,63,0.71 [0.45-1.10],0.1219232552543025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZN,Kazrin,21177,56,0.86 [0.67-1.09],0.2165717541694247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNC4,Potassium voltage-gated channel subfamily C member 4,20613,54,0.87 [0.52-1.47],0.611112634483588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNH2,Potassium voltage-gated channel subfamily H member 2,20684,55,1.00 [0.71-1.41],0.9978234406466724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNIP4,Kv channel-interacting protein 4,23939,60,0.74 [0.43-1.29],0.2937293378659759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCTD5,BTB/POZ domain-containing protein KCTD5,20797,56,0.92 [0.51-1.65],0.7831679104028005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDM3A,Lysine-specific demethylase 3A,20661,55,0.88 [0.63-1.22],0.4362892293325288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDR,Vascular endothelial growth factor receptor 2,24569,66,0.91 [0.40-2.09],0.8271384410095566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KEL,Kell blood group glycoprotein,23939,60,0.79 [0.42-1.50],0.4661473657496078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHDC3L,KH domain-containing protein 3,20513,53,0.97 [0.64-1.46],0.8872928967929106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHK,Ketohexokinase,20682,56,0.72 [0.48-1.07],0.1015345697856907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA0319,Dyslexia-associated protein KIAA0319,21213,57,1.74 [0.90-3.38],0.0995061392926432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549,UPF0606 protein KIAA1549,20866,52,0.97 [0.66-1.42],0.8684210557698494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549L,UPF0606 protein KIAA1549L,20866,52,1.55 [0.67-3.57],0.3067342399538031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA2013,Uncharacterized protein KIAA2013,21153,56,0.90 [0.54-1.48],0.6665986802832524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF1C,Kinesin-like protein KIF1C,20607,56,0.76 [0.34-1.72],0.517428744400127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF20B,Kinesin-like protein KIF20B,20613,54,1.06 [0.77-1.47],0.7006639693487513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF22,Kinesin-like protein KIF22,20607,56,0.89 [0.73-1.10],0.2952011397478451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIFBP,KIF-binding protein,24399,63,0.84 [0.65-1.08],0.1744364455768686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,21153,56,1.06 [0.78-1.44],0.7022087684047943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,23935,64,1.28 [0.96-1.71],0.0907408603176239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,21177,56,0.86 [0.73-1.01],0.0586867904818819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,23935,64,1.11 [0.92-1.33],0.2728560889173543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,20513,53,0.68 [0.43-1.09],0.1121065882723807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL1,Kin of IRRE-like protein 1,20613,54,1.01 [0.66-1.54],0.9622345158435198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL2,Kin of IRRE-like protein 2,23939,60,1.74 [1.05-2.88],0.0312323804899409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIT,Mast/stem cell growth factor receptor Kit,24549,66,0.93 [0.44-1.96],0.847509498967079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KITLG,Kit ligand,24532,66,0.70 [0.40-1.24],0.2197355140129365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLB,Beta-klotho,23939,60,1.20 [0.88-1.63],0.2430021165194331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLF4,Krueppel-like factor 4,20613,54,0.69 [0.34-1.38],0.2929584710788394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLHL41,Kelch-like protein 41,21237,57,1.39 [0.96-2.02],0.0783053525263416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK1,Kallikrein-1,24263,63,0.97 [0.81-1.16],0.7631644508922891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK10,Kallikrein-10,24496,66,1.37 [0.81-2.31],0.2465582051058864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK11,Kallikrein-11,24319,65,1.90 [1.04-3.45],0.0358132235721592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK12,Kallikrein-12,23935,64,0.98 [0.83-1.15],0.7759423124281529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK13,Kallikrein-13,23946,62,1.12 [0.66-1.89],0.670244704239906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK14,Kallikrein-14,24740,66,0.84 [0.52-1.36],0.4885680104717746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK15,Kallikrein-15,21120,56,0.63 [0.39-1.03],0.0661444817219162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK3,Prostate-specific antigen,21263,58,1.36 [1.02-1.83],0.03711491122868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK4,Kallikrein-4,24740,66,0.93 [0.64-1.35],0.7003312428091591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK6,Kallikrein-6,24534,66,1.32 [0.63-2.77],0.463284759318551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK7,Kallikrein-7,20243,53,0.92 [0.46-1.83],0.8142252770006086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK8,Kallikrein-8,23665,61,1.48 [0.78-2.81],0.224453812561589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLKB1,Plasma kallikrein,20894,58,0.56 [0.20-1.51],0.2483220728105773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRB1,Killer cell lectin-like receptor subfamily B member 1,24821,67,1.21 [0.67-2.20],0.5343590976846107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,20613,54,1.28 [0.92-1.76],0.1380394762310596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRD1,Natural killer cells antigen CD94,24821,67,1.17 [0.73-1.87],0.5160408056053292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRF1,Killer cell lectin-like receptor subfamily F member 1,20661,55,0.91 [0.46-1.79],0.7798765832778071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRK1,NKG2-D type II integral membrane protein,21213,57,0.87 [0.50-1.51],0.6265563324563552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT14,"Keratin, type I cytoskeletal 14",23183,57,1.12 [0.53-2.39],0.7618423059943137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT17,"Keratin, type I cytoskeletal 17",20607,56,0.93 [0.47-1.83],0.8247425278326953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT18,"Keratin, type I cytoskeletal 18",24399,63,0.80 [0.60-1.07],0.1323601998052598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT19,"Keratin, type I cytoskeletal 19",24482,66,1.04 [0.75-1.46],0.7977223872221091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT5,"Keratin, type II cytoskeletal 5",23939,60,1.56 [1.06-2.31],0.0256216710379521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT6C,"Keratin, type II cytoskeletal 6C",20607,56,0.77 [0.37-1.61],0.4854781463068041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT8,"Keratin, type II cytoskeletal 8",20613,54,0.79 [0.47-1.32],0.3639701650270965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYAT1,Kynurenine--oxoglutarate transaminase 1,24482,66,1.14 [0.79-1.66],0.4857620975764238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYNU,Kynureninase,24821,67,0.54 [0.33-0.89],0.0156302521182153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L1CAM,Neural cell adhesion molecule L1,24569,66,0.77 [0.36-1.63],0.4930731442840246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,21270,57,0.91 [0.68-1.21],0.5112476116179627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACRT,Extracellular glycoprotein lacritin,21116,56,1.25 [0.79-1.97],0.3407157348714681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACTB2,Endoribonuclease LACTB2,24532,66,0.92 [0.66-1.27],0.6050473226032632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAG3,Lymphocyte activation gene 3 protein,24399,63,1.38 [0.85-2.25],0.1933429087830597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,24494,65,1.26 [0.66-2.40],0.4858522145653425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,24363,64,1.03 [0.83-1.28],0.7588967572267864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA1,Laminin subunit alpha-1,20607,56,1.03 [0.66-1.62],0.892010217624324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA4,Laminin subunit alpha-4,24614,65,1.11 [0.59-2.10],0.7470855446686593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMB1,Laminin subunit beta-1,20682,56,0.54 [0.24-1.23],0.1434629839134416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP1,Lysosome-associated membrane glycoprotein 1,20686,54,0.76 [0.25-2.27],0.6216472517809656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP2,Lysosome-associated membrane glycoprotein 2,23782,64,0.42 [0.14-1.25],0.1179680673310201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP3,Lysosome-associated membrane glycoprotein 3,24773,67,1.22 [0.80-1.85],0.3591133497609944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMTOR5,Ragulator complex protein LAMTOR5,21153,56,1.41 [0.87-2.28],0.1672522801216362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAP3,Cytosol aminopeptidase,24074,64,0.92 [0.57-1.47],0.726933861210873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LARP1,La-related protein 1,21153,56,0.96 [0.64-1.44],0.8494679802055756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT,Linker for activation of T-cells family member 1,24821,67,0.80 [0.61-1.04],0.0996453717634203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT2,Linker for activation of T-cells family member 2,24399,63,0.88 [0.73-1.05],0.1567649505387071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LATS1,Serine/threonine-protein kinase LATS1,20661,55,0.86 [0.63-1.17],0.3391734212246637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAYN,Layilin,24316,64,1.46 [0.74-2.89],0.2717212746864111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBP,Lipopolysaccharide-binding protein,24578,66,1.21 [0.84-1.75],0.3078935030474777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBR,Delta(14)-sterol reductase LBR,24755,65,0.93 [0.67-1.28],0.6537932694218107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCAT,Phosphatidylcholine-sterol acyltransferase,21274,56,0.63 [0.20-2.00],0.4322096538091815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN15,Lipocalin-15,21237,57,1.27 [0.91-1.77],0.1633841878437599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN2,Neutrophil gelatinase-associated lipocalin,23738,64,1.88 [1.13-3.13],0.0150251252124293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCP1,Plastin-2,21263,58,0.92 [0.54-1.56],0.7513102866936343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLR,Low-density lipoprotein receptor,24578,66,0.82 [0.54-1.25],0.3587174024209068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLRAP1,Low density lipoprotein receptor adapter protein 1,21237,57,0.88 [0.68-1.13],0.3217292681865102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LECT2,Leukocyte cell-derived chemotaxin-2,21270,57,0.88 [0.59-1.32],0.5367052212910092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEFTY2,Left-right determination factor 2,24708,66,1.19 [0.79-1.79],0.3991314792475703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEG1,Protein LEG1 homolog,20049,54,1.00 [0.67-1.47],0.9808843412128456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LELP1,Late cornified envelope-like proline-rich protein 1,20613,54,0.99 [0.69-1.43],0.9723453051254012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEO1,RNA polymerase-associated protein LEO1,21237,57,1.52 [0.82-2.80],0.1823174833578749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEP,Leptin,24532,66,0.93 [0.67-1.27],0.6357530739297492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEPR,Leptin receptor,24532,66,1.36 [0.70-2.63],0.3618360120740228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LETM1,Mitochondrial proton/calcium exchanger protein,21237,57,0.89 [0.54-1.45],0.6315349569093699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS1,Galectin-1,24532,66,0.79 [0.41-1.54],0.4929373632889893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3,Galectin-3,24574,65,1.13 [0.55-2.35],0.7373177409792947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3BP,Galectin-3-binding protein,21296,58,0.89 [0.38-2.07],0.7904338065361982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS4,Galectin-4,24494,65,0.79 [0.51-1.23],0.2994598472459246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS7_LGALS7B,Galectin-7,24485,65,1.35 [0.83-2.20],0.2207821836345034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS8,Galectin-8,24755,65,0.82 [0.57-1.19],0.3037189890369438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS9,Galectin-9,24491,65,1.26 [0.62-2.54],0.5189490976089396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGMN,Legumain,24614,65,1.04 [0.57-1.90],0.8938173325359545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHB,Lutropin subunit beta,23935,64,1.09 [0.87-1.37],0.4347601130201494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,24526,65,1.03 [0.71-1.49],0.8689894006891741
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIF,Leukemia inhibitory factor,23939,60,0.94 [0.59-1.49],0.7835994919469984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIFR,Leukemia inhibitory factor receptor,24511,66,2.18 [1.03-4.62],0.0407176007460422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,24511,65,0.97 [0.52-1.82],0.9345552905458648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,21263,58,1.09 [0.88-1.36],0.4375514729766676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,20607,56,1.00 [0.61-1.64],0.9868239650400442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,24504,66,0.98 [0.49-1.94],0.947205143935368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,21270,57,1.14 [0.80-1.61],0.4687624459116376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24814,66,1.34 [0.60-2.97],0.4715313577005193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24677,66,1.60 [0.83-3.07],0.1609050178514935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24074,64,1.01 [0.59-1.73],0.975890335426442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,24814,66,0.93 [0.69-1.26],0.6439999613881464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIPF,Gastric triacylglycerol lipase,20682,56,0.87 [0.55-1.36],0.5360100620969397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB1,Lamin-B1,21132,56,1.14 [0.80-1.61],0.474625600296232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB2,Lamin-B2,21213,57,0.85 [0.33-2.18],0.7359309109857217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD1,Leiomodin-1,21237,57,1.30 [0.69-2.44],0.4129926582889982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD2,Leiomodin-2,20613,54,0.99 [0.66-1.49],0.9593093963810936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LONP1,"Lon protease homolog, mitochondrial",20682,56,0.89 [0.65-1.20],0.4313544746326585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPA,Apolipoprotein(a),20783,58,0.97 [0.84-1.11],0.6323063307011042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPCAT2,Lysophosphatidylcholine acyltransferase 2,24399,63,0.96 [0.57-1.64],0.8908677591481591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPL,Lipoprotein lipase,24532,66,1.01 [0.64-1.60],0.9620465554606816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPO,Lactoperoxidase,23746,62,0.91 [0.62-1.34],0.6472352095351934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPP,Lipoma-preferred partner,20607,56,0.83 [0.56-1.22],0.3422771488798585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,20607,56,0.74 [0.50-1.10],0.1367080471263885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,20684,55,1.31 [0.90-1.92],0.1603804471359877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRG1,Leucine-rich alpha-2-glycoprotein,21296,58,1.09 [0.41-2.88],0.8578888781257572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,24677,66,2.48 [1.38-4.44],0.0022594743659146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,20590,55,0.80 [0.29-2.17],0.6571912283138188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP1,Prolow-density lipoprotein receptor-related protein 1,24399,63,1.63 [0.74-3.60],0.2248798853155599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP11,Low-density lipoprotein receptor-related protein 11,24532,66,1.44 [0.78-2.69],0.245405509161818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2,Low-density lipoprotein receptor-related protein 2,20684,55,0.95 [0.46-1.94],0.8836355720191257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2BP,LRP2-binding protein,20684,55,1.10 [0.84-1.46],0.4837223473760174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,24755,65,1.21 [0.87-1.69],0.2646354605755073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC25,Leucine-rich repeat-containing protein 25,24399,63,0.97 [0.55-1.74],0.9280955366059168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC37A2,Leucine-rich repeat-containing protein 37A2,21177,56,0.88 [0.49-1.59],0.6697833731166946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC38,Leucine-rich repeat-containing protein 38,20684,55,0.54 [0.30-0.98],0.0423448618429174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC59,Leucine-rich repeat-containing protein 59,21270,57,0.86 [0.49-1.51],0.6003073241205241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,21153,56,0.92 [0.54-1.57],0.754717549812197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRN1,Leucine-rich repeat neuronal protein 1,24074,64,1.07 [0.60-1.90],0.8124568681842611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,20684,55,0.83 [0.42-1.64],0.5995901646567681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,21237,57,1.44 [0.62-3.36],0.3933512274132126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM1,U6 snRNA-associated Sm-like protein LSm1,23935,64,0.96 [0.64-1.45],0.8532121720820399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM8,U6 snRNA-associated Sm-like protein LSm8,20866,52,0.95 [0.69-1.31],0.7587560266144291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSP1,Lymphocyte-specific protein 1,24511,66,0.62 [0.35-1.08],0.0887995129808959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA,Lymphotoxin-alpha,24511,66,1.45 [0.87-2.42],0.156799578591263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA4H,Leukotriene A-4 hydrolase,24740,66,0.91 [0.63-1.31],0.5979177098693716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTB,Lymphotoxin-beta,21153,56,1.53 [0.91-2.58],0.1105828137675882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP2,Latent-transforming growth factor beta-binding protein 2,24814,66,0.87 [0.42-1.81],0.7065237734915496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP3,Latent-transforming growth factor beta-binding protein 3,23935,64,1.18 [0.82-1.70],0.3798588114027098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBR,Tumor necrosis factor receptor superfamily member 3,24355,65,1.91 [0.87-4.17],0.1053476400567382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTO1,Protein LTO1 homolog,24074,64,1.43 [0.98-2.09],0.0654778362360241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LUZP2,Leucine zipper protein 2,21153,56,0.97 [0.54-1.75],0.9200250252082872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LXN,Latexin,24246,64,1.18 [0.88-1.60],0.2695198740719149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY6D,Lymphocyte antigen 6D,24354,65,1.41 [0.81-2.47],0.2240774442190241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY75,Lymphocyte antigen 75,24511,66,1.23 [0.69-2.18],0.4872580865118699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY9,T-lymphocyte surface antigen Ly-9,24284,65,0.93 [0.42-2.04],0.8563014318420201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY96,Lymphocyte antigen 96,24363,64,0.87 [0.46-1.64],0.6565853555096888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYAR,Cell growth-regulating nucleolar protein,23935,64,1.17 [0.85-1.63],0.3408660548174714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYN,Tyrosine-protein kinase Lyn,24399,63,0.88 [0.68-1.14],0.3296916696597907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD1,Ly6/PLAUR domain-containing protein 1,23939,60,0.83 [0.54-1.28],0.393692754257588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD3,Ly6/PLAUR domain-containing protein 3,24383,65,1.04 [0.54-2.00],0.9107186997292234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD8,Ly6/PLAUR domain-containing protein 8,23935,64,0.92 [0.58-1.46],0.7258968735744963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPLA2,Acyl-protein thioesterase 2,20613,54,1.15 [0.94-1.40],0.1716423157748988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,20684,55,1.01 [0.78-1.30],0.9317129291366176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,21296,58,0.87 [0.24-3.21],0.8321333637912366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYZL2,Lysozyme-like protein 2,20513,53,1.26 [0.67-2.37],0.4725330729681702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LZTFL1,Leucine zipper transcription factor-like protein 1,20790,55,0.87 [0.60-1.25],0.446957454333925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,M6PR,Cation-dependent mannose-6-phosphate receptor,20682,56,1.04 [0.57-1.90],0.8984910773214413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24285,64,1.27 [0.90-1.78],0.172806581624467
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAEA,E3 ubiquitin-protein transferase MAEA,23935,64,1.09 [0.64-1.85],0.764631420112539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAG,Myelin-associated glycoprotein,20684,55,0.98 [0.56-1.71],0.9461366072845192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGEA3,Melanoma-associated antigen 3,20866,52,0.83 [0.64-1.08],0.1592610834195459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGED1,Melanoma-associated antigen D1,23935,64,1.00 [0.63-1.59],0.9924260129190976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC2,MAM domain-containing protein 2,21270,57,1.22 [0.56-2.64],0.6148965354537728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC4,Apical endosomal glycoprotein,21153,56,0.81 [0.51-1.30],0.3800759605801435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20682,56,1.91 [0.71-5.16],0.20291479973921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN2B2,Epididymis-specific alpha-mannosidase,21270,57,0.88 [0.57-1.34],0.5358894053913982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",20513,53,0.84 [0.49-1.43],0.5124956186528316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANF,Mesencephalic astrocyte-derived neurotrophic factor,24614,65,0.86 [0.73-1.02],0.0786000421466116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC1,MANSC domain-containing protein 1,24569,66,1.30 [0.58-2.88],0.5221683926332812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC4,MANSC domain-containing protein 4,20607,56,0.65 [0.42-1.02],0.0624155883371622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,20613,54,1.17 [0.52-2.64],0.7085652657179438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,20607,56,1.14 [0.82-1.60],0.4363565222886703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2,Microtubule-associated protein 2,21213,57,1.06 [0.61-1.84],0.8330110802416621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,21177,56,0.92 [0.61-1.37],0.666227923137455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,24511,66,0.89 [0.72-1.10],0.28534161382874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,23935,64,1.02 [0.82-1.28],0.8494080462288278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,24316,64,0.91 [0.75-1.11],0.3624158710163682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK13,Mitogen-activated protein kinase 13,20513,53,1.56 [1.09-2.23],0.0146086243712891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK9,Mitogen-activated protein kinase 9,24511,66,0.98 [0.59-1.61],0.9320874619013366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPKAPK2,MAP kinase-activated protein kinase 2,20866,52,0.84 [0.58-1.22],0.3599469817056847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPRE3,Microtubule-associated protein RP/EB family member 3,20513,53,1.01 [0.85-1.21],0.8793161878321378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPT,Microtubule-associated protein tau,23939,60,0.88 [0.58-1.33],0.5378373665415558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARCO,Macrophage receptor MARCO,24532,66,0.88 [0.38-2.04],0.7655040607127841
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARS1,"Methionine--tRNA ligase, cytoplasmic",20744,55,0.88 [0.65-1.19],0.3933538996918972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MASP1,Mannan-binding lectin serine protease 1,24316,64,0.50 [0.20-1.26],0.1426813985453295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN2,Matrilin-2,24538,65,0.36 [0.18-0.75],0.0064302101752006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN3,Matrilin-3,24322,64,1.63 [0.81-3.27],0.1666570330437775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAVS,Mitochondrial antiviral-signaling protein,23935,64,0.96 [0.75-1.23],0.7430230480533717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAX,Protein max,23939,60,0.88 [0.70-1.09],0.2352493844183769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MB,Myoglobin,24814,66,1.50 [1.07-2.10],0.0200025291341979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MBL2,Mannose-binding protein C,20997,58,1.17 [0.92-1.48],0.2096559213433589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCAM,Cell surface glycoprotein MUC18,24578,66,1.74 [0.94-3.23],0.0784699775584845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",21237,57,1.13 [0.66-1.92],0.6556859932961594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEMP1,Mast cell-expressed membrane protein 1,20661,55,0.74 [0.54-1.01],0.0548359539739292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCFD2,Multiple coagulation factor deficiency protein 2,24422,64,1.03 [0.63-1.69],0.9042522869525772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCTS1,Malignant T-cell-amplified sequence 1,21177,56,0.52 [0.16-1.66],0.270596385962017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,24363,64,1.01 [0.74-1.38],0.9461916915121672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDH1,"Malate dehydrogenase, cytoplasmic",21151,56,0.86 [0.45-1.65],0.658397927661815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDK,Midkine,24489,66,1.19 [0.80-1.76],0.3935012187024582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDM1,Nuclear protein MDM1,20684,55,0.72 [0.30-1.69],0.4497123558177983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",20682,56,0.91 [0.69-1.21],0.5362641944817538
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED18,Mediator of RNA polymerase II transcription subunit 18,23935,64,0.93 [0.70-1.24],0.6422646852572984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED21,Mediator of RNA polymerase II transcription subunit 21,20607,56,0.96 [0.56-1.63],0.8723837639303453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF10,Multiple epidermal growth factor-like domains protein 10,24494,65,1.13 [0.66-1.95],0.649026964581378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF11,Multiple epidermal growth factor-like domains protein 11,20607,56,0.40 [0.15-1.08],0.0704088496548472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF9,Multiple epidermal growth factor-like domains protein 9,24724,66,2.02 [0.87-4.67],0.1017901781466632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MELTF,Melanotransferrin,21270,57,1.14 [0.48-2.75],0.7655561133919747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MENT,Protein MENT,20790,55,0.69 [0.22-2.17],0.5241158219141328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1A,Meprin A subunit alpha,21177,56,0.87 [0.60-1.27],0.4755402317328995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1B,Meprin A subunit beta,24532,66,0.94 [0.78-1.13],0.5171859308986237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEPE,Matrix extracellular phosphoglycoprotein,24494,65,0.91 [0.37-2.24],0.8380307766815831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MERTK,Tyrosine-protein kinase Mer,24821,67,1.59 [0.68-3.70],0.2857870214170627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MESD,LRP chaperone MESD,24511,65,0.90 [0.75-1.08],0.2538556429780875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MET,Hepatocyte growth factor receptor,24571,66,1.90 [0.63-5.76],0.2548678288291904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1,Methionine aminopeptidase 1,23939,60,0.56 [0.24-1.28],0.1689246014053672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",24511,66,0.83 [0.64-1.08],0.1706897791202904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP2,Methionine aminopeptidase 2,24708,66,0.79 [0.55-1.14],0.2041044960378476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3,Microfibril-associated glycoprotein 3,24088,63,1.02 [0.65-1.60],0.938845028562874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3L,Microfibrillar-associated protein 3-like,20684,55,0.75 [0.45-1.25],0.262805609616177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP4,Microfibril-associated glycoprotein 4,20790,55,0.84 [0.37-1.93],0.6853797104214328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP5,Microfibrillar-associated protein 5,24814,66,1.54 [0.89-2.65],0.1194483942830766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFGE8,Lactadherin,24511,65,1.20 [0.74-1.96],0.4524388717892318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGLL,Monoglyceride lipase,24579,65,0.83 [0.66-1.06],0.13173624448204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGMT,Methylated-DNA--protein-cysteine methyltransferase,24511,66,0.82 [0.70-0.97],0.0190625933319191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIA,Melanoma-derived growth regulatory protein,24569,66,1.36 [0.76-2.42],0.297102315082122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICALL2,MICAL-like protein 2,20684,55,1.03 [0.70-1.51],0.8754611658919367
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,24511,66,0.94 [0.82-1.07],0.3528059330300028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIF,Macrophage migration inhibitory factor,24468,65,0.94 [0.69-1.29],0.7136846259436402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MILR1,Allergin-1,24074,64,0.99 [0.64-1.55],0.9797029532483182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,21153,56,0.99 [0.79-1.26],0.9610869449630284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINK1,Misshapen-like kinase 1,21213,57,0.94 [0.72-1.24],0.6715859531208758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MITD1,MIT domain-containing protein 1,24363,64,0.90 [0.72-1.13],0.3588030822229052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MKI67,Proliferation marker protein Ki-67,20661,55,1.09 [0.61-1.93],0.7796434562372712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLLT1,Protein ENL,20513,53,0.98 [0.68-1.43],0.9256270650690644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLN,Promotilin,24511,66,1.12 [0.88-1.43],0.3540149401040861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MME,Neprilysin,24399,63,0.96 [0.72-1.27],0.7676881416901864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP1,Interstitial collagenase,23651,63,0.95 [0.74-1.21],0.6674868830261427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP10,Stromelysin-2,24471,65,1.33 [0.93-1.88],0.1143926312288091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP12,Macrophage metalloelastase,24564,66,1.34 [0.89-2.03],0.1663060028648758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP13,Collagenase 3,23939,60,1.61 [0.79-3.30],0.1902203911200727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP15,Matrix metalloproteinase-15,21270,57,1.08 [0.69-1.69],0.7360483395334863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP3,Stromelysin-1,24511,65,1.46 [0.94-2.26],0.0915892517333299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP7,Matrilysin,24049,63,1.25 [0.78-2.01],0.3624144626233069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP8,Neutrophil collagenase,24717,65,1.07 [0.80-1.43],0.6617160111298531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP9,Matrix metalloproteinase-9,24478,65,0.97 [0.68-1.40],0.8880600957962858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",20607,56,1.01 [0.61-1.69],0.9640153757229332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MN1,Transcriptional activator MN1,20684,55,1.34 [0.97-1.86],0.0748834327542655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNAT1,CDK-activating kinase assembly factor MAT1,20866,52,1.28 [0.78-2.09],0.3262711492036369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNDA,Myeloid cell nuclear differentiation antigen,24496,65,1.06 [0.87-1.30],0.5503382209844845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOCS2,Molybdopterin synthase catalytic subunit,20790,55,1.01 [0.69-1.48],0.9584711667144112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOG,Myelin-oligodendrocyte glycoprotein,24740,66,1.67 [0.85-3.28],0.1402795507190717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORC3,MORC family CW-type zinc finger protein 3,21213,57,1.33 [0.63-2.82],0.4614747748083477
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L1,Mortality factor 4-like protein 1,20866,52,0.81 [0.39-1.67],0.5654804271484286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L2,Mortality factor 4-like protein 2,20513,53,1.45 [0.82-2.55],0.1969396765067937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORN4,MORN repeat-containing protein 4,20513,53,0.84 [0.57-1.25],0.3975685980934551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPHOSPH8,M-phase phosphoprotein 8,24088,63,1.01 [0.75-1.35],0.9732041689809184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPI,Mannose-6-phosphate isomerase,24399,63,0.86 [0.66-1.11],0.2482499880648581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,24579,65,0.86 [0.66-1.12],0.2705575787433045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPO,Myeloperoxidase,24511,65,0.80 [0.49-1.31],0.3726587290821793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPRIP,Myosin phosphatase Rho-interacting protein,21118,56,0.80 [0.44-1.43],0.452494465329601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRC1,Macrophage mannose receptor 1,21274,56,1.01 [0.40-2.56],0.9812617303173174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRI1,Methylthioribose-1-phosphate isomerase,20684,55,0.96 [0.65-1.41],0.8370649790001242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL24,"39S ribosomal protein L24, mitochondrial",20607,56,0.65 [0.30-1.43],0.2847537555592142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL28,"39S ribosomal protein L28, mitochondrial",21237,57,0.93 [0.45-1.94],0.8455232871707237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL46,"39S ribosomal protein L46, mitochondrial",23939,60,0.88 [0.37-2.10],0.7713264720119766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL52,"39S ribosomal protein L52, mitochondrial",20477,53,1.27 [0.46-3.48],0.6407814090352617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",21237,57,0.77 [0.50-1.18],0.2297915404076974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPS16,"28S ribosomal protein S16, mitochondrial",20661,55,0.92 [0.37-2.27],0.8495966406597499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLN,Mesothelin,24368,63,1.22 [0.81-1.84],0.3392744067251229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLNL,Mesothelin-like protein,20684,55,0.87 [0.42-1.80],0.7042440142066635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSMB,Beta-microseminoprotein,24443,65,1.09 [0.79-1.52],0.5987716987489847
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSR1,Macrophage scavenger receptor types I and II,24755,65,0.84 [0.52-1.33],0.4496994483432194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSRA,Mitochondrial peptide methionine sulfoxide reductase,24569,66,0.86 [0.64-1.16],0.3278536107236623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MST1,Hepatocyte growth factor-like protein,20968,56,0.95 [0.66-1.36],0.7698515292279188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSTN,Growth/differentiation factor 8,24088,63,1.20 [0.79-1.84],0.3988655266729519
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTDH,Protein LYRIC,20661,55,0.87 [0.66-1.16],0.3557467916327963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",21213,57,1.36 [0.59-3.11],0.4718900272619655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,20866,52,0.92 [0.73-1.16],0.4860318328800398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTIF3,"Translation initiation factor IF-3, mitochondrial",21177,56,0.85 [0.64-1.15],0.295349472654497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTPN,Myotrophin,24088,63,1.09 [0.57-2.07],0.794424248352271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTR,Methionine synthase,20607,56,0.81 [0.51-1.30],0.3796566334660416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS1,Protein MTSS 1,21177,56,0.99 [0.79-1.25],0.947690903137675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS2,Protein MTSS 2,21153,56,0.79 [0.61-1.03],0.0806129896484589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTUS1,Microtubule-associated tumor suppressor 1,20866,52,0.84 [0.51-1.37],0.4794104462331758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC13,Mucin-13,23939,60,1.49 [0.95-2.33],0.0789250739311376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC16,Mucin-16,24399,63,0.97 [0.87-1.09],0.6385367801821684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC2,Mucin-2,21263,58,0.91 [0.69-1.21],0.5247395093560399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUCL3,Mucin-like protein 3,20513,53,0.59 [0.26-1.35],0.2111239745003288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MVK,Mevalonate kinase,24074,64,0.81 [0.60-1.08],0.1494012550842496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MXRA8,Matrix remodeling-associated protein 8,20790,55,1.18 [0.50-2.76],0.7069905828208415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC1,"Myosin-binding protein C, slow-type",21270,57,1.47 [1.08-1.98],0.0127631506130409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC2,"Myosin-binding protein C, fast-type",20682,56,1.13 [0.87-1.48],0.357701534839864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21237,57,1.08 [0.75-1.54],0.6865007625825916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYDGF,Myeloid-derived growth factor,21270,57,0.88 [0.68-1.13],0.3240857471552574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH4,Myosin-4,20607,56,0.67 [0.33-1.34],0.2573294994328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH7B,Myosin-7B,20513,53,0.92 [0.49-1.71],0.79374830387201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH9,Myosin-9,21263,58,0.97 [0.78-1.22],0.8127306978068453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",20607,56,0.84 [0.42-1.67],0.6187305900121891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL3,Myosin light chain 3,20682,56,1.29 [0.93-1.80],0.1318952698368292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL4,Myosin light chain 4,20682,56,0.99 [0.61-1.62],0.97457714495696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL6B,Myosin light chain 6B,20684,55,1.05 [0.81-1.37],0.718635242517919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",20684,55,1.25 [0.80-1.95],0.3295396810395397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO6,Unconventional myosin-VI,21237,57,1.47 [0.96-2.24],0.0775138255419513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO9B,Unconventional myosin-IXb,24074,64,0.99 [0.70-1.39],0.9373783170927572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOC,Myocilin,24511,65,1.10 [0.68-1.79],0.6888538998575148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM1,Myomesin-1,20613,54,1.47 [1.04-2.06],0.0274415989303445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM2,Myomesin-2,20607,56,1.05 [0.65-1.72],0.8362589027080695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM3,Myomesin-3,20790,55,1.16 [0.89-1.52],0.2823982022581793
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZB1,Marginal zone B- and B1-cell-specific protein,24573,65,0.89 [0.57-1.39],0.6043006434170368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZT1,Mitotic-spindle organizing protein 1,23935,64,0.97 [0.63-1.49],0.8857870960086294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA10,N-alpha-acetyltransferase 10,20607,56,0.59 [0.36-0.96],0.0326975815494767
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA80,N-alpha-acetyltransferase 80,20684,55,0.92 [0.74-1.14],0.4472294401935169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAAA,N-acylethanolamine-hydrolyzing acid amidase,24253,64,0.99 [0.68-1.44],0.952701027317426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NACC1,Nucleus accumbens-associated protein 1,21153,56,0.77 [0.46-1.26],0.292500105168635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NADK,NAD kinase,24532,66,0.98 [0.67-1.45],0.9374287086680584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGA,Alpha-N-acetylgalactosaminidase,20627,55,0.87 [0.54-1.40],0.5631465868897871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGK,N-acetyl-D-glucosamine kinase,20643,55,0.96 [0.61-1.50],0.8501740135926259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,20790,55,0.49 [0.15-1.54],0.220730124670322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAMPT,Nicotinamide phosphoribosyltransferase,23935,64,1.04 [0.71-1.54],0.8258226298035183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAP1L4,Nucleosome assembly protein 1-like 4,21141,56,0.91 [0.50-1.66],0.7584006216253674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAPRT,Nicotinate phosphoribosyltransferase,21213,57,0.68 [0.29-1.56],0.3609236679969453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NARS1,"Asparagine--tRNA ligase, cytoplasmic",21237,57,0.83 [0.50-1.39],0.478982962980628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBL1,Neuroblastoma suppressor of tumorigenicity 1,24569,66,1.58 [0.68-3.67],0.2892188687253905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBN,Nibrin,24074,64,1.16 [0.82-1.64],0.412154499000735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM1,Neural cell adhesion molecule 1,24578,66,1.11 [0.55-2.25],0.7691877757048369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM2,Neural cell adhesion molecule 2,24511,65,0.66 [0.29-1.50],0.3200966302861502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAN,Neurocan core protein,24755,65,0.81 [0.45-1.46],0.49141329424768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCF2,Neutrophil cytosol factor 2,24470,66,0.97 [0.75-1.25],0.8325446792430142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCK2,Cytoplasmic protein NCK2,24614,65,0.86 [0.70-1.06],0.1529991422709345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCLN,Nicalin,24074,64,1.20 [0.88-1.65],0.2485557317745959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR1,Natural cytotoxicity triggering receptor 1,24478,66,1.01 [0.54-1.87],0.9854641649317528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,21177,56,0.79 [0.36-1.75],0.5693377743116439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCS1,Neuronal calcium sensor 1,24740,66,1.78 [0.82-3.87],0.1461049829542858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDRG1,Protein NDRG1,23939,60,1.00 [0.73-1.39],0.9793814642353004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,21153,56,0.73 [0.43-1.24],0.2380682924228928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,20616,55,1.74 [0.91-3.33],0.0936755201433405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,21177,56,0.85 [0.64-1.14],0.2848390009074684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",23935,64,1.10 [0.86-1.41],0.4442829813947394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEB,Nebulin,20607,56,1.31 [0.73-2.34],0.3599620241621427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECAP2,Adaptin ear-binding coat-associated protein 2,20607,56,0.70 [0.44-1.09],0.1129784105770747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN1,Nectin-1,20661,55,1.09 [0.51-2.34],0.826225431606218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN2,Nectin-2,24504,66,1.64 [0.76-3.55],0.2049739467434583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN4,Nectin-4,24569,66,1.87 [0.96-3.63],0.0647708849865647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,20661,55,0.86 [0.51-1.44],0.5557992566383256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD9,Enhancer of filamentation 1,20661,55,0.59 [0.24-1.43],0.2396263752960584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEFL,Neurofilament light polypeptide,23862,60,1.28 [0.76-2.16],0.3531130287774484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEK7,Serine/threonine-protein kinase Nek7,20866,52,0.89 [0.60-1.33],0.5789889336143645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL1,Protein kinase C-binding protein NELL1,24569,66,0.67 [0.39-1.13],0.1349611976357659
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL2,Protein kinase C-binding protein NELL2,24614,65,0.76 [0.34-1.69],0.4972969388239086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NENF,Neudesin,21153,56,0.99 [0.79-1.24],0.9232659779766292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEO1,Neogenin,21237,57,1.04 [0.34-3.22],0.9452036146981132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEXN,Nexilin,21274,56,0.95 [0.65-1.39],0.7791036322830821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFASC,Neurofascin,24821,67,0.86 [0.39-1.90],0.7047977058540056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFAT5,Nuclear factor of activated T-cells 5,20661,55,1.03 [0.77-1.39],0.8316430664592331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",24511,66,0.88 [0.71-1.10],0.2710372413262927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",24074,64,0.90 [0.62-1.32],0.5862370704746159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFE2,Transcription factor NF-E2 45 kDa subunit,20682,56,0.99 [0.69-1.40],0.933007718097058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFIC,Nuclear factor 1 C-type,21237,57,1.50 [1.07-2.10],0.0195270502764459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB1,Nuclear factor NF-kappa-B p105 subunit,20607,56,0.79 [0.56-1.12],0.1797261903351244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB2,Nuclear factor NF-kappa-B p100 subunit,20866,52,1.24 [0.91-1.69],0.1768503575572376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKBIE,NF-kappa-B inhibitor epsilon,23935,64,1.01 [0.64-1.58],0.9812837506091332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",21177,56,0.92 [0.72-1.18],0.5320291117535976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFX1,Transcriptional repressor NF-X1,20607,56,0.72 [0.47-1.09],0.1163693054296826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFYA,Nuclear transcription factor Y subunit alpha,20607,56,0.87 [0.43-1.74],0.6876572678026014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGF,Beta-nerve growth factor,24363,64,1.38 [0.28-6.85],0.6971219315919459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGFR,Tumor necrosis factor receptor superfamily member 16,21270,57,0.96 [0.40-2.29],0.9288607986216914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGRN,Neugrin,21213,57,1.20 [0.39-3.65],0.7528472758520226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NHLRC3,NHL repeat-containing protein 3,20304,52,0.79 [0.34-1.85],0.5931931884728682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID1,Nidogen-1,24507,66,1.20 [0.68-2.11],0.5219919770690066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID2,Nidogen-2,24511,65,1.06 [0.80-1.42],0.6725848532961267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NINJ1,Ninjurin-1,23935,64,0.92 [0.60-1.40],0.7004401246746909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT1,Deaminated glutathione amidase,20682,56,1.01 [0.59-1.72],0.974762840537584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT2,Omega-amidase NIT2,21193,57,0.86 [0.62-1.21],0.3918056195028796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN1,Neuroligin-1,20684,55,1.10 [0.79-1.53],0.5769771058333979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN2,Neuroligin-2,20613,54,0.76 [0.40-1.44],0.3943874646997318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME1,Nucleoside diphosphate kinase A,20661,55,2.07 [0.74-5.80],0.1678781653574107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME3,Nucleoside diphosphate kinase 3,24538,65,0.84 [0.32-2.23],0.7316793098237014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMI,N-myc-interactor,21066,56,0.78 [0.54-1.14],0.198534501378792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24363,64,1.09 [0.84-1.43],0.5088524864443669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMRK2,Nicotinamide riboside kinase 2,20513,53,0.70 [0.31-1.55],0.3764468500551213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,21237,57,0.92 [0.61-1.37],0.6719889109885149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOMO1,Nodal modulator 1,24511,65,1.38 [0.56-3.36],0.482374724227274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOP56,Nucleolar protein 56,20607,56,0.99 [0.79-1.25],0.9619913282907768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS1,"Nitric oxide synthase, brain",23939,60,1.30 [0.87-1.92],0.1962941919411433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS2,"Nitric oxide synthase, inducible",20607,56,1.27 [0.70-2.29],0.4278370218406285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS3,"Nitric oxide synthase, endothelial",23939,60,0.96 [0.60-1.53],0.8620566471746369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH1,Neurogenic locus notch homolog protein 1,24814,66,2.68 [0.70-10.20],0.149406945445247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH2,Neurogenic locus notch homolog protein 2,21263,58,0.81 [0.25-2.67],0.7316696619259606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH3,Neurogenic locus notch homolog protein 3,24814,66,1.18 [0.62-2.24],0.6148006376392918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPC2,NPC intracellular cholesterol transporter 2,20911,57,1.06 [0.46-2.45],0.8939140614734291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPDC1,Neural proliferation differentiation and control protein 1,24532,66,1.16 [0.55-2.44],0.692832091138076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS1,Nephrin,20661,55,0.65 [0.41-1.02],0.0604071326790303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS2,Podocin,20661,55,1.05 [0.82-1.33],0.7076400929677669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPL,N-acetylneuraminate lyase,21270,57,0.62 [0.35-1.11],0.1100936421791002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPB,Natriuretic peptides B,24088,63,0.97 [0.82-1.16],0.7630685547822734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPC,C-type natriuretic peptide,24511,66,0.84 [0.51-1.36],0.474331823988782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPR1,Atrial natriuretic peptide receptor 1,20607,56,1.20 [0.70-2.06],0.5135612453873797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTN,Neuroplastin,23935,64,0.80 [0.57-1.13],0.2070107408310753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX1,Neuronal pentraxin-1,24511,65,0.72 [0.41-1.26],0.2469555898412425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX2,Neuronal pentraxin-2,21263,58,0.61 [0.29-1.27],0.1842684279948434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTXR,Neuronal pentraxin receptor,24532,66,0.92 [0.48-1.75],0.8033477875647284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPY,Pro-neuropeptide Y,24740,66,0.90 [0.65-1.25],0.5403017740975866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRCAM,Neuronal cell adhesion molecule,24532,66,1.28 [0.58-2.78],0.5412887677146021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRGN,Neurogranin,21274,56,0.86 [0.65-1.14],0.3032794586721745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRN1,Neuritin,21237,57,1.24 [0.72-2.14],0.4302410547534747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP1,Neuropilin-1,24631,66,0.62 [0.29-1.32],0.2140933093028044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP2,Neuropilin-2,24511,65,1.21 [0.57-2.57],0.6103841296212207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRTN,Neurturin,24074,64,1.09 [0.72-1.66],0.6907512189701689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRXN3,Neurexin-3,20684,55,1.14 [0.58-2.23],0.7023873329728203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NSFL1C,NSFL1 cofactor p47,24755,65,1.02 [0.73-1.42],0.909481024439714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",21270,57,0.92 [0.66-1.29],0.6263636651526193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C1A,Cytosolic 5'-nucleotidase 1A,21213,57,0.94 [0.41-2.15],0.8842927575395234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C3A,Cytosolic 5'-nucleotidase 3A,24468,66,0.84 [0.66-1.07],0.1525534898752856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5E,5'-nucleotidase,24569,66,0.76 [0.50-1.16],0.2021653709895166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF3,Neurotrophin-3,24511,66,0.83 [0.44-1.56],0.560669589230838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF4,Neurotrophin-4,23935,64,1.07 [0.62-1.84],0.8070993768003586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK2,BDNF/NT-3 growth factors receptor,24532,66,0.45 [0.19-1.07],0.071115478973716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK3,NT-3 growth factor receptor,24755,65,1.14 [0.41-3.19],0.7992807732980579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTproBNP,N-terminal prohormone of brain natriuretic peptide,24532,66,1.26 [1.02-1.57],0.0358788628329622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUB1,NEDD8 ultimate buster 1,24511,66,0.91 [0.70-1.18],0.4774028202826179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,21153,56,1.03 [0.81-1.32],0.8047191514208576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUCB2,Nucleobindin-2,24705,66,1.16 [0.65-2.05],0.6200797421889472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDC,Nuclear migration protein nudC,24821,67,0.82 [0.60-1.14],0.2461613105157326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,20682,56,1.15 [0.48-2.76],0.7508577225407844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,20607,56,0.67 [0.35-1.27],0.217301207943668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT16,U8 snoRNA-decapping enzyme,21145,56,0.87 [0.65-1.17],0.358137332124658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],24399,63,0.79 [0.52-1.18],0.2493816880988854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT5,ADP-sugar pyrophosphatase,24511,65,1.05 [0.69-1.61],0.8127667834905244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUMB,Protein numb homolog,20661,55,0.81 [0.60-1.10],0.1735821856811195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUP50,Nuclear pore complex protein Nup50,20607,56,1.76 [1.13-2.76],0.0130651917026862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPE4,NXPE family member 4,20607,56,0.88 [0.40-1.96],0.7598943993481349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH1,Neurexophilin-1,23939,60,1.20 [0.68-2.10],0.5307292497304708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH3,Neurexophilin-3,20661,55,0.76 [0.32-1.78],0.5273572462200034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OBP2B,Odorant-binding protein 2b,24282,64,1.01 [0.70-1.45],0.9619248808358728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OCLN,Occludin,21237,57,0.72 [0.39-1.35],0.3123016928823213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ODAM,Odontogenic ameloblast-associated protein,23902,60,1.05 [0.69-1.62],0.8116568982551983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OFD1,Oral-facial-digital syndrome 1 protein,20866,52,0.80 [0.49-1.29],0.3553145142336794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGA,Protein O-GlcNAcase,21177,56,0.74 [0.51-1.07],0.1091529864269281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGFR,Opioid growth factor receptor,24399,63,0.44 [0.22-0.89],0.022631968604754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGN,Mimecan,24511,65,1.99 [1.18-3.35],0.0097183678531906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,20866,52,0.81 [0.50-1.31],0.380615071247366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLFM4,Olfactomedin-4,20026,53,0.92 [0.75-1.14],0.4588988252552594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLR1,Oxidized low-density lipoprotein receptor 1,24284,66,1.01 [0.71-1.45],0.9384026282992878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMD,Osteomodulin,24614,65,0.76 [0.46-1.23],0.2584319335954984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMG,Oligodendrocyte-myelin glycoprotein,24399,63,1.01 [0.72-1.41],0.9679239752341392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMP,Olfactory marker protein,20613,54,0.81 [0.45-1.46],0.4754008308495435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPHN1,Oligophrenin-1,21213,57,0.90 [0.71-1.13],0.3622418195879042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPLAH,5-oxoprolinase,20682,56,0.96 [0.66-1.38],0.813164103319463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPTC,Opticin,24399,63,1.12 [0.70-1.80],0.624712359438236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ORM1,Alpha-1-acid glycoprotein 1,21221,57,0.83 [0.23-2.96],0.7691291633102838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSBPL2,Oxysterol-binding protein-related protein 2,21213,57,1.36 [0.86-2.17],0.188330158931503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSCAR,Osteoclast-associated immunoglobulin-like receptor,24538,65,1.81 [0.93-3.53],0.0822722286223914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSM,Oncostatin-M,24380,66,0.95 [0.70-1.29],0.7441222540432306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSMR,Oncostatin-M-specific receptor subunit beta,24631,66,0.60 [0.20-1.75],0.3505845870545289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSTN,Osteocrin,20684,55,1.14 [0.65-2.03],0.6432923728311956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTOA,Otoancorin,20613,54,1.50 [1.13-1.98],0.0049417237540124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD6B,Deubiquitinase OTUD6B,21177,56,0.89 [0.57-1.38],0.5961562816353018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD7B,OTU domain-containing protein 7B,21237,57,0.76 [0.50-1.14],0.1778734100602407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",20682,56,1.04 [0.71-1.51],0.8464627470759192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXT,Oxytocin-neurophysin 1,24755,65,1.06 [0.91-1.24],0.450818797389061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,P4HB,Protein disulfide-isomerase,24375,64,1.06 [0.61-1.87],0.8295833046315622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PACS2,Phosphofurin acidic cluster sorting protein 2,20607,56,0.63 [0.40-0.98],0.0418290716861627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI2,Protein-arginine deiminase type-2,24074,64,1.03 [0.71-1.48],0.8926826813807781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI4,Protein-arginine deiminase type-4,23902,60,1.16 [0.91-1.49],0.2401352636562601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAEP,Glycodelin,24363,64,0.94 [0.80-1.11],0.4775274611523736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,21237,57,1.04 [0.86-1.27],0.6834118705894912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",20866,52,1.20 [0.72-1.99],0.4880461791570663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,24088,63,0.83 [0.55-1.26],0.3784300596842999
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAGR1,PAXIP1-associated glutamate-rich protein 1,20682,56,0.85 [0.46-1.56],0.598299878371007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,20470,53,1.05 [0.64-1.70],0.8551841929662038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAK4,Serine/threonine-protein kinase PAK 4,23939,60,0.81 [0.54-1.20],0.2871618587279647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALLD,Palladin,20661,55,0.81 [0.38-1.69],0.5662909939672872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM,Paralemmin-1,21062,56,1.02 [0.42-2.50],0.9592944408188148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM2,Paralemmin-2,21213,57,0.47 [0.23-0.96],0.0395296579861819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM3,Paralemmin-3,20607,56,1.02 [0.74-1.41],0.9030718911147336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAM,Peptidyl-glycine alpha-amidating monooxygenase,24687,66,1.30 [0.59-2.90],0.5163857878082971
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAMR1,Inactive serine protease PAMR1,24511,65,0.40 [0.19-0.87],0.0210106812688798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAPPA,Pappalysin-1,24074,64,1.04 [0.65-1.67],0.8669127827281301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARD3,Partitioning defective 3 homolog,20866,52,1.03 [0.73-1.47],0.850697381903051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARK7,Parkinson disease protein 7,24511,65,0.89 [0.59-1.35],0.5897048838205026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARP1,Poly [ADP-ribose] polymerase 1,24511,66,0.85 [0.55-1.33],0.4849486498383316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAXX,Protein PAXX,20790,55,0.58 [0.33-1.02],0.0608351999768425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBK,Lymphokine-activated killer T-cell-originated protein kinase,20513,53,1.14 [0.48-2.67],0.7720980962388594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBLD,Phenazine biosynthesis-like domain-containing protein,23939,60,0.66 [0.41-1.06],0.0853790118638341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,21177,56,0.70 [0.28-1.76],0.4457046967674867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCARE,Photoreceptor cilium actin regulator,20613,54,1.03 [0.77-1.37],0.8611811950855035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,20740,55,0.35 [0.18-0.67],0.001467302394931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBP2,Poly(rC)-binding protein 2,21237,57,0.94 [0.67-1.33],0.7276401740641822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH1,Protocadherin-1,24738,67,1.27 [0.50-3.24],0.619668045787102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH12,Protocadherin-12,21237,57,1.28 [0.49-3.30],0.6158867793139583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH17,Protocadherin-17,24532,66,0.87 [0.46-1.65],0.6779637686340877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH7,Protocadherin-7,21177,56,1.51 [0.88-2.58],0.1344591550744206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH9,Protocadherin-9,21177,56,1.77 [0.83-3.80],0.142077880807426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDHB15,Protocadherin beta-15,21153,56,1.68 [1.02-2.76],0.042028740536432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCNA,Proliferating cell nuclear antigen,20513,53,1.03 [0.70-1.51],0.8903317453042155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK7,Proprotein convertase subtilisin/kexin type 7,21153,56,0.98 [0.55-1.73],0.940671815568266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK9,Proprotein convertase subtilisin/kexin type 9,24814,66,0.67 [0.39-1.16],0.155230589573731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCYT2,Ethanolamine-phosphate cytidylyltransferase,21177,56,0.88 [0.63-1.23],0.4573441899931708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDAP1,28 kDa heat- and acid-stable phosphoprotein,21270,57,0.94 [0.73-1.22],0.6426455811511789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1,Programmed cell death protein 1,24705,66,0.88 [0.50-1.54],0.6511347484943749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1LG2,Programmed cell death 1 ligand 2,24399,63,0.84 [0.41-1.74],0.643484635448329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD5,Programmed cell death protein 5,24755,65,0.95 [0.65-1.37],0.7707820514284174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD6,Programmed cell death protein 6,24532,66,1.00 [0.74-1.36],0.9993514219437384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCL2,Phosducin-like protein 2,20513,53,1.19 [0.79-1.80],0.4062335924576729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",20513,53,1.10 [0.72-1.70],0.6567089312742638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",20607,56,1.19 [0.86-1.65],0.2984919736545863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",20790,55,0.86 [0.68-1.09],0.2093454835948208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFA,Platelet-derived growth factor subunit A,24814,66,0.98 [0.72-1.31],0.8695920158699171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFB,Platelet-derived growth factor subunit B,24614,65,0.96 [0.74-1.23],0.7203589497792033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFC,Platelet-derived growth factor C,23935,64,0.65 [0.30-1.44],0.2920619520383167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRA,Platelet-derived growth factor receptor alpha,24532,66,1.05 [0.48-2.29],0.909856882435486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRB,Platelet-derived growth factor receptor beta,24814,66,1.31 [0.70-2.45],0.4050778074725386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA2,Protein disulfide-isomerase A2,20513,53,1.26 [0.72-2.21],0.4224654001166135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA3,Protein disulfide-isomerase A3,20790,55,0.41 [0.13-1.29],0.1282880092425098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA4,Protein disulfide-isomerase A4,21263,58,0.81 [0.53-1.23],0.3197767191622757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA5,Protein disulfide-isomerase A5,20513,53,0.89 [0.56-1.41],0.6252768015844485
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM5,PDZ and LIM domain protein 5,21237,57,0.93 [0.75-1.13],0.4552756870114701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM7,PDZ and LIM domain protein 7,24614,65,0.89 [0.75-1.06],0.1795683949263794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",23935,64,0.85 [0.53-1.37],0.5126983502915617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDRG1,p53 and DNA damage-regulated protein 1,20684,55,0.62 [0.33-1.16],0.1333928978446902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,20513,53,0.66 [0.32-1.39],0.2747959945530913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZD2,PDZ domain-containing protein 2,20607,56,1.27 [0.85-1.89],0.2389923838448307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,20661,55,0.47 [0.23-0.95],0.0363403667709434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEAR1,Platelet endothelial aggregation receptor 1,24814,66,0.76 [0.29-1.95],0.5621999617394862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEBP1,Phosphatidylethanolamine-binding protein 1,24511,65,0.90 [0.62-1.31],0.5904543847576391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECAM1,Platelet endothelial cell adhesion molecule,24511,65,1.49 [0.73-3.02],0.2711079247348049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECR,Peroxisomal trans-2-enoyl-CoA reductase,20682,56,1.24 [0.56-2.72],0.5957287167592378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PENK,Proenkephalin-A,20790,55,1.06 [0.43-2.60],0.8940097874905153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEPD,Xaa-Pro dipeptidase,21274,56,0.50 [0.19-1.30],0.1551776671098404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PER3,Period circadian protein homolog 3,20661,55,0.90 [0.71-1.13],0.3539033816764489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PF4,Platelet factor 4,21133,56,0.89 [0.69-1.16],0.396042428193385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN2,Prefoldin subunit 2,23939,60,0.72 [0.49-1.07],0.1069807055131633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN4,Prefoldin subunit 4,20513,53,0.97 [0.60-1.58],0.9124319206603656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN6,Prefoldin subunit 6,20684,55,1.21 [0.90-1.64],0.2114917588753146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",24365,63,0.84 [0.63-1.12],0.2429592873470433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGA4,Pepsin A-4,21274,56,1.16 [0.77-1.74],0.4889569882738359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",21270,57,0.84 [0.52-1.34],0.4564173540988844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGF,Placenta growth factor,24821,67,1.82 [1.06-3.14],0.0302689663650026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP1,Peptidoglycan recognition protein 1,24677,66,1.26 [0.77-2.08],0.3577314572438638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,21020,58,0.41 [0.19-0.87],0.0197002436255203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP4,Peptidoglycan recognition protein 4,20607,56,0.80 [0.49-1.32],0.384136081514363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGM2,Phosphoglucomutase-2,20684,55,0.65 [0.35-1.19],0.1591374930241023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGR,Progesterone receptor,20661,55,1.01 [0.80-1.28],0.9356362066953996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHACTR2,Phosphatase and actin regulator 2,21237,57,0.90 [0.73-1.12],0.3546770751402283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB1,Pleckstrin homology-like domain family B member 1,21177,56,0.76 [0.46-1.26],0.2890844598812951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB2,Pleckstrin homology-like domain family B member 2,20513,53,1.13 [0.89-1.45],0.3190840699414042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,24363,64,1.01 [0.47-2.17],0.971902244506084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,20790,55,0.67 [0.36-1.23],0.1929260560647407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI16,Peptidase inhibitor 16,21274,56,1.81 [0.63-5.21],0.2700403710901011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI3,Elafin,24174,66,1.14 [0.76-1.69],0.5310730567250006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",21237,57,1.06 [0.77-1.46],0.7247642436236733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIGR,Polymeric immunoglobulin receptor,24210,65,0.91 [0.49-1.67],0.7537226257304624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24511,66,0.71 [0.49-1.03],0.0679822670691119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24511,65,2.34 [1.08-5.08],0.0311954280538693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,20661,55,0.85 [0.52-1.40],0.5311957219804575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRA,Paired immunoglobulin-like type 2 receptor alpha,24511,65,1.08 [0.63-1.84],0.7851040783066324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRB,Paired immunoglobulin-like type 2 receptor beta,24532,66,0.96 [0.66-1.41],0.845882265749186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,20790,55,0.86 [0.59-1.24],0.4139909817412718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PITHD1,PITH domain-containing protein 1,20470,53,0.87 [0.60-1.27],0.4653670788967037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD1,Polycystin-1,21270,57,0.80 [0.30-2.12],0.6578894750229327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD2,Polycystin-2,20607,56,0.89 [0.56-1.40],0.5999965062330435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKLR,Pyruvate kinase PKLR,24528,65,0.96 [0.69-1.35],0.8271993185963524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKN3,Serine/threonine-protein kinase N3,20866,52,0.70 [0.48-1.03],0.0697008060241717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G10,Group 10 secretory phospholipase A2,24363,64,1.10 [0.75-1.59],0.6316892995184585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G15,Phospholipase A2 group XV,24569,66,1.74 [0.79-3.85],0.169976296440781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G1B,Phospholipase A2,24771,66,1.30 [0.77-2.20],0.3185880597213165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G2A,"Phospholipase A2, membrane associated",24456,65,1.07 [0.73-1.56],0.7389533492247418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G4A,Cytosolic phospholipase A2,24614,65,0.86 [0.68-1.11],0.2479843748583116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G7,Platelet-activating factor acetylhydrolase,24511,65,0.72 [0.35-1.46],0.3605853620836685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAT,Tissue-type plasminogen activator,24724,66,0.94 [0.61-1.45],0.7897111978623557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAU,Urokinase-type plasminogen activator,24511,65,1.91 [1.28-2.86],0.0015213750586159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAUR,Urokinase plasminogen activator surface receptor,24330,65,0.91 [0.39-2.09],0.8178933428522861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLB1,"Phospholipase B1, membrane-associated",21213,57,0.81 [0.54-1.21],0.3049255811066492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",20661,55,0.73 [0.37-1.42],0.3486890613459731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",21213,57,0.92 [0.72-1.19],0.5339918618506114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLEKHO1,Pleckstrin homology domain-containing family O member 1,21213,57,0.79 [0.54-1.16],0.2260087549460849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLG,Plasminogen,20741,58,0.56 [0.29-1.07],0.0794063743034213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN1,Perilipin-1,23939,60,0.74 [0.36-1.51],0.4018272371318868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN3,Perilipin-3,24532,66,1.14 [0.70-1.86],0.5861219585867286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLPBP,Pyridoxal phosphate homeostasis protein,24532,66,0.97 [0.70-1.33],0.8336546010768455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLSCR3,Phospholipid scramblase 3,21182,57,0.98 [0.63-1.50],0.913685086233912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLTP,Phospholipid transfer protein,24720,66,1.05 [0.57-1.91],0.884584569310492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC1,Plexin domain-containing protein 1,23935,64,0.99 [0.53-1.85],0.9680537840402818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC2,Plexin domain-containing protein 2,21213,57,0.73 [0.27-1.92],0.5189749903905458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNA4,Plexin-A4,24511,66,0.94 [0.72-1.23],0.6643266929831473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB2,Plexin-B2,24697,66,1.08 [0.43-2.72],0.875918202713981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB3,Plexin-B3,24450,64,0.94 [0.59-1.50],0.7968563229040966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,24438,66,1.10 [0.97-1.25],0.1469164045606129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMCH,Pro-MCH,20607,56,0.73 [0.46-1.16],0.1808149226503402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMM2,Phosphomannomutase 2,20607,56,0.90 [0.58-1.39],0.6295097254127898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMS1,PMS1 protein homolog 1,20684,55,1.10 [0.68-1.80],0.6984346002577946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMVK,Phosphomevalonate kinase,23901,60,0.93 [0.76-1.13],0.4630618127199142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIP,Pancreatic triacylglycerol lipase,21274,56,0.88 [0.58-1.35],0.5647936949777544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP1,Inactive pancreatic lipase-related protein 1,21213,57,1.26 [0.91-1.73],0.1615218985901548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP2,Pancreatic lipase-related protein 2,24494,65,1.04 [0.96-1.13],0.3233172619565392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA1,Paraneoplastic antigen Ma1,20682,56,0.96 [0.61-1.51],0.8531313908851704
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA2,Paraneoplastic antigen Ma2,20613,54,0.87 [0.47-1.61],0.6520638187383132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",24074,64,0.95 [0.79-1.15],0.6183631820550037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL,Podocalyxin,24399,63,0.40 [0.09-1.73],0.2225627281987581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL2,Podocalyxin-like protein 2,24569,66,2.14 [1.00-4.55],0.0486232486577284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POF1B,Protein POF1B,20661,55,0.95 [0.53-1.72],0.8742190414623001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2A,DNA-directed RNA polymerase II subunit RPB1,20661,55,0.36 [0.13-0.95],0.0385090205115662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24399,63,0.96 [0.50-1.83],0.9021310656609024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POMC,Pro-opiomelanocortin,20682,56,1.21 [0.85-1.71],0.2980952410758934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON1,Serum paraoxonase/arylesterase 1,21274,56,1.45 [0.52-4.05],0.4771532492117315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON2,Serum paraoxonase/arylesterase 2,24088,63,1.06 [0.55-2.03],0.8653881987332739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON3,Serum paraoxonase/lactonase 3,24614,65,1.22 [0.52-2.83],0.6481377723488746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POSTN,Periostin,21263,58,1.07 [0.54-2.10],0.850975476554706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPBP,Platelet basic protein,21126,57,0.95 [0.71-1.28],0.7552757879743528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPCDC,Phosphopantothenoylcysteine decarboxylase,24755,65,0.82 [0.52-1.32],0.4217198203265163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIB,Peptidyl-prolyl cis-trans isomerase B,24502,66,0.88 [0.71-1.10],0.2603242313916796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIE,Peptidyl-prolyl cis-trans isomerase E,20866,52,1.07 [0.72-1.61],0.7265384476999719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",21263,58,0.91 [0.60-1.38],0.6604644117979592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPL,Periplakin,20661,55,0.82 [0.36-1.91],0.6525797608839177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1A,Protein phosphatase 1A,23935,64,0.73 [0.34-1.60],0.4341619953891675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1B,Protein phosphatase 1B,20661,55,0.83 [0.52-1.35],0.4587285858316863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1F,Protein phosphatase 1F,21270,57,0.80 [0.50-1.30],0.3663376209704782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPME1,Protein phosphatase methylesterase 1,24399,63,0.89 [0.62-1.28],0.5246547832851287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,21153,56,0.85 [0.62-1.17],0.315655980333982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,24569,66,0.88 [0.70-1.11],0.2918865918912099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,20866,52,0.60 [0.36-1.00],0.0490268257821619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,21237,57,0.97 [0.70-1.35],0.870476521072172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,21237,57,0.93 [0.46-1.87],0.8378407798012096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R2,Protein phosphatase inhibitor 2,24532,66,0.86 [0.66-1.13],0.2884671474249516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R9B,Neurabin-2,24821,67,0.83 [0.66-1.05],0.1154189871056945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,21177,56,0.96 [0.77-1.19],0.6836764777890347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP3R1,Calcineurin subunit B type 1,24363,64,1.13 [0.67-1.91],0.6571106887442788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPT1,Palmitoyl-protein thioesterase 1,20684,55,0.88 [0.60-1.30],0.5318378447436412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPY,Pancreatic prohormone,24443,66,1.03 [0.83-1.27],0.8194685718855153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PQBP1,Polyglutamine-binding protein 1,23935,64,1.14 [0.81-1.60],0.4582409561537639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAME,Melanoma antigen preferentially expressed in tumors,20513,53,1.06 [0.39-2.90],0.910249432877434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAP1,Proline-rich acidic protein 1,21263,58,0.88 [0.47-1.63],0.685075669493655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRC1,Protein regulator of cytokinesis 1,21153,56,1.15 [0.75-1.76],0.5137099055279782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRCP,Lysosomal Pro-X carboxypeptidase,24650,66,0.48 [0.24-0.96],0.0381335324431454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX1,Peroxiredoxin-1,23857,61,0.97 [0.75-1.26],0.8379007341970327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX2,Peroxiredoxin-2,20932,56,1.02 [0.68-1.54],0.918716691538033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",24074,64,0.88 [0.64-1.20],0.4147756989092757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX5,"Peroxiredoxin-5, mitochondrial",24821,67,0.86 [0.64-1.15],0.3119835820554241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX6,Peroxiredoxin-6,24740,66,0.95 [0.66-1.37],0.7888587280927531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PREB,Prolactin regulatory element-binding protein,24074,64,0.81 [0.37-1.81],0.6099695472668234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRELP,Prolargin,24494,65,0.60 [0.28-1.29],0.1887713290148564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG2,Bone marrow proteoglycan,21263,58,1.20 [0.74-1.95],0.4638016427556708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG3,Proteoglycan 3,21263,58,1.18 [0.71-1.96],0.5158638276109819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,24074,64,0.88 [0.58-1.33],0.5357715364384457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,20684,55,1.26 [0.60-2.64],0.5413479946781644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,24532,66,0.89 [0.69-1.15],0.3742213081405753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,21173,57,0.95 [0.70-1.28],0.7332674104982797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKCQ,Protein kinase C theta type,24074,64,0.90 [0.52-1.55],0.6931311432851759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKD2,Serine/threonine-protein kinase D2,20607,56,1.10 [0.67-1.80],0.6972458851159116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKG1,cGMP-dependent protein kinase 1,20790,55,0.91 [0.74-1.11],0.3608034298097325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23935,64,0.94 [0.67-1.30],0.6936697821525082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRL,Prolactin,24755,65,1.24 [0.94-1.63],0.122064253009441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRND,Prion-like protein doppel,21213,57,1.00 [0.60-1.66],0.9960372005860996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROC,Vitamin K-dependent protein C,24549,66,0.77 [0.33-1.79],0.5369960398040599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROCR,Endothelial protein C receptor,20607,56,0.92 [0.44-1.92],0.8236401144177228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROK1,Prokineticin-1,24511,66,0.75 [0.51-1.11],0.1488776089058139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROS1,Vitamin K-dependent protein S,21296,58,0.32 [0.12-0.89],0.0282274874918453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR4,Proline-rich protein 4,20652,55,1.27 [0.90-1.79],0.1790722892415416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR5,Proline-rich protein 5,20661,55,0.85 [0.47-1.54],0.5891067779409265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRRT3,Proline-rich transmembrane protein 3,20682,56,0.88 [0.43-1.81],0.726334891106003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS2,Trypsin-2,24578,66,1.39 [0.95-2.02],0.0881515061520229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS22,Brain-specific serine protease 4,20661,55,1.25 [0.63-2.47],0.5258636125089191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS27,Serine protease 27,24442,66,0.91 [0.52-1.59],0.7398393286247967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS53,Serine protease 53,21213,57,0.46 [0.23-0.93],0.0315054094749669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS8,Prostasin,24404,65,1.14 [0.66-1.96],0.6363639606278855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,23939,60,0.94 [0.77-1.15],0.5723991416652525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTG,Protogenin,24740,66,0.98 [0.41-2.33],0.9547886013712972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTN3,Myeloblastin,23892,65,1.18 [0.77-1.81],0.4549961253946112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRUNE2,Protein prune homolog 2,20866,52,0.48 [0.17-1.41],0.1840551539088401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAP,Prosaposin,21071,57,0.76 [0.30-1.94],0.5686655564096229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAPL1,Proactivator polypeptide-like 1,21177,56,1.86 [1.14-3.03],0.0123833550241923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSCA,Prostate stem cell antigen,21177,56,0.90 [0.82-0.99],0.0296694346700478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSG1,Pregnancy-specific beta-1-glycoprotein 1,24363,64,0.96 [0.79-1.16],0.6794878976345183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSIP1,PC4 and SFRS1-interacting protein,24511,66,0.84 [0.58-1.22],0.3544234799998103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMA1,Proteasome subunit alpha type-1,23935,64,0.87 [0.53-1.43],0.5819072756833077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMC3,26S proteasome regulatory subunit 6A,20513,53,0.79 [0.32-1.94],0.6072619833012118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD1,26S proteasome non-ATPase regulatory subunit 1,21237,57,0.80 [0.47-1.36],0.4029632786489224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD5,26S proteasome non-ATPase regulatory subunit 5,20684,55,1.04 [0.66-1.65],0.8610913823981967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD9,26S proteasome non-ATPase regulatory subunit 9,24399,63,0.95 [0.64-1.42],0.8124667370943148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME1,Proteasome activator complex subunit 1,24336,64,0.82 [0.45-1.50],0.5267187206293555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME2,Proteasome activator complex subunit 2,24251,64,0.97 [0.53-1.78],0.9203981941715086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG3,Proteasome assembly chaperone 3,24511,66,0.90 [0.59-1.39],0.6444998240855622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG4,Proteasome assembly chaperone 4,20661,55,0.83 [0.51-1.35],0.4538663188239634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSPN,Persephin,24511,66,0.90 [0.72-1.14],0.3830866337294729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSRC1,Proline/serine-rich coiled-coil protein 1,23935,64,1.12 [0.78-1.59],0.5472428440761403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,20017,52,0.89 [0.70-1.13],0.3432094509236788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",23939,60,0.64 [0.30-1.36],0.2404306410949545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGDS,Prostaglandin-H2 D-isomerase,24310,66,1.50 [0.73-3.10],0.2701861341890087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGES2,Prostaglandin E synthase 2,20504,53,1.09 [0.68-1.76],0.7094826439974349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGR1,Prostaglandin reductase 1,21270,57,0.72 [0.52-0.99],0.044996737244305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH,Parathyroid hormone,20684,55,0.97 [0.70-1.36],0.8791462080364365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,24511,66,0.68 [0.33-1.41],0.2993001060988118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTK7,Inactive tyrosine-protein kinase 7,23939,60,0.71 [0.39-1.30],0.2652209527916204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTN,Pleiotrophin,24088,63,0.89 [0.57-1.40],0.6179157895135888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTP4A3,Protein tyrosine phosphatase type IVA 3,20661,55,0.49 [0.26-0.90],0.0218808369297827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,24363,64,0.93 [0.70-1.24],0.636301947058407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,24579,65,0.85 [0.68-1.06],0.1580500619865997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,20618,55,0.63 [0.29-1.35],0.2342450433745923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRB,Receptor-type tyrosine-protein phosphatase beta,21270,57,0.71 [0.30-1.67],0.4278973329950454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRC,Receptor-type tyrosine-protein phosphatase C,21263,58,0.59 [0.19-1.82],0.3560049247937114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRF,Receptor-type tyrosine-protein phosphatase F,24814,66,1.67 [0.78-3.59],0.1885183536254051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRH,Receptor-type tyrosine-protein phosphatase H,21177,56,1.03 [0.61-1.74],0.9125524734110207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,21177,56,0.44 [0.11-1.72],0.2365588610986225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRM,Receptor-type tyrosine-protein phosphatase mu,24465,66,0.91 [0.37-2.24],0.8346226800406512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,24273,64,2.58 [1.36-4.91],0.003887814325197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRR,Receptor-type tyrosine-protein phosphatase R,21213,57,1.10 [0.55-2.23],0.7846351617399656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRS,Receptor-type tyrosine-protein phosphatase S,24814,66,0.67 [0.28-1.62],0.3726630873444796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,21270,57,0.96 [0.43-2.12],0.920797378186798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,20790,55,0.87 [0.57-1.34],0.5306994329257069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTS,6-pyruvoyl tetrahydrobiopterin synthase,23831,60,0.67 [0.42-1.04],0.076270397645702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTTG1,Securin,20866,52,0.97 [0.51-1.85],0.9196553011226568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTX3,Pentraxin-related protein PTX3,24511,66,0.88 [0.58-1.33],0.5320977425434648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVALB,Parvalbumin alpha,24646,66,0.94 [0.78-1.13],0.5238866953098144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVR,Poliovirus receptor,24755,65,1.38 [0.78-2.43],0.2653663826519191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXDNL,Peroxidasin-like protein,21153,56,0.90 [0.56-1.46],0.6749568061046736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXN,Paxillin,23939,60,1.10 [0.74-1.64],0.6358605511880091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYDC1,Pyrin domain-containing protein 1,20682,56,1.43 [0.89-2.31],0.1391269626152961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYY,Peptide YY,20607,56,0.89 [0.67-1.19],0.433623034148843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PZP,Pregnancy zone protein,21296,58,1.60 [1.09-2.36],0.0166083412841427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QDPR,Dihydropteridine reductase,24414,66,0.95 [0.57-1.56],0.8302183707898692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QPCT,Glutaminyl-peptide cyclotransferase,24515,66,1.01 [0.43-2.37],0.982964384674087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QSOX1,Sulfhydryl oxidase 1,20854,57,0.84 [0.40-1.76],0.65044318677882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB10,Ras-related protein Rab-10,21270,57,0.90 [0.56-1.46],0.671489692876342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB11FIP3,Rab11 family-interacting protein 3,21270,57,0.90 [0.71-1.13],0.3556248034294627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB27B,Ras-related protein Rab-27B,21270,57,0.90 [0.67-1.21],0.4995849607916512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB2B,Ras-related protein Rab-2B,21153,56,0.96 [0.64-1.45],0.8566786505400537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB33A,Ras-related protein Rab-33A,20607,56,1.00 [0.68-1.48],0.9806626507161628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB37,Ras-related protein Rab-37,24074,64,0.86 [0.64-1.15],0.3156647393162979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB39B,Ras-related protein Rab-39B,20607,56,1.19 [0.97-1.46],0.1033869071168134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,20613,54,1.09 [0.74-1.60],0.6745548448776404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB44,Ras-related protein Rab-44,21153,56,1.22 [0.84-1.79],0.3005985583753471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6A,Ras-related protein Rab-6A,24511,66,1.33 [0.86-2.03],0.1965507761999401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6B,Ras-related protein Rab-6B,23939,60,1.14 [0.74-1.76],0.5549461860500131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEP1,Rab GTPase-binding effector protein 1,20790,55,0.83 [0.59-1.17],0.2863542507663289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEPK,Rab9 effector protein with kelch motifs,23935,64,1.05 [0.74-1.49],0.803218311629404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABGAP1L,Rab GTPase-activating protein 1-like,24074,64,0.89 [0.61-1.29],0.5331848001167749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAC3,Ras-related C3 botulinum toxin substrate 3,20684,55,0.86 [0.55-1.34],0.4968029842898962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD23B,UV excision repair protein RAD23 homolog B,23935,64,0.93 [0.58-1.51],0.778980895283376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD51,DNA repair protein RAD51 homolog 1,20866,52,0.84 [0.48-1.48],0.5527716743407323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALB,Ras-related protein Ral-B,20661,55,1.33 [0.58-3.05],0.4980873782329301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALY,RNA-binding protein Raly,21153,56,1.04 [0.65-1.67],0.8769807590112197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP1,Ran-specific GTPase-activating protein,20682,56,0.85 [0.52-1.39],0.5160275773726111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP2,E3 SUMO-protein ligase RanBP2,20613,54,1.12 [0.53-2.37],0.7747684895238327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANGAP1,Ran GTPase-activating protein 1,23935,64,1.16 [0.79-1.70],0.4548491617707388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAP1A,Ras-related protein Rap-1A,20661,55,0.82 [0.52-1.29],0.392176126277038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAPGEF2,Rap guanine nucleotide exchange factor 2,20866,52,0.77 [0.45-1.32],0.3441635584683099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES1,Retinoic acid receptor responder protein 1,23935,64,1.14 [0.63-2.05],0.6737836433313482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES2,Retinoic acid receptor responder protein 2,24631,66,0.93 [0.58-1.47],0.7473915116390197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASA1,Ras GTPase-activating protein 1,23939,60,1.45 [0.86-2.44],0.1674376463803724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,20513,53,1.05 [0.57-1.93],0.8677467460596823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASSF2,Ras association domain-containing protein 2,23935,64,1.04 [0.72-1.48],0.8485870586709794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBFOX3,RNA binding protein fox-1 homolog 3,21237,57,1.10 [0.57-2.11],0.7743864441775343
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBKS,Ribokinase,23965,64,0.77 [0.49-1.19],0.2342236966220037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM17,Splicing factor 45,21237,57,0.94 [0.67-1.31],0.6994453363005053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM19,Probable RNA-binding protein 19,20607,56,0.94 [0.53-1.66],0.8261123900504811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM25,RNA-binding protein 25,20513,53,0.83 [0.45-1.51],0.5372338262517892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP1,Retinol-binding protein 1,20684,55,1.02 [0.72-1.44],0.9076844385344872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP2,Retinol-binding protein 2,24399,63,1.05 [0.79-1.41],0.7240560671557077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP5,Retinol-binding protein 5,24399,63,0.86 [0.57-1.30],0.4724894323480051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP7,Retinoid-binding protein 7,21177,56,1.08 [0.74-1.59],0.6908653395502289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS,RNA-binding protein with multiple splicing,20661,55,1.13 [0.81-1.58],0.4734274714561568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS2,RNA-binding protein with multiple splicing 2,20682,56,0.94 [0.73-1.22],0.6597070209533076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCC1,Regulator of chromosome condensation,21153,56,0.76 [0.42-1.39],0.3796850389269383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCOR1,REST corepressor 1,24088,63,1.07 [0.68-1.68],0.7693431123077639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,20682,56,1.54 [0.46-5.19],0.4862521986717363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REEP4,Receptor expression-enhancing protein 4,21237,57,0.89 [0.58-1.38],0.6116657778957353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1A,Lithostathine-1-alpha,24361,66,1.33 [0.88-2.02],0.1761592095356187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1B,Lithostathine-1-beta,24814,66,1.35 [0.96-1.88],0.0845413395063423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3A,Regenerating islet-derived protein 3-alpha,24814,66,1.03 [0.72-1.48],0.8704025144901547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3G,Regenerating islet-derived protein 3-gamma,21153,56,0.97 [0.51-1.87],0.9332864783957612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG4,Regenerating islet-derived protein 4,24538,65,1.08 [0.68-1.73],0.7342933136039493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELB,Transcription factor RelB,20661,55,0.98 [0.58-1.66],0.95059993555742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELT,Tumor necrosis factor receptor superfamily member 19L,24511,65,2.10 [0.97-4.56],0.0606989181914377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REN,Renin,24532,66,1.08 [0.79-1.48],0.629778851408509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REPS1,RalBP1-associated Eps domain-containing protein 1,20661,55,0.97 [0.49-1.92],0.9271442872569364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REST,RE1-silencing transcription factor,20513,53,1.35 [0.74-2.48],0.3316681954397246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,24399,63,0.75 [0.42-1.33],0.3249912741354873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RETN,Resistin,24441,66,1.84 [1.26-2.71],0.0018110419807974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REXO2,"Oligoribonuclease, mitochondrial",20607,56,0.84 [0.46-1.54],0.5702698291205035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RFC4,Replication factor C subunit 4,21153,56,0.67 [0.33-1.35],0.2616578508906984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGCC,Regulator of cell cycle RGCC,21237,57,0.76 [0.55-1.06],0.1074926635287401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,20866,52,0.76 [0.46-1.27],0.2956632271045901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMA,Repulsive guidance molecule A,24755,65,1.11 [0.54-2.25],0.7788297016342786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMB,RGM domain family member B,24755,65,2.37 [1.05-5.36],0.0375310617367154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS10,Regulator of G-protein signaling 10,21237,57,0.90 [0.58-1.38],0.6202272201129116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS8,Regulator of G-protein signaling 8,24074,64,0.97 [0.69-1.38],0.8802156641619469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RHOC,Rho-related GTP-binding protein RhoC,24212,64,0.91 [0.76-1.09],0.2914090155126874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RICTOR,Rapamycin-insensitive companion of mTOR,20661,55,1.08 [0.64-1.79],0.7807578002404663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,20790,55,0.55 [0.31-0.97],0.0401799559589045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILP,Rab-interacting lysosomal protein,24677,66,0.86 [0.60-1.23],0.4081454543994386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILPL2,RILP-like protein 2,21270,57,0.91 [0.71-1.17],0.4753733565740899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,20607,56,1.17 [0.84-1.62],0.3528093603642521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN1,Prorelaxin H1,21237,57,0.96 [0.67-1.36],0.7994930274387911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN2,Prorelaxin H2,20758,55,1.06 [0.89-1.27],0.5195446839974872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE1,Ribonuclease pancreatic,21274,56,1.18 [0.39-3.57],0.7632597391769882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE10,Inactive ribonuclease-like protein 10,20682,56,1.44 [0.93-2.22],0.1026332433946594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE3,Eosinophil cationic protein,24406,65,0.98 [0.80-1.20],0.8523383662057492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE4,Ribonuclease 4,20588,56,1.11 [0.42-2.96],0.8344846613797772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE6,Ribonuclease K6,21120,56,1.61 [0.84-3.09],0.1516050232543411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASEH2A,Ribonuclease H2 subunit A,21237,57,1.23 [0.81-1.88],0.3285479693321284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASET2,Ribonuclease T2,24694,66,2.01 [0.93-4.35],0.0762006667243202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF149,E3 ubiquitin-protein ligase RNF149,20682,56,0.99 [0.42-2.38],0.9890959917239918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF168,E3 ubiquitin-protein ligase RNF168,20661,55,0.69 [0.34-1.42],0.3177165235722206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF31,E3 ubiquitin-protein ligase RNF31,20661,55,0.96 [0.47-1.96],0.9018059530947732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF4,E3 ubiquitin-protein ligase RNF4,20866,52,0.87 [0.56-1.35],0.5313318126833864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF41,E3 ubiquitin-protein ligase NRDP1,23935,64,1.03 [0.75-1.42],0.8545677866778802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF43,E3 ubiquitin-protein ligase RNF43,20866,52,0.71 [0.38-1.30],0.2644283892629495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF5,E3 ubiquitin-protein ligase RNF5,20682,56,0.82 [0.58-1.14],0.239079612820977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO1,Roundabout homolog 1,24538,65,0.45 [0.17-1.17],0.1016795571096889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO2,Roundabout homolog 2,24755,65,0.52 [0.20-1.37],0.1860857871741734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO4,Roundabout homolog 4,20682,56,5.20 [1.28-21.15],0.0210989310521813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,24532,66,1.30 [0.64-2.63],0.4739910573354442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RP2,Protein XRP2,24399,63,0.76 [0.44-1.32],0.3291202232006111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPA2,Replication protein A 32 kDa subunit,20661,55,1.32 [0.63-2.78],0.4659627897383878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPE,Ribulose-phosphate 3-epimerase,20866,52,1.04 [0.72-1.49],0.830153859188292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPGR,X-linked retinitis pigmentosa GTPase regulator,20684,55,0.98 [0.51-1.86],0.9477169220603198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPL14,60S ribosomal protein L14,20682,56,1.13 [0.64-2.00],0.6658031121163916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPS10,40S ribosomal protein S10,20607,56,1.53 [1.02-2.30],0.0398613684201953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRAS,Ras-related protein R-Ras,20684,55,0.99 [0.81-1.21],0.9315997152586092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2,Ribonucleoside-diphosphate reductase subunit M2,23935,64,0.78 [0.46-1.32],0.3533577276808417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,23935,64,0.83 [0.60-1.16],0.2716275701676527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRP15,RRP15-like protein,20613,54,1.18 [0.91-1.52],0.2035250370149325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO1,R-spondin-1,24363,64,1.16 [0.62-2.16],0.6377599456253796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO3,R-spondin-3,24740,66,1.11 [0.49-2.49],0.8091426153514303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTBDN,Retbindin,24399,63,0.91 [0.42-2.00],0.8193530228124781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTKN2,Rhotekin-2,20607,56,0.51 [0.25-1.03],0.0590816099920082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",21237,57,0.94 [0.71-1.24],0.660809772524599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4R,Reticulon-4 receptor,24740,66,1.35 [0.76-2.39],0.3069552470995151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RUVBL1,RuvB-like 1,23935,64,0.80 [0.61-1.04],0.0900542930770385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RWDD1,RWD domain-containing protein 1,24755,65,0.83 [0.59-1.17],0.282596395436427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RYR1,Ryanodine receptor 1,20607,56,0.73 [0.30-1.74],0.4714042499179668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A11,Protein S100-A11,24331,65,0.94 [0.59-1.51],0.8068718781355666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A12,Protein S100-A12,24166,62,0.89 [0.66-1.21],0.451190865219941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A13,Protein S100-A13,20661,55,0.58 [0.26-1.29],0.1823961406732466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A14,Protein S100-A14,21237,57,0.83 [0.50-1.40],0.4917272111455546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A16,Protein S100-A16,23902,60,0.96 [0.66-1.40],0.8441130403646595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A3,Protein S100-A3,21153,56,0.60 [0.26-1.40],0.2370867587269285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A4,Protein S100-A4,24569,66,0.81 [0.56-1.18],0.2775930521802949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100G,Protein S100-G,21237,57,1.17 [0.69-2.01],0.5552088701591575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100P,Protein S100-P,24088,63,1.01 [0.68-1.52],0.9423279061101802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAA4,Serum amyloid A-4 protein,21296,58,0.83 [0.51-1.35],0.4430690634525157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAFB2,Scaffold attachment factor B2,21237,57,1.27 [0.56-2.89],0.5747790068565855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAG,S-arrestin,20613,54,0.98 [0.60-1.62],0.950824042098426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAMD9L,Sterile alpha motif domain-containing protein 9-like,24511,66,0.93 [0.69-1.25],0.640707054926503
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAP18,Histone deacetylase complex subunit SAP18,20866,52,1.02 [0.72-1.45],0.9153620815651042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SARG,Specifically androgen-regulated gene protein,21203,57,0.85 [0.68-1.06],0.1447074018316889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SART1,U4/U6.U5 tri-snRNP-associated protein 1,20607,56,0.77 [0.35-1.70],0.5181125619785558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT1,Diamine acetyltransferase 1,20607,56,1.26 [0.83-1.93],0.2801297018963314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT2,Thialysine N-epsilon-acetyltransferase,20866,52,0.94 [0.63-1.40],0.756994857747041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SATB1,DNA-binding protein SATB1,21237,57,1.17 [0.56-2.43],0.6764509869888177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SBSN,Suprabasin,21224,57,1.15 [0.56-2.38],0.7035237020188123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCAMP3,Secretory carrier-associated membrane protein 3,24399,63,0.85 [0.65-1.12],0.2520623518927961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARA5,Scavenger receptor class A member 5,24755,65,1.29 [0.61-2.73],0.5113582859168913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB1,Scavenger receptor class B member 1,23939,60,0.88 [0.56-1.39],0.5887110619307834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB2,Lysosome membrane protein 2,23893,61,1.57 [0.72-3.44],0.2581819675181755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF1,Scavenger receptor class F member 1,24814,66,0.99 [0.59-1.65],0.9737358237814074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF2,Scavenger receptor class F member 2,24755,65,1.36 [0.61-3.04],0.452532021183053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG2,Secretogranin-2,24642,66,1.02 [0.50-2.07],0.9550807632031568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG3,Secretogranin-3,24538,65,1.15 [0.59-2.25],0.6784481073046444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB1A1,Uteroglobin,24547,65,1.05 [0.70-1.59],0.8037560972144198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB2A2,Mammaglobin-A,20607,56,1.03 [0.46-2.30],0.9520265049884292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A1,Secretoglobin family 3A member 1,20790,55,0.90 [0.31-2.62],0.849599898148178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A2,Secretoglobin family 3A member 2,24579,65,1.04 [0.79-1.36],0.7788633975584327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGN,Secretagogin,24074,64,1.39 [0.85-2.27],0.1835811004680702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCIN,Adseverin,20613,54,1.02 [0.72-1.44],0.917838986114329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCLY,Selenocysteine lyase,24677,66,0.67 [0.42-1.07],0.0919899832657746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2A,Sodium channel protein type 2 subunit alpha,20613,54,0.68 [0.35-1.32],0.2579328852735734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2B,Sodium channel subunit beta-2,20684,55,1.17 [0.49-2.78],0.7202116091058044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3A,Sodium channel protein type 3 subunit alpha,20684,55,0.74 [0.34-1.63],0.4599542252207245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3B,Sodium channel subunit beta-3,20613,54,1.62 [1.11-2.37],0.0116925672716361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN4B,Sodium channel subunit beta-4,20682,56,0.99 [0.53-1.85],0.9695607045276132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCP2,Non-specific lipid-transfer protein,23935,64,1.05 [0.81-1.37],0.7019120815330333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCPEP1,Retinoid-inducible serine carboxypeptidase,20610,55,0.91 [0.54-1.53],0.7096927088885769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRG1,Scrapie-responsive protein 1,21270,57,1.24 [0.48-3.19],0.6515441751761386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRIB,Protein scribble homolog,20682,56,1.00 [0.76-1.32],0.9916714106687128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRN1,Secernin-1,24511,66,0.94 [0.64-1.39],0.7675903398612904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCT,Secretin,20684,55,1.42 [0.82-2.46],0.2104965521104972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC1,Syndecan-1,24532,66,1.14 [0.66-1.97],0.6398851652242963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC4,Syndecan-4,24532,66,0.91 [0.56-1.46],0.6827403555583592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDCCAG8,Serologically defined colon cancer antigen 8,21153,56,0.96 [0.77-1.19],0.6921840860633779
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDHB,Succinate dehydrogenase,21177,56,0.91 [0.62-1.35],0.6481189062224706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDK2,Protein sidekick-2,20790,55,1.10 [0.55-2.22],0.7808762026472487
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEC31A,Protein transport protein Sec31A,20682,56,0.89 [0.64-1.23],0.4700834176897278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEL1L,Protein sel-1 homolog 1,20682,56,1.36 [0.78-2.36],0.2750548627251294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELE,E-selectin,24814,66,0.81 [0.53-1.24],0.3331500941993689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELENOP,Selenoprotein P,21296,58,0.87 [0.28-2.74],0.8141779831890608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELL,L-selectin,21296,58,0.89 [0.29-2.69],0.8332397740745031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELP,P-selectin,24578,66,0.88 [0.60-1.29],0.5231447148117543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELPLG,P-selectin glycoprotein ligand 1,24511,66,0.88 [0.38-2.06],0.7685791939192018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3F,Semaphorin-3F,24532,66,0.91 [0.39-2.15],0.8283093602969415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3G,Semaphorin-3G,20790,55,1.50 [0.87-2.59],0.1462004307282263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4C,Semaphorin-4C,24399,63,1.34 [0.70-2.56],0.3705215575055655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4D,Semaphorin-4D,24755,65,1.01 [0.49-2.09],0.975032926241991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA6C,Semaphorin-6C,20661,55,0.92 [0.35-2.42],0.8611782524583937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA7A,Semaphorin-7A,24724,66,1.52 [0.69-3.35],0.3040681009374242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN3,Neuronal-specific septin-3,21237,57,0.84 [0.59-1.20],0.3462076740536643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN7,Septin-7,20866,52,0.88 [0.49-1.56],0.6519100126594596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN8,Septin-8,21165,57,0.71 [0.31-1.64],0.4284037024722806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN9,Septin-9,24399,63,0.79 [0.35-1.77],0.5705243425346004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA1,Alpha-1-antitrypsin,20911,58,0.53 [0.08-3.50],0.5103487545772045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA11,Serpin A11,24814,66,1.22 [0.72-2.08],0.4572138260189201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA12,Serpin A12,23859,64,0.90 [0.71-1.15],0.4062930120215017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA3,Alpha-1-antichymotrypsin,21231,58,0.64 [0.23-1.78],0.3967274343837493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA4,Kallistatin,20910,58,0.39 [0.14-1.12],0.0801785600516989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA5,Plasma serine protease inhibitor,20985,58,0.46 [0.18-1.14],0.0940517359156591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA6,Corticosteroid-binding globulin,21296,58,1.11 [0.27-4.62],0.8852145156816764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA7,Thyroxine-binding globulin,21296,58,0.75 [0.19-2.90],0.6760316595219993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA9,Serpin A9,24277,63,0.81 [0.58-1.12],0.1996112185975012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB1,Leukocyte elastase inhibitor,24435,65,0.99 [0.78-1.25],0.915444508748497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB5,Serpin B5,24088,63,0.86 [0.56-1.32],0.4863905385160221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB6,Serpin B6,24678,65,0.83 [0.57-1.19],0.3109889994087688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB8,Serpin B8,24821,67,1.13 [0.81-1.56],0.4720475729102339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB9,Serpin B9,24363,64,0.86 [0.45-1.65],0.653214239827109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINC1,Antithrombin-III,21254,58,0.38 [0.14-1.02],0.0556587473474656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPIND1,Heparin cofactor 2,21254,58,0.47 [0.19-1.12],0.0874809976729933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE1,Plasminogen activator inhibitor 1,24814,66,0.94 [0.68-1.29],0.6873436615125053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE2,Glia-derived nexin,21270,57,0.96 [0.65-1.41],0.8187288409554553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF1,Pigment epithelium-derived factor,20989,58,0.45 [0.17-1.19],0.1075248245403215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF2,Alpha-2-antiplasmin,20904,58,0.51 [0.08-3.20],0.4693627932746583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPING1,Plasma protease C1 inhibitor,21254,58,0.57 [0.15-2.13],0.4009682371081461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINH1,Serpin H1,20866,52,0.90 [0.73-1.11],0.3291217979183788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI1,Neuroserpin,20744,55,1.44 [0.66-3.15],0.3641124539377127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI2,Serpin I2,21177,56,1.24 [0.81-1.90],0.3253624402307766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,23939,60,1.13 [0.80-1.60],0.4738078454790384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SETMAR,Histone-lysine N-methyltransferase SETMAR,24286,64,0.53 [0.29-0.97],0.0390773119406837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6,Seizure protein 6 homolog,20684,55,1.01 [0.43-2.38],0.9890174422269336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L,Seizure 6-like protein,24569,66,1.38 [0.61-3.10],0.4350165117434356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L2,Seizure 6-like protein 2,24399,63,1.60 [0.65-3.94],0.3089566873912215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SF3B4,Splicing factor 3B subunit 4,24399,63,1.05 [0.78-1.40],0.7584116138652132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP1,Secreted frizzled-related protein 1,24279,64,1.11 [0.66-1.85],0.6946189218192522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP4,Secreted frizzled-related protein 4,20790,55,1.48 [0.79-2.76],0.222455531213778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA1,Pulmonary surfactant-associated protein A1,23935,64,1.02 [0.70-1.49],0.9300769990418892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA2,Pulmonary surfactant-associated protein A2,23935,64,1.66 [1.12-2.44],0.011164157567595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPD,Pulmonary surfactant-associated protein D,24532,66,0.97 [0.70-1.35],0.8540186285502355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SGSH,N-sulphoglucosamine sulphohydrolase,20932,56,0.75 [0.46-1.23],0.2572041794474458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2B3,SH2B adapter protein 3,23935,64,0.92 [0.74-1.15],0.4873269945953365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2D1A,SH2 domain-containing protein 1A,24511,66,0.72 [0.46-1.12],0.1429900953919526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,20613,54,0.96 [0.61-1.51],0.8631358806200665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BP1,SH3 domain-binding protein 1,21177,56,0.74 [0.41-1.34],0.3231424033618103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GL3,Endophilin-A3,20738,52,1.01 [0.74-1.38],0.9492219160448014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GLB2,Endophilin-B2,21213,57,0.91 [0.62-1.32],0.6098717267533221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHBG,Sex hormone-binding globulin,21274,56,1.35 [0.82-2.23],0.2438064314899912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHC1,SHC-transforming protein 1,20513,53,1.06 [0.85-1.32],0.6006765667891335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHD,SH2 domain-containing adapter protein D,20572,56,0.93 [0.66-1.30],0.6648608840513361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHH,Sonic hedgehog protein,20661,55,0.61 [0.32-1.19],0.1464454431429911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHISA5,Protein shisa-5,21263,58,1.20 [0.42-3.44],0.738711704589018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHMT1,"Serine hydroxymethyltransferase, cytosolic",24579,65,0.84 [0.65-1.08],0.1734741169725163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHPK,Sedoheptulokinase,20866,52,1.15 [0.64-2.06],0.6328449445516375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIAE,Sialate O-acetylesterase,24526,66,1.06 [0.67-1.67],0.8067079503065838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC1,Sialoadhesin,24614,65,1.33 [0.79-2.22],0.2827204235143246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC10,Sialic acid-binding Ig-like lectin 10,24511,66,0.90 [0.45-1.79],0.7582387069630787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC15,Sialic acid-binding Ig-like lectin 15,23939,60,0.96 [0.71-1.30],0.8134469121314967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC5,Sialic acid-binding Ig-like lectin 5,24511,65,1.14 [0.91-1.42],0.2650518618687639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC6,Sialic acid-binding Ig-like lectin 6,24740,66,1.32 [0.69-2.52],0.4072377696387442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC7,Sialic acid-binding Ig-like lectin 7,24532,66,0.46 [0.24-0.90],0.022784305871134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC8,Sialic acid-binding Ig-like lectin 8,20682,56,0.69 [0.39-1.22],0.2012271010812719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC9,Sialic acid-binding Ig-like lectin 9,24709,66,0.36 [0.18-0.74],0.0051118581650785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIL1,Nucleotide exchange factor SIL1,20682,56,0.77 [0.31-1.91],0.5798384753128268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,24561,66,1.29 [0.86-1.95],0.2197259007261528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPB1,Signal-regulatory protein beta-1,24443,65,1.44 [0.88-2.35],0.1465695797716699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT1,NAD-dependent protein deacetylase sirtuin-1,20661,55,0.96 [0.71-1.30],0.7796374294019949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT2,NAD-dependent protein deacetylase sirtuin-2,24399,63,0.90 [0.70-1.15],0.3935469216950936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",23939,60,0.55 [0.32-0.94],0.0289062696507821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIT1,Signaling threshold-regulating transmembrane adapter 1,24074,64,0.82 [0.55-1.24],0.3557957109996156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP1,Src kinase-associated phosphoprotein 1,24316,64,0.81 [0.59-1.10],0.1823121478859433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP2,Src kinase-associated phosphoprotein 2,24614,65,0.92 [0.75-1.14],0.4544911270705921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKIV2L,Helicase SKI2W,20607,56,0.53 [0.24-1.19],0.1228850101690121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLA2,Src-like-adapter 2,21237,57,0.91 [0.71-1.15],0.414897770622783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF1,Signaling lymphocytic activation molecule,24074,64,1.19 [0.81-1.74],0.3871965492407277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF6,SLAM family member 6,23935,64,1.38 [0.78-2.44],0.2623069998735053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF7,SLAM family member 7,24511,66,0.85 [0.58-1.24],0.3912174212940768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF8,SLAM family member 8,23935,64,1.25 [0.81-1.94],0.3147476707700204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC12A2,Solute carrier family 12 member 2,20607,56,0.65 [0.23-1.83],0.4129327343910273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC13A1,Solute carrier family 13 member 1,21153,56,1.06 [0.72-1.56],0.7615711133963199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC16A1,Monocarboxylate transporter 1,23939,60,1.11 [0.77-1.59],0.5910038336911658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC1A4,Neutral amino acid transporter A,20684,55,1.31 [0.89-1.92],0.1710099543623499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC27A4,Long-chain fatty acid transport protein 4,23939,60,0.69 [0.45-1.05],0.081754690721691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC28A1,Sodium/nucleoside cotransporter 1,20513,53,0.62 [0.35-1.10],0.10449005283565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC34A3,Sodium-dependent phosphate transport protein 2C,20513,53,1.28 [0.83-1.97],0.2577717170956159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A14,Zinc transporter ZIP14,23939,60,1.43 [0.79-2.58],0.2346303840948353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A5,Zinc transporter ZIP5,24511,66,1.26 [0.88-1.78],0.2040353221063991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC44A4,Choline transporter-like protein 4,20684,55,0.66 [0.39-1.11],0.1187145407463364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC4A1,Band 3 anion transport protein,21263,58,0.83 [0.49-1.43],0.5116844408634209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC51B,Organic solute transporter subunit beta,20607,56,0.94 [0.66-1.34],0.7374777506832716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,20790,55,0.86 [0.63-1.16],0.3202018793037722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,21177,56,0.84 [0.47-1.50],0.5514662361936417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",20513,53,0.94 [0.58-1.52],0.8016745333064843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIT2,Slit homolog 2 protein,23939,60,1.11 [0.73-1.70],0.6299000731952644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK1,SLIT and NTRK-like protein 1,20661,55,0.89 [0.40-2.01],0.7855180406301713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK2,SLIT and NTRK-like protein 2,24740,66,0.89 [0.51-1.55],0.6680059261182868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK6,SLIT and NTRK-like protein 6,24088,63,0.97 [0.50-1.88],0.9394855369168184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLK,STE20-like serine/threonine-protein kinase,20866,52,1.08 [0.79-1.46],0.6342643791535214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLMAP,Sarcolemmal membrane-associated protein,21177,56,1.07 [0.79-1.45],0.6534745533354818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLURP1,Secreted Ly-6/uPAR-related protein 1,21112,57,1.00 [0.50-1.97],0.9900621183508556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD1,Mothers against decapentaplegic homolog 1,23935,64,0.94 [0.72-1.24],0.6731960964947172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD2,Mothers against decapentaplegic homolog 2,21153,56,0.86 [0.59-1.26],0.4523328662693525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD3,Mothers against decapentaplegic homolog 3,21153,56,0.72 [0.42-1.22],0.2252331669103148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD5,Mothers against decapentaplegic homolog 5,24399,63,0.55 [0.20-1.51],0.2442629046537598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMARCA2,Probable global transcription activator SNF2L2,23939,60,0.87 [0.63-1.22],0.4251111372445237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMC3,Structural maintenance of chromosomes protein 3,20513,53,0.71 [0.39-1.27],0.244721277826541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMNDC1,Survival of motor neuron-related-splicing factor 30,21177,56,1.11 [0.79-1.56],0.550650699977332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC1,SPARC-related modular calcium-binding protein 1,24740,66,0.71 [0.37-1.37],0.3067311566793546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC2,SPARC-related modular calcium-binding protein 2,24614,65,1.11 [0.62-1.99],0.728599327304696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD1,Sphingomyelin phosphodiesterase,24636,65,1.43 [0.94-2.18],0.0914038895649814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD3,Sphingomyelin phosphodiesterase 3,20661,55,0.82 [0.49-1.39],0.4620592544749986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,24563,65,1.08 [0.77-1.53],0.6429338095993324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,21153,56,1.32 [1.05-1.65],0.0167666144306084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMS,Spermine synthase,20613,54,0.95 [0.62-1.44],0.7975704323450421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMTN,Smoothelin,21166,57,1.02 [0.78-1.33],0.8828705377983761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP23,Synaptosomal-associated protein 23,24532,66,0.87 [0.69-1.11],0.2571260378909218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP25,Synaptosomal-associated protein 25,20613,54,0.90 [0.51-1.58],0.7097675267394145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP29,Synaptosomal-associated protein 29,24569,66,0.91 [0.72-1.15],0.4172259864016656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAPIN,SNARE-associated protein Snapin,21237,57,0.96 [0.62-1.50],0.8737006348645915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCA,Alpha-synuclein,20790,55,0.98 [0.78-1.22],0.8296217759014435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCG,Gamma-synuclein,24363,64,1.01 [0.72-1.42],0.953359785187025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",20682,56,1.06 [0.49-2.31],0.8750825055607458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNRPB2,U2 small nuclear ribonucleoprotein B'',21213,57,1.28 [0.91-1.81],0.1492867320978443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNU13,NHP2-like protein 1,20607,56,1.01 [0.69-1.48],0.960301276373926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX15,Sorting nexin-15,20790,55,0.79 [0.49-1.28],0.342946147861763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX18,Sorting nexin-18,21177,56,0.90 [0.50-1.62],0.7238241612669553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX2,Sorting nexin-2,21153,56,1.04 [0.76-1.41],0.8141173045708832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX5,Sorting nexin-5,20682,56,1.02 [0.44-2.36],0.9620031031100682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX9,Sorting nexin-9,24532,66,0.91 [0.66-1.26],0.5718372076594012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD1,Superoxide dismutase [Cu-Zn],23982,65,1.08 [0.69-1.68],0.7472051466447606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD2,"Superoxide dismutase [Mn], mitochondrial",24511,65,0.77 [0.42-1.41],0.3907169063625583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD3,Extracellular superoxide dismutase,21274,56,1.02 [0.67-1.54],0.9335445237300576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORBS1,Sorbin and SH3 domain-containing protein 1,21237,57,1.00 [0.52-1.92],0.9903256690577042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORCS2,VPS10 domain-containing receptor SorCS2,23935,64,2.13 [1.13-4.01],0.019019164534768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORD,Sorbitol dehydrogenase,24631,66,0.78 [0.58-1.04],0.0890122551019307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORT1,Sortilin,24504,66,0.74 [0.41-1.33],0.3116496798073145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOST,Sclerostin,24504,66,0.73 [0.41-1.27],0.2637625477765597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,20684,55,0.78 [0.42-1.48],0.4549217575938614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX2,Transcription factor SOX-2,21201,57,0.52 [0.17-1.60],0.2544181401589825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX9,Transcription factor SOX-9,20684,55,1.28 [0.48-3.39],0.6266032895518368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,21237,57,2.04 [1.27-3.29],0.0032794088260596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPAG1,Sperm-associated antigen 1,21237,57,1.04 [0.69-1.58],0.8406087794773933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARC,SPARC,24569,66,0.92 [0.69-1.24],0.5903340253747675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARCL1,SPARC-like protein 1,24496,65,1.07 [0.49-2.34],0.8727068357565932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPART,Spartin,20790,55,0.94 [0.67-1.31],0.7094343832884444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPESP1,Sperm equatorial segment protein 1,21270,57,1.43 [0.64-3.22],0.3870240616877715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK1,Serine protease inhibitor Kazal-type 1,24511,65,1.96 [1.25-3.09],0.0036647119211963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK2,Serine protease inhibitor Kazal-type 2,20790,55,1.12 [0.54-2.34],0.7544211625602939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK4,Serine protease inhibitor Kazal-type 4,24511,66,1.31 [0.94-1.83],0.1080612327237461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK5,Serine protease inhibitor Kazal-type 5,24511,65,1.19 [0.62-2.29],0.5923070114631478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK6,Serine protease inhibitor Kazal-type 6,24740,66,1.28 [0.85-1.93],0.2308861482529989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK8,Serine protease inhibitor Kazal-type 8,20607,56,0.64 [0.28-1.49],0.2994967626034872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT1,Kunitz-type protease inhibitor 1,24424,65,1.44 [0.63-3.31],0.3867837320189169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT2,Kunitz-type protease inhibitor 2,24614,65,0.88 [0.52-1.50],0.6410345131286327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT3,Kunitz-type protease inhibitor 3,21177,56,0.96 [0.81-1.13],0.6259760562109942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPOCK1,Testican-1,24363,64,0.56 [0.23-1.34],0.1933857892407623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON1,Spondin-1,24538,65,0.67 [0.33-1.37],0.2760154385866562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON2,Spondin-2,24418,66,1.79 [0.95-3.38],0.0710445490388318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPP1,Osteopontin,24767,66,0.76 [0.47-1.24],0.276539539784708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",20661,55,1.08 [0.61-1.91],0.7794528257520563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRING1,SREBP regulating gene protein,20513,53,0.99 [0.64-1.54],0.9759741553283584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR1B,Cornifin-B,20866,52,1.23 [0.98-1.56],0.0768506449458613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR3,Small proline-rich protein 3,21213,57,1.07 [0.73-1.57],0.7156582194742832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRY2,Protein sprouty homolog 2,24074,64,0.83 [0.64-1.06],0.1328671945297365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",20613,54,1.30 [0.64-2.66],0.4709715550594077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTLC1,Serine palmitoyltransferase 1,21213,57,1.33 [0.77-2.29],0.3108778840790784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRC,Proto-oncogene tyrosine-protein kinase Src,24528,65,0.97 [0.81-1.16],0.7341812856531862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRP14,Signal recognition particle 14 kDa protein,24399,63,0.95 [0.66-1.36],0.7773744185289436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPK2,SRSF protein kinase 2,24511,66,0.90 [0.69-1.18],0.4570316778442429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPX,Sushi repeat-containing protein SRPX,21270,57,0.93 [0.45-1.93],0.849876591544381
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSB,Lupus La protein,23939,60,0.99 [0.67-1.47],0.9691011191212092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",20661,55,1.13 [0.59-2.17],0.7115228045195869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,24504,66,0.77 [0.63-0.94],0.0101589736692895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,24578,66,0.71 [0.42-1.17],0.1793969962185355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSH3,Protein phosphatase Slingshot homolog 3,20513,53,1.96 [1.03-3.74],0.0408645620259443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSNA1,Sjoegren syndrome nuclear autoantigen 1,21177,56,0.76 [0.45-1.29],0.3150188360367863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST13,Hsc70-interacting protein,20790,55,0.77 [0.48-1.22],0.2658806820314977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",24399,63,1.35 [0.87-2.09],0.1811689034189484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",24814,66,1.58 [0.76-3.27],0.2197489266415915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",20661,55,0.43 [0.18-1.02],0.0548425897217395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAB2,Stabilin-2,21263,58,0.42 [0.24-0.72],0.0017455190125857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAM,Signal transducing adapter molecule 1,21153,56,0.85 [0.41-1.76],0.6614595637142154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAMBP,STAM-binding protein,24316,64,0.94 [0.66-1.32],0.7054785211131039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT2,Signal transducer and activator of transcription 2,20661,55,0.83 [0.59-1.18],0.2995687471885856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT5B,Signal transducer and activator of transcription 5B,24399,63,0.88 [0.75-1.03],0.1087114107385282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,20513,53,1.00 [0.69-1.47],0.980218226763468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC1,Stanniocalcin-1,24755,65,1.46 [0.90-2.37],0.1230265248641451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC2,Stanniocalcin-2,24473,65,1.07 [0.45-2.56],0.8710564751356964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STEAP4,Metalloreductase STEAP4,20613,54,0.95 [0.65-1.37],0.7705643096142637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STIP1,Stress-induced-phosphoprotein 1,24468,65,0.94 [0.67-1.32],0.7196692604684642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK11,Serine/threonine-protein kinase STK11,24088,63,0.96 [0.71-1.31],0.7973084422195263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK24,Serine/threonine-protein kinase 24,23939,60,0.85 [0.58-1.24],0.4020380712034833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK4,Serine/threonine-protein kinase 4,24532,66,0.88 [0.69-1.13],0.3160028050208431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STOML2,"Stomatin-like protein 2, mitochondrial",20513,53,0.96 [0.72-1.28],0.7733373196362747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX16,Syntaxin-16,23935,64,0.90 [0.60-1.36],0.6301321962328266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX1B,Syntaxin-1B,20684,55,1.11 [0.64-1.93],0.7095255532166506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX3,Syntaxin-3,21213,57,1.08 [0.59-1.99],0.8019113038626792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX4,Syntaxin-4,24399,63,0.90 [0.60-1.34],0.6023451922580048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX5,Syntaxin-5,20661,55,0.66 [0.30-1.43],0.2946594972821423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX6,Syntaxin-6,23935,64,0.97 [0.69-1.35],0.8394001779668034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX7,Syntaxin-7,20661,55,0.96 [0.57-1.63],0.8923205407113399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX8,Syntaxin-8,24511,66,0.85 [0.53-1.34],0.4754877818720288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP1,Syntaxin-binding protein 1,21237,57,1.04 [0.75-1.43],0.8195448177091089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP3,Syntaxin-binding protein 3,23935,64,0.74 [0.43-1.30],0.2967583822316505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGP1,SURP and G-patch domain-containing protein 1,21177,56,1.04 [0.57-1.92],0.8950022853751073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGT1,Protein SGT1 homolog,23935,64,1.01 [0.77-1.33],0.9514485511956948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT1A1,Sulfotransferase 1A1,24755,65,0.89 [0.76-1.05],0.165074718863761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT2A1,Bile salt sulfotransferase,24511,66,1.00 [0.68-1.47],0.9879472548862142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF1,Formylglycine-generating enzyme,20661,55,0.86 [0.55-1.35],0.5128595665771107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,24755,65,0.88 [0.59-1.31],0.5307850214611883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUOX,"Sulfite oxidase, mitochondrial",21237,57,0.72 [0.46-1.13],0.1508723965083521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD1,Sushi domain-containing protein 1,24088,63,1.16 [0.73-1.85],0.529459214617161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD2,Sushi domain-containing protein 2,24511,65,0.76 [0.34-1.69],0.5027746529005812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD4,Sushi domain-containing protein 4,21153,56,1.59 [0.99-2.55],0.0533336499244915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD5,Sushi domain-containing protein 5,20680,55,0.94 [0.44-2.04],0.880440570012579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SV2A,Synaptic vesicle glycoprotein 2A,20684,55,1.20 [0.83-1.74],0.3278042591322634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SWAP70,Switch-associated protein 70,21177,56,1.02 [0.51-2.05],0.952743693467579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYAP1,Synapse-associated protein 1,20790,55,0.74 [0.45-1.20],0.2210502430447072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,20613,54,0.67 [0.37-1.19],0.1674585054900924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYT1,Synaptotagmin-1,21213,57,1.41 [0.88-2.26],0.1483228605563376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYTL4,Synaptotagmin-like protein 4,21270,57,0.81 [0.56-1.18],0.265529996537536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,20866,52,0.91 [0.71-1.17],0.4655499512064475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACC3,Transforming acidic coiled-coil-containing protein 3,24399,63,0.84 [0.70-1.01],0.0608468026978428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACSTD2,Tumor-associated calcium signal transducer 2,21752,58,1.57 [0.69-3.54],0.2812266397961052
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TADA3,Transcriptional adapter 3,21153,56,0.60 [0.31-1.17],0.1344128324915219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAFA5,Chemokine-like protein TAFA-5,24399,63,0.85 [0.43-1.68],0.6453678039675985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAGLN3,Transgelin-3,20513,53,1.21 [0.85-1.72],0.2961851210421867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TALDO1,Transaldolase,21193,58,0.71 [0.40-1.25],0.2342680285909312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TANK,TRAF family member-associated NF-kappa-B activator,24074,64,0.80 [0.58-1.11],0.1769453093066898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAP1,Antigen peptide transporter 1,20866,52,0.84 [0.49-1.43],0.5116547671776207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARBP2,RISC-loading complex subunit TARBP2,23939,60,0.87 [0.65-1.17],0.3634174050698957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",20684,55,1.27 [1.00-1.62],0.0539634898639553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",21153,56,1.17 [0.61-2.24],0.6392727245643091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAX1BP1,Tax1-binding protein 1,21213,57,1.02 [0.68-1.52],0.941128532106882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D17,TBC1 domain family member 17,23939,60,1.04 [0.63-1.74],0.8655425882246505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D23,TBC1 domain family member 23,24399,63,0.87 [0.68-1.12],0.2816663500142923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D5,TBC1 domain family member 5,24511,66,1.10 [0.84-1.42],0.4897534352569821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCA,Tubulin-specific chaperone A,20790,55,0.91 [0.67-1.23],0.5248992248889137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCB,Tubulin-folding cofactor B,24363,64,0.88 [0.71-1.08],0.2258343841364013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCC,Tubulin-specific chaperone C,24363,64,0.84 [0.64-1.10],0.2075458372183608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBL1X,F-box-like/WD repeat-containing protein TBL1X,23935,64,1.04 [0.80-1.34],0.7919230673475968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBR1,T-box brain protein 1,20684,55,1.06 [0.63-1.79],0.8164435492196043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1A,T-cell leukemia/lymphoma protein 1A,24318,64,1.02 [0.81-1.30],0.8406151574706454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1B,T-cell leukemia/lymphoma protein 1B,24088,63,0.89 [0.64-1.23],0.4694099973863616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN1,Transcobalamin-1,20852,56,0.85 [0.39-1.87],0.6901429619834476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN2,Transcobalamin-2,24767,66,1.80 [0.96-3.40],0.0679156683847545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCOF1,Treacle protein,21270,57,0.49 [0.20-1.19],0.1174675377642413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCP11,T-complex protein 11 homolog,20866,52,0.72 [0.39-1.34],0.2951835454400997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCTN3,Tectonic-3,21270,57,0.32 [0.14-0.73],0.0064801492735344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDGF1,Teratocarcinoma-derived growth factor 1,23939,60,0.99 [0.84-1.16],0.8610216192656214
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDO2,"Tryptophan 2,3-dioxygenase",20684,55,0.78 [0.37-1.62],0.5028116004157684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDP1,Tyrosyl-DNA phosphodiesterase 1,21153,56,0.97 [0.68-1.37],0.8446927727148703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDRKH,Tudor and KH domain-containing protein,23939,60,0.87 [0.65-1.16],0.3544971303193255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEF,Thyrotroph embryonic factor,20607,56,0.57 [0.29-1.11],0.0989742719546886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEK,Angiopoietin-1 receptor,24569,66,1.25 [0.46-3.37],0.6660733924864002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TERF1,Telomeric repeat-binding factor 1,20661,55,1.57 [0.74-3.33],0.242371602170909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TET2,Methylcytosine dioxygenase TET2,20837,52,0.88 [0.64-1.21],0.4307475602721068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX101,Testis-expressed protein 101,20684,55,1.19 [0.72-1.97],0.4970113234418379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX33,Testis-expressed protein 33,20866,52,1.25 [0.73-2.12],0.4156034554952074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TF,Serotransferrin,21296,58,0.77 [0.25-2.40],0.6502960062231904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFAP2A,Transcription factor AP-2-alpha,20613,54,1.25 [0.88-1.79],0.2132192951597183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF1,Trefoil factor 1,24400,65,1.13 [0.85-1.50],0.4021626869153234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF2,Trefoil factor 2,24579,65,1.06 [0.72-1.58],0.7552686009611926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF3,Trefoil factor 3,24479,65,1.64 [1.24-2.16],0.0005744673865913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI,Tissue factor pathway inhibitor,24418,66,0.43 [0.21-0.87],0.0185585981715718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI2,Tissue factor pathway inhibitor 2,24486,66,1.46 [1.04-2.05],0.0302148343408556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFRC,Transferrin receptor protein 1,24597,66,1.03 [0.59-1.81],0.9163115482209668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TG,Thyroglobulin,21153,56,0.95 [0.75-1.21],0.6785360514053844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFA,Protransforming growth factor alpha,24511,66,0.81 [0.49-1.33],0.4046196319852746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB1,Transforming growth factor beta-1 proprotein,24773,67,1.01 [0.58-1.76],0.975542843913832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB2,Transforming growth factor beta-2 proprotein,21153,56,1.05 [0.66-1.67],0.8470360218403226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBI,Transforming growth factor-beta-induced protein ig-h3,24341,66,0.98 [0.43-2.19],0.952246386734851
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR1,TGF-beta receptor type-1,20661,55,2.09 [1.18-3.69],0.0110218331065913
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR2,TGF-beta receptor type-2,24569,66,1.97 [1.02-3.78],0.0426736119195002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR3,Transforming growth factor beta receptor type 3,24814,66,1.11 [0.54-2.26],0.7783908335468769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGM2,Protein-glutamine gamma-glutamyltransferase 2,24489,66,1.19 [0.89-1.58],0.2428720234517449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGOLN2,Trans-Golgi network integral membrane protein 2,21274,56,0.57 [0.20-1.61],0.2891359563566239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THAP12,52 kDa repressor of the inhibitor of the protein kinase,20470,53,0.99 [0.74-1.32],0.9365239019056578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBD,Thrombomodulin,24532,66,1.75 [0.80-3.82],0.1585517135402766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS2,Thrombospondin-2,24511,65,0.97 [0.52-1.79],0.9154185589969842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS4,Thrombospondin-4,24507,66,1.11 [0.68-1.80],0.6798119640746778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THOP1,Thimet oligopeptidase,24433,66,0.74 [0.36-1.52],0.4094597318039891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THPO,Thrombopoietin,24088,63,0.79 [0.44-1.43],0.4375958202952628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THRAP3,Thyroid hormone receptor-associated protein 3,20607,56,1.06 [0.87-1.30],0.5692230194763239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THSD1,Thrombospondin type-1 domain-containing protein 1,20509,53,0.56 [0.25-1.30],0.1783067135667465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THTPA,Thiamine-triphosphatase,21112,56,0.97 [0.73-1.29],0.8271673823416085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THY1,Thy-1 membrane glycoprotein,24755,65,1.38 [0.61-3.12],0.4438930710282595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIA1,Nucleolysin TIA-1 isoform p40,23823,63,0.90 [0.75-1.09],0.2793616029594253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIE1,Tyrosine-protein kinase receptor Tie-1,24814,66,1.31 [0.73-2.35],0.3724129417183522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",23892,60,0.64 [0.40-1.02],0.0589704321544716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,20866,52,1.16 [0.57-2.35],0.6877651228150957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,24578,66,0.89 [0.53-1.48],0.6427972881476594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,21270,57,0.90 [0.47-1.71],0.7382128603715323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,21213,57,1.00 [0.75-1.34],0.9921295558791812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP1,Metalloproteinase inhibitor 1,24217,65,1.18 [0.54-2.58],0.6828084741544109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP2,Metalloproteinase inhibitor 2,21270,57,0.69 [0.21-2.24],0.5346600361918687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP3,Metalloproteinase inhibitor 3,24614,65,0.95 [0.80-1.12],0.5503918346778515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP4,Metalloproteinase inhibitor 4,24511,65,1.36 [0.80-2.32],0.2512650906494828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TINAGL1,Tubulointerstitial nephritis antigen-like,24458,66,1.60 [0.61-4.20],0.3359445747980959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJAP1,Tight junction-associated protein 1,24569,66,0.87 [0.67-1.13],0.3071710376356842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJP3,Tight junction protein ZO-3,20613,54,0.97 [0.52-1.80],0.9199476644366378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TK1,"Thymidine kinase, cytosolic",20866,52,0.66 [0.33-1.32],0.24592724376569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR1,Toll-like receptor 1,20661,55,0.95 [0.34-2.62],0.922859559462757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR2,Toll-like receptor 2,20866,52,0.37 [0.12-1.17],0.0915683768826909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR3,Toll-like receptor 3,24821,67,0.95 [0.68-1.33],0.7617998553814785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR4,Toll-like receptor 4,20661,55,1.99 [0.92-4.31],0.0819027348338595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,20684,55,0.85 [0.51-1.41],0.5300789894899383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED1,Transmembrane emp24 domain-containing protein 1,20866,52,0.98 [0.60-1.60],0.9455122800857496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED10,Transmembrane emp24 domain-containing protein 10,20607,56,1.10 [0.71-1.72],0.6584191751780624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED4,Transmembrane emp24 domain-containing protein 4,20607,56,0.86 [0.51-1.44],0.5564631627643039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED8,Protein TMED8,21177,56,0.90 [0.70-1.14],0.3802606262477637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM106A,Transmembrane protein 106A,21153,56,1.15 [0.82-1.61],0.4245120491128528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM132A,Transmembrane protein 132A,20682,56,1.18 [0.79-1.76],0.4173663708539837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM25,Transmembrane protein 25,21237,57,1.03 [0.60-1.78],0.914948760747428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMOD4,Tropomodulin-4,20513,53,0.93 [0.49-1.80],0.8401394393091816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11B,Transmembrane protease serine 11B,20613,54,1.20 [0.91-1.58],0.1863158830389643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11D,Transmembrane protease serine 11D,21165,57,1.02 [0.51-2.03],0.9520464970167196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS15,Enteropeptidase,24399,63,1.08 [0.84-1.39],0.5456719431250197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS5,Transmembrane protease serine 5,24239,64,1.18 [0.66-2.14],0.573516140957069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMSB10,Thymosin beta-10,24511,65,0.96 [0.72-1.27],0.7526545704429878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNC,Tenascin,24578,66,0.89 [0.56-1.42],0.6250504916402135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNF,Tumor necrosis factor,24047,63,1.08 [0.61-1.92],0.7838424586817775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,21177,56,0.92 [0.55-1.56],0.7685406517551465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,24074,64,0.53 [0.28-1.00],0.0498884789613335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,20790,55,0.88 [0.58-1.34],0.5597241473686506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,24363,64,1.32 [0.68-2.56],0.4128154523317217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,24363,64,1.04 [0.62-1.74],0.8906848644476716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,24548,66,1.27 [0.81-1.99],0.3008423819767857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,24821,67,1.04 [0.57-1.89],0.8915930226302125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,24494,65,0.80 [0.37-1.70],0.5563740974322391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,24569,66,1.53 [0.84-2.78],0.1639606196683419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24538,65,2.22 [1.34-3.69],0.0019531212967393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24074,64,1.42 [0.84-2.42],0.1894370601617761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,24538,65,1.23 [0.58-2.59],0.5946372280289303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20790,55,1.25 [0.64-2.44],0.5220187627846027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,24740,66,1.58 [0.78-3.22],0.2071158896722306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,24511,65,1.79 [0.84-3.84],0.1321373564867034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,24511,65,1.55 [1.06-2.28],0.0254180920454982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,24755,65,1.71 [0.77-3.80],0.1880022805813543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24773,67,0.87 [0.46-1.64],0.6680906193817158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,24363,64,1.01 [0.67-1.52],0.9605168126129934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24755,65,1.01 [0.61-1.66],0.980013901990053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24363,64,1.47 [0.84-2.56],0.173619156586873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF10,Tumor necrosis factor ligand superfamily member 10,24821,67,0.96 [0.42-2.19],0.9221920424695192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF11,Tumor necrosis factor ligand superfamily member 11,24511,66,0.89 [0.63-1.26],0.5187007683577922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF12,Tumor necrosis factor ligand superfamily member 12,24821,67,0.59 [0.28-1.25],0.1719484670516162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13,Tumor necrosis factor ligand superfamily member 13,24614,65,0.89 [0.38-2.08],0.7964344673211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,24764,66,0.54 [0.22-1.31],0.1738669055538211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF14,Tumor necrosis factor ligand superfamily member 14,24363,64,1.00 [0.68-1.46],0.9970531710049308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF8,Tumor necrosis factor ligand superfamily member 8,21263,58,0.85 [0.42-1.74],0.6580501825176053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNIP1,TNFAIP3-interacting protein 1,21213,57,0.99 [0.75-1.31],0.934460748953946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNN,Tenascin-N,21263,58,0.49 [0.27-0.89],0.0185819224468819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNNI3,"Troponin I, cardiac muscle",24088,63,1.01 [0.77-1.31],0.9621973678429648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNPO1,Transportin-1,20866,52,0.65 [0.30-1.42],0.2806368561045581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNR,Tenascin-R,24363,64,1.38 [0.82-2.33],0.230216156052584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNXB,Tenascin-X,24511,65,0.67 [0.28-1.57],0.3554230464949464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,21270,57,0.92 [0.66-1.28],0.6103968730041175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1,DNA topoisomerase 1,21177,56,1.15 [0.92-1.44],0.2113968945085912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1MT,"DNA topoisomerase I, mitochondrial",20513,53,0.93 [0.53-1.66],0.8156823746396312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP2B,DNA topoisomerase 2-beta,20661,55,0.88 [0.63-1.23],0.4657646012354548
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOR1AIP1,Torsin-1A-interacting protein 1,20682,56,0.97 [0.60-1.56],0.8978984228969605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53,Cellular tumor antigen p53,23935,64,1.05 [0.64-1.74],0.8432266586577866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53BP1,TP53-binding protein 1,20661,55,1.04 [0.78-1.39],0.7955276014782786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53I3,Quinone oxidoreductase PIG3,20332,51,0.73 [0.43-1.23],0.2394335583726655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53INP1,Tumor protein p53-inducible nuclear protein 1,24088,63,1.02 [0.50-2.07],0.9647166300458644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP73,Tumor protein p73,20684,55,1.23 [0.58-2.59],0.5925771463515555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPBGL,Trophoblast glycoprotein-like,20684,55,0.82 [0.41-1.64],0.5829926978006521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPD52L2,Tumor protein D54,20790,55,0.90 [0.71-1.13],0.3648500947339644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPK1,Thiamin pyrophosphokinase 1,21270,57,0.69 [0.28-1.73],0.4329384782543953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPM3,Tropomyosin alpha-3 chain,20607,56,1.07 [0.61-1.88],0.8076697043490981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPMT,Thiopurine S-methyltransferase,23935,64,1.14 [0.86-1.51],0.3717275682501288
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPP1,Tripeptidyl-peptidase 1,24343,65,1.06 [0.66-1.69],0.8207134387244994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP2,Tubulin polymerization-promoting protein family member 2,20866,52,1.12 [0.83-1.53],0.4485205368396169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP3,Tubulin polymerization-promoting protein family member 3,23939,60,0.67 [0.34-1.34],0.255369900091167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPR,Nucleoprotein TPR,20607,56,0.87 [0.50-1.51],0.6183791959258066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPRKB,EKC/KEOPS complex subunit TPRKB,20513,53,1.18 [0.85-1.65],0.322769666700368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSAB1,Tryptase alpha/beta-1,24781,67,1.02 [0.68-1.53],0.9354797125917008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSD1,Tryptase delta,21237,57,0.88 [0.43-1.83],0.7409396539397131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSG1,Tryptase gamma,20661,55,0.63 [0.22-1.79],0.388269299333966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPT1,Translationally-controlled tumor protein,24074,64,0.68 [0.44-1.06],0.092636686661753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF2,TNF receptor-associated factor 2,24511,66,0.95 [0.70-1.29],0.7356894802569172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3,"TNF receptor-associated factor 3, Isoform 2",20661,55,1.15 [0.63-2.10],0.6461653729750687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,20607,56,1.00 [0.59-1.70],0.9984302961389075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,20866,52,0.85 [0.60-1.20],0.3574028421332966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREH,Trehalase,21263,58,0.86 [0.63-1.19],0.3707659022332078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREM2,Triggering receptor expressed on myeloid cells 2,24494,65,0.82 [0.54-1.26],0.3699394168650384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML1,Trem-like transcript 1 protein,21274,56,1.18 [0.74-1.89],0.4810537194714834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML2,Trem-like transcript 2 protein,24511,65,1.67 [0.88-3.17],0.1134742942495322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIAP1,TP53-regulated inhibitor of apoptosis 1,24740,66,0.96 [0.68-1.35],0.8017058826837646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM21,E3 ubiquitin-protein ligase TRIM21,24511,66,0.91 [0.68-1.22],0.5407137600501557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM24,Transcription intermediary factor 1-alpha,20820,52,0.73 [0.47-1.13],0.1615674687838421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,21177,56,0.91 [0.72-1.15],0.4337241918970217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM26,Tripartite motif-containing protein 26,20513,53,0.87 [0.53-1.43],0.5858330116457444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM40,E3 ubiquitin ligase TRIM40,20684,55,0.83 [0.57-1.20],0.3107032070361082
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM5,Tripartite motif-containing protein 5,24511,66,0.92 [0.72-1.19],0.5351727622176208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM58,E3 ubiquitin-protein ligase TRIM58,21153,56,0.99 [0.73-1.33],0.9430424033113656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRPV3,Transient receptor potential cation channel subfamily V member 3,20607,56,1.40 [0.99-1.96],0.0555172339181531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC1,Hamartin,20661,55,0.89 [0.60-1.30],0.5435223357682424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC22D1,TSC22 domain family protein 1,21237,57,0.80 [0.54-1.19],0.2671944396651976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSHB,Thyrotropin subunit beta,24532,66,0.89 [0.67-1.20],0.4546949320494886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSLP,Thymic stromal lymphopoietin,24088,63,0.96 [0.65-1.41],0.8338011253186328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSNAX,Translin-associated protein X,20607,56,1.04 [0.55-1.98],0.900329636769136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN1,Tetraspanin-1,24088,63,1.59 [1.07-2.36],0.020853004667923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN15,Tetraspanin-15,20607,56,0.87 [0.49-1.54],0.638069312634255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN7,Tetraspanin-7,20613,54,1.06 [0.83-1.37],0.6323260245807533
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN8,Tetraspanin-8,21177,56,1.05 [0.81-1.37],0.716728614156801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPYL1,Testis-specific Y-encoded-like protein 1,20661,55,0.71 [0.36-1.42],0.3385578643691345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TST,Thiosulfate sulfurtransferase,23908,60,0.96 [0.71-1.31],0.8183201823742757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTF2,Transcription termination factor 2,20684,55,0.93 [0.54-1.58],0.7794705549940896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTN,Titin,20607,56,1.19 [0.88-1.61],0.2553263363556423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTR,Transthyretin,21064,58,0.71 [0.41-1.22],0.2113162088173881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TUBB3,Tubulin beta-3 chain,20613,54,1.33 [0.54-3.24],0.5329214894633101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TWF2,Twinfilin-2,21263,58,0.83 [0.62-1.13],0.2361546534897952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXK,Tyrosine-protein kinase TXK,20866,52,0.79 [0.51-1.22],0.2950616415495771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXLNA,Alpha-taxilin,24363,64,0.84 [0.66-1.08],0.1672642007507026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXN,Thioredoxin,20919,56,0.81 [0.43-1.51],0.5035487484593132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC15,Thioredoxin domain-containing protein 15,24569,66,1.30 [0.59-2.84],0.513648479530946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC5,Thioredoxin domain-containing protein 5,24755,65,0.82 [0.59-1.14],0.2451751384737417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC9,Thioredoxin domain-containing protein 9,21213,57,0.82 [0.49-1.35],0.4308154053381953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNL1,Thioredoxin-like protein 1,20576,54,0.99 [0.76-1.29],0.9576999458651476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",24511,65,0.78 [0.48-1.25],0.2982690451788785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYMP,Thymidine phosphorylase,24382,66,0.87 [0.63-1.20],0.3898728364045304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRO3,Tyrosine-protein kinase receptor TYRO3,24532,66,0.88 [0.41-1.88],0.7333883235617259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",20661,55,1.58 [1.01-2.47],0.0454187033899352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBAC1,Ubiquitin-associated domain-containing protein 1,24399,63,0.85 [0.44-1.61],0.6108327734331496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2B,Ubiquitin-conjugating enzyme E2 B,21153,56,0.96 [0.40-2.30],0.9312028966119136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,21270,57,0.86 [0.56-1.30],0.4627424806282707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,20661,55,1.16 [0.79-1.70],0.4613098097817097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBQLN3,Ubiquilin-3,20607,56,1.04 [0.61-1.77],0.880019158553692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBXN1,UBX domain-containing protein 1,20790,55,0.81 [0.55-1.20],0.2974295681055952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,21177,56,0.94 [0.79-1.13],0.5088027644289836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UGDH,UDP-glucose 6-dehydrogenase,20607,56,1.04 [0.82-1.32],0.7258156535561574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UHRF2,E3 ubiquitin-protein ligase UHRF2,20607,56,1.05 [0.52-2.13],0.8821932315505664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ULBP2,UL16-binding protein 2,24363,64,1.05 [0.56-1.96],0.880232730607402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UMOD,Uromodulin,24728,66,0.56 [0.39-0.79],0.000993590122036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC5D,Netrin receptor UNC5D,20661,55,0.90 [0.34-2.38],0.8346576295415429
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC79,Protein unc-79 homolog,20513,53,0.93 [0.58-1.50],0.7627079158962906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNG,Uracil-DNA glycosylase,21153,56,0.92 [0.43-1.94],0.8189572317371416
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPB1,Beta-ureidopropionase,21270,57,0.71 [0.53-0.94],0.0189195099276068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3A,Uroplakin-3a,20613,54,0.79 [0.45-1.38],0.4022493775676001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3BL1,Uroplakin-3b-like protein 1,20830,52,0.69 [0.35-1.35],0.2777022550814631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROD,Uroporphyrinogen decarboxylase,20790,55,0.77 [0.53-1.13],0.1776193231500163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROS,Uroporphyrinogen-III synthase,20684,55,1.27 [0.93-1.73],0.1368021651739537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USO1,General vesicular transport factor p115,24399,63,0.86 [0.67-1.10],0.2233689958550684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP25,Ubiquitin carboxyl-terminal hydrolase 25,21153,56,0.87 [0.61-1.23],0.4261243150542828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP28,Ubiquitin carboxyl-terminal hydrolase 28,21213,57,1.12 [0.60-2.10],0.7111773344282105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP47,Ubiquitin carboxyl-terminal hydrolase 47,20607,56,0.96 [0.71-1.30],0.7827409028892681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP8,Ubiquitin carboxyl-terminal hydrolase 8,24088,63,0.92 [0.72-1.16],0.4651288381914085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UXS1,UDP-glucuronic acid decarboxylase 1,23935,64,0.98 [0.64-1.50],0.9338683621960306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP5,Vesicle-associated membrane protein 5,24088,63,0.66 [0.39-1.12],0.1216694257960936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP8,Vesicle-associated membrane protein 8,20661,55,0.89 [0.66-1.20],0.4381471449811036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASH1,Tubulinyl-Tyr carboxypeptidase 1,24511,66,0.86 [0.66-1.13],0.2779337698963631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASN,Vasorin,24109,65,0.92 [0.41-2.07],0.8448685806161892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASP,Vasodilator-stimulated phosphoprotein,21274,56,0.87 [0.61-1.24],0.4425872397464595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,24399,63,0.33 [0.10-1.03],0.0558987670913177
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAV3,Guanine nucleotide exchange factor VAV3,20613,54,0.96 [0.74-1.25],0.7579411587030218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAM1,Vascular cell adhesion protein 1,24549,66,1.80 [0.82-3.97],0.1448413426283096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAN,Versican core protein,24755,65,1.90 [0.92-3.92],0.0806132390243607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCPKMT,Protein-lysine methyltransferase METTL21D,20513,53,0.92 [0.66-1.28],0.6170038269606066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFA,Vascular endothelial growth factor A,24742,67,0.85 [0.57-1.25],0.4027903625916669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFB,Vascular endothelial growth factor B,20661,55,0.74 [0.30-1.86],0.5266006266429097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFC,Vascular endothelial growth factor C,24569,66,1.02 [0.69-1.49],0.9373591153626344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFD,Vascular endothelial growth factor D,24781,67,1.57 [0.85-2.93],0.151942967066411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VGF,Neurosecretory protein VGF,21237,57,0.94 [0.40-2.22],0.8917026520057192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIM,Vimentin,24088,63,1.14 [0.93-1.40],0.2181020917056945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIPR1,Vasoactive intestinal polypeptide receptor 1,20682,56,0.80 [0.27-2.31],0.6734316805639579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIT,Vitrin,21270,57,0.83 [0.42-1.64],0.5905668338430969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VMO1,Vitelline membrane outer layer protein 1 homolog,24399,63,1.22 [0.86-1.74],0.2689663091090331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN1,Pantetheinase,21274,56,0.78 [0.57-1.08],0.1410228262182681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN2,Vascular non-inflammatory molecule 2,24399,63,0.97 [0.60-1.57],0.9091801701969277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS28,Vacuolar protein sorting-associated protein 28 homolog,20866,52,0.99 [0.66-1.48],0.9673147774295991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS37A,Vacuolar protein sorting-associated protein 37A,24399,63,0.77 [0.58-1.03],0.0819788991462521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS4B,Vacuolar protein sorting-associated protein 4B,21153,56,0.98 [0.75-1.28],0.8956512432036448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS53,Vacuolar protein sorting-associated protein 53 homolog,24399,63,0.76 [0.56-1.03],0.080528133428923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10,V-set and immunoglobulin domain-containing protein 10,21153,56,0.82 [0.38-1.77],0.6075127740774132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,20607,56,0.66 [0.29-1.52],0.3294465510853595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG2,V-set and immunoglobulin domain-containing protein 2,21153,56,1.20 [0.76-1.88],0.4309357620744695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG4,V-set and immunoglobulin domain-containing protein 4,24473,65,1.49 [0.84-2.63],0.1695935548327646
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,24496,65,1.03 [0.72-1.46],0.8825455723355579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSNL1,Visinin-like protein 1,21213,57,0.76 [0.53-1.08],0.1294563039349992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM1,V-set and transmembrane domain-containing protein 1,23939,60,1.46 [0.96-2.22],0.074686342082677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2B,V-set and transmembrane domain-containing protein 2B,20866,52,1.09 [0.61-1.95],0.7789772505929701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,24088,63,0.94 [0.63-1.41],0.781342118681712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,24755,65,0.85 [0.62-1.15],0.290146791747472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTCN1,V-set domain-containing T-cell activation inhibitor 1,23935,64,1.70 [0.93-3.12],0.0868672046347639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,20790,55,0.87 [0.55-1.39],0.5656299520546167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA1,von Willebrand factor A domain-containing protein 1,24708,66,0.76 [0.46-1.26],0.2860215351157195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA5A,von Willebrand factor A domain-containing protein 5A,20513,53,0.45 [0.25-0.82],0.0086780388723176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2,Brorin,24275,64,0.93 [0.51-1.67],0.7984878223702521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2L,von Willebrand factor C domain-containing protein 2-like,21237,57,0.69 [0.35-1.39],0.3022773685022171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWF,von Willebrand factor,24814,66,1.08 [0.81-1.45],0.5912757069919712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WARS,"Tryptophan--tRNA ligase, cytoplasmic",24511,65,0.76 [0.43-1.36],0.360334024239995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WAS,Wiskott-Aldrich syndrome protein,24074,64,0.91 [0.65-1.28],0.5920135831764324
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF1,Wiskott-Aldrich syndrome protein family member 1,24088,63,0.92 [0.72-1.18],0.5103382667394208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF3,Wiskott-Aldrich syndrome protein family member 3,23939,60,0.80 [0.63-1.02],0.0740417957958301
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASHC3,WASH complex subunit 3,21213,57,0.98 [0.70-1.37],0.9030852740015426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASL,Neural Wiskott-Aldrich syndrome protein,20661,55,1.12 [0.77-1.63],0.5415198458486137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WDR46,WD repeat-containing protein 46,21153,56,0.94 [0.47-1.87],0.8609590156050737
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC1,WAP four-disulfide core domain protein 1,20738,56,0.97 [0.59-1.60],0.919485817093688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC12,WAP four-disulfide core domain protein 12,24697,65,1.24 [0.88-1.73],0.2151391698652178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC2,WAP four-disulfide core domain protein 2,23230,62,1.77 [0.99-3.18],0.0555536096927832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",24286,64,0.80 [0.46-1.39],0.4295877675414522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",24538,65,1.37 [0.71-2.64],0.3424249344587316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WIF1,Wnt inhibitory factor 1,24740,66,0.98 [0.51-1.87],0.9518666186978996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WNT9A,Protein Wnt-9a,24074,64,0.92 [0.41-2.06],0.8486461357752016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,24363,64,0.83 [0.54-1.26],0.3791463965449958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XCL1,Lymphotactin,24740,66,0.91 [0.60-1.38],0.6573948115360783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XG,Glycoprotein Xg,24686,66,1.72 [0.87-3.42],0.1195801890719342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XIAP,E3 ubiquitin-protein ligase XIAP,20661,55,1.12 [0.73-1.74],0.6014630613506089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XPNPEP2,Xaa-Pro aminopeptidase 2,24569,66,1.05 [0.85-1.31],0.6420983055824727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XRCC4,DNA repair protein XRCC4,23939,60,0.94 [0.50-1.75],0.8392142241884573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YAP1,Transcriptional coactivator YAP1,21213,57,0.61 [0.22-1.68],0.3437564459107963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",21177,56,0.98 [0.82-1.16],0.7891530412843871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YES1,Tyrosine-protein kinase Yes,24399,63,0.83 [0.69-1.01],0.0674501080379316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YJU2,Splicing factor YJU2,21153,56,1.57 [0.79-3.11],0.2014413935448586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YOD1,Ubiquitin thioesterase OTU1,20607,56,0.85 [0.56-1.28],0.4421039328622786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YTHDF3,YTH domain-containing family protein 3,24074,64,0.92 [0.70-1.19],0.5111556020879566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YWHAQ,14-3-3 protein theta,20790,55,0.93 [0.65-1.33],0.696277195553873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YY1,Transcriptional repressor protein YY1,20661,55,0.76 [0.29-1.96],0.5674801866561727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBP1,Z-DNA-binding protein 1,20661,55,0.97 [0.52-1.81],0.9258166311188613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB16,Zinc finger and BTB domain-containing protein 16,23935,64,0.78 [0.56-1.10],0.1590251602671797
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB17,Zinc finger and BTB domain-containing protein 17,24088,63,1.38 [0.89-2.13],0.145945907293778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZCCHC8,Zinc finger CCHC domain-containing protein 8,20607,56,1.19 [0.83-1.70],0.3490896481503664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZFYVE19,Abscission/NoCut checkpoint regulator,21177,56,0.91 [0.68-1.20],0.4979714257471811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZHX2,Zinc fingers and homeoboxes protein 2,21213,57,1.16 [0.64-2.11],0.6276642833242572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF174,Zinc finger protein 174,20661,55,1.33 [0.79-2.26],0.283667840153276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF75D,Zinc finger protein 75D,20866,52,1.32 [0.97-1.80],0.0822194526412693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF830,Zinc finger protein 830,21153,56,1.05 [0.78-1.41],0.7616127713941683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRD2,Protein ZNRD2,21177,56,1.14 [0.79-1.64],0.4722584076656854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,21153,56,0.73 [0.44-1.22],0.2313209602661991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP3,Zona pellucida sperm-binding protein 3,20682,56,1.01 [0.92-1.12],0.8123439782238193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP4,Zona pellucida sperm-binding protein 4,20513,53,1.13 [0.55-2.32],0.7471936983473726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZPR1,Zinc finger protein ZPR1,20613,54,0.73 [0.50-1.06],0.0935721919499884
